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 The meteoric rise in the use of nanotechnology in recent years has 
heralded a new era of engineering. Researchers are now presented with a new sort 
of material which has proven to be more flexible, versatile and stronger than their 
bulk counterparts. Optimism for the potential of nanomaterials is high, with 
funding for nanoresearch set to reach 1 trillion US dollars by 2015. Nanoparticles 
(NPs) refers to particles of a general spherical shape and the diameter of the 
sphere lying in the 1 to 100 nm range. Gold nanoparticles (AuNPs) are just one 
type of such NPs and they possess characteristics that are different from their bulk 
counterparts. While bulk gold is a solid, inert, bright yellow metal, AuNPs can 
exist in a spectrum of colours at different nanosizes, able to form colloids in 
solution and may possess biological reactivity different from bulk gold. 
As with any new and emerging technologies, it is the uncertainties of the 
unknown effects and impact that these NPs will have on the lives of people and 
society. Over the last five years, there has been an exponential increase in 
nanotoxicology studies on the effect of NM on human health and the environment. 
However, the toxicity profiles of many NPs are still yet to be determined. The 
difficulty is compounded by the fact that NPs are available in different sizes, 
shapes, elemental makeup and surface functionalizations. 
 The hypothesis of this study is that AuNPs exert cytotoxic and genotoxic 
effects on lung cells in vitro. This thesis aims to study the effect of AuNPs on 
human lung cells in vitro, investigating various aspects of toxicity including 
uptake of AuNPs into cells, cell viability, DNA damage, presence of oxidative 
stress and proteomic changes upon AuNP treatment. 
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 AuNPs were readily taken up by lung cells but at the same time cause 
large vacuoles to form in the cell cytoplasm. Lung fibroblast cells (MRC-5) 
showed high tolerance for the AuNPs, with no significant cell death but a 
significant decrease of total cell numbers at 1 nM concentration at 72 h treatment. 
Small airways epithelial cells (SAEC) were more sensitive to AuNP treatment and 
showed both a significant increase in percentage of non-viability and decrease in 
total cell count. The decrease in cell count was also reflected in the 
downregulation of various cell cycle genes observed. 
 A variety of methods were used to assess DNA damage. High performance 
liquid chromatograpghy (HPLC), single-cell gel electrophoresis assay (Comet 
assay) and fluorescence in situ hybridizaton (FISH) assay and results consistently 
showed DNA damage was significantly higher in AuNP treated cells compared 
with the untreated controls. Two dimensional gel electrophoresis (2D-GE) was 
done to look at proteomic changes upon AuNP treatment. There were 16 proteins 
which were significantly up or down-regulated in the AuNP treated samples. 
These proteins had functions related to cell cycle or oxidative stress pathways 
which correlates well with our previous data.  
 In the course of the study, it was observed that there was formation of 
autophagosomes in the AuNP treated cells. Western blotting with antibodies 
against autophagosome proteins also verified that autophagy maybe initiated on 
AuNP treatment. This could be a likely explanation for cell survival despite the 
harsh treatment with AuNPs as autophagy could be the cell survival mechanism in 
times of stress. In addition, realtime RT-PCR was performed on some AuNP 
exposed rat lung tissues samples. The results only proved significant for the 
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upregulation of Cox-2 but the fold change trend in the other genes were quite 
consistent with our in vitro data. 
In sum, the presence of AuNPs in the cell is likely to induce generation of 
ROS leading to oxidative stress and subsequent cytotoxicity effects which 
includes lipid peroxidation, DNA damage, differential expression of cell cycle 
genes and various proteins. Oxidative stress also triggers the phenomenon of 
autophagy which could be the cell survival mechanism aiding the cell to escape 
death in times of stress. This could be the reason why, in the face of such 
oxidative damage within the cell, there is still high cell viability upon AuNP 
treatment. These data are useful for the scientific community with intent in 

























 Nanotechnology is said to be the latest frontier for the next generation of 
technological advancements. The word “nano” certainly has been making waves 
not just in the research field but also in popular culture. With funding for 
nanoresearch set to reach 1 trillion US dollars by 2015 (Roco, 2005), there is 
much optimism and expectations of what nanotechnology is able to do.  
 
1.1.1 Definition of “Nano-“ 
 Nanotechnology may be defined as the study of the applications and the 
materials at the nanoscale. The term “nano” is taken from the Greek meaning 
“dwarf” therefore referring to objects of minute proportions (Joachim, 2005). 
“Nano” is also the term used for the metric prefix to denote the billionth of unit 
measurement. Nanomaterials, in this case, may be taken generally to refer to 
materials with at least one dimension in the nanometer (nm) range (Auffan et al., 
2009). Nanoparticles (NPs) are a subset of this group and taken more specifically 
to refer to materials of a general spherical shape and the diameter of the sphere 
lying in the 1 to 100 nm range. In recent times however, the term most likely 
refers to engineered nanoparticles. The term ‘engineered’ is used to denote NPs 
synthesized in a controlled setting as opposed to the free generation of NPs in the 
environment, for example, generation of sparks in metal friction or carbon 
particulates in combustion (Donaldson et al., 2005). Unless otherwised specified, 





1.1.2 A Brief History of Engineered Nanoparticles (NPs) 
 Nanomaterials (NM) have appeared in history through time, even if they 
were not known nor called by that term. Works of art like the Lycurgus Cup 
(www.britishmuseum.com) from the 4th Century Rome that changes colour in 
light (due to the presence of gold nanoparticles) and the beautiful stained glass 
windows of the 16th century (Chang, 2005) are some excellent examples. Even 
these ancient craftsmen were aware that by putting a little silver or gold into glass 
would produce the beautiful shades of colour in stained glass. However, the 
concept for modern day nanotechnology may be recalled from an after-dinner 
speech by Richard P. Feymann to the American Physical Society in 1959 
(Feynman, 1991). It was much later that the term “Nanotechology”, coined by 
Norio Taniguchi in 1974 at the University of Tokyo, was brought into common 
usage. One of the very first NP innovations came in the form of carbon fullerenes 
(C60) known as ‘Buckyballs’ named after the designer R Buckminister Fuller. The 
material is extremely malleable, light and strong, so different from other carbon 
products. It brought about a new wave of innovation and possibilities for the use 
of this novel material. Other carbon nanoproducts were soon developed, the single 
and multi-walled carbon nanotubes, metal and metal oxide NPs and more recently, 
the use of new rare earth elements like ceria and polymer or plastic nano-sized 
particles. 
 
1.1.3 Applications of Nanotechnology 
Currently in the nanotechnology research field, there are many on-going 
research projects investigating novel and innovative ways to apply these new 
nanomaterials for a myriad of technologies ranging from cutting edge spacecraft 
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materials to the everyday household wares and anti-microbial clothings. In the 
biomedical field the list is just as diverse with the these main areas making the 
primary focus of researchers in the life sciences; imaging, drug delivery, 
photothermal therapy and diagnostic applications (Brigger et al., 2002; De Jong 
and Borm, 2008; Kumar et al., 2007; LaRocque et al., 2009).  
 
1.1.4 Gold and Gold Nanoparticles (AuNPs) 
Gold is a bright, shiny, yellowish metal, which is highly valued throughout 
human history across society and period. It has long been considered an inert, 
noble metal with some therapeutic and even medicinal value. Even now, gold salts 
and compounds are still routinely prescribed to treat ailments such as rheumatoid 
arthritis (anti-inflammatory drugs from gold, Auranofin® and Tauredon®) (Shaw, 
1999). As such, gold nanoparticles (AuNPs) are thought also to be relatively 
biocompatible and non-cytotoxic (Connor et al., 2005). Colliodal gold, as AuNPs 
suspended in solution may be called, has properties far different from the bulk 
metal. For example, gold metal, as we know has a shiny yellowish colour but 
AuNPs may appear in red (Figure 1.1, A), blue, green or brown depending on the 
shape and size of the particles (Alkilany and Murphy, 2010). The individual 
particles can only be seen under very high magnification under electron 
microscopy (Figure 1.1, B). These colours come about due to the phenomenon 
called localized surface plasmon resonance (LSPR). It occurs when metallic NPs 
are excited by light, the narrow range of frequencies of incident light induces 
resonant conduction band electron oscillation.  
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Figure 1.1:  Appearance of 20 nm diameter sized gold nanoparticles (AuNP) 
under (A) incident light and (B) transmission electron microscope (TEM). The 20 
nm sized AuNPs appear wine red in colour and the solution is clear without any 
particulates in suspension. Under high magnification in TEM, the AuNPs may be 
seen to have a generally spherical shape and the particles of an average diameter 
length of 20 nm. Scale bar  =  100 nm. 
 
Faraday was one of the earliest scientist to describe this gold solution 
(Edwards and Thomas, 2007), a form of gold derived from citrate reduction of 
gold salts with yet undetermined biological properties. In the modern biomedical 
sciences, AuNPs are being developed as novel gene and drug delivery agents 
(Everts et al., 2006; Paciotti et al., 2004), transfection vectors (Noh et al., 2007), 
agents in imaging techniques (Kumar et al., 2007) and photothermal therapy 
(Wang et al., 2010a). Many researchers have commented that AuNP is one of the 
material of choice in biomedical research as they are considered to be relatively 
biocompatible, versatile and easy to synthesize (Goodman et al., 2004). 
 
1.2 Impact of Nanoparticles on Safety and Health 
Although nanotechnology has brought about new possibilities for many 
novel technologies, toxicity and safety issues always emerges as a concern. As 
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with any new and emerging technologies, it is the uncertainties of the unknown 
effects and impact that these NPs will have on the lives of people and society.  
As more nanomaterials products are developed and brought into regular use, there 
is an increasing risk of exposure to these nanomaterials in workplace as well as 
from environmental exposure. Over the last five years, there has been an 
exponential increase in nanotoxicology studies on the effect of NM on human 
health and the environment. Recent research has brought to light concerns over 
the safety of use of these nanomaterials (Oberdorster et al., 2005a) and also the 
long-term adverse effect of their use. The environmental impact of nanomaterial 
exposure has also been carefully studied alongside toxicological studies on NP 
impact on human health (Donaldson et al., 2004).  
 
1.2.1 Hazards and Risks 
‘Hazard’ may be defined as the source of harm or the inherent toxicity of a 
substance while ‘risk’ is the potential of the hazard to cause harm (Hristozov, 
2009; Warheit et al., 2008). Therefore, this gives rise to the more pertinent 
questions should be that are NPs hazardous and what are the risks of NP toxicity? 
While it may be currently challenging to address these issues fully, it is essential 
to first address some basic questions regarding the risk framework. 
There is also the ‘known risks’ and ‘potential risks’. The former refers to 
cases whereby there is an established cause and effect to the hazard and toxicity 
and prevention is possible if the cause is removed. However, ‘potential risk’ 
comes in when the relationship between the cause and effect is not well known 
and there is an air of suspicion rather than awareness used to deal with the hazard. 
This is very much the case for NPs at this point in time.  
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Risk assessment for NPs are recommended to follow the four stages of risk 
assessment for chemicals (Hristozov, 2009): 
(1) Identify hazards 
(2) Assess dose-response 
(3) Evaluate exposure  
(4) Characterize risk 
In this study, points (1) and (2) would be more pertinent in this study with regards 
to AuNPs in an in vitro setting. These are still early days as more research is 
generated and more is known about the limitations and extent of NP toxicity, then 
more thorough risk assessment and toxicity profile for NPs will be required. 
Research on NP safety, particularly those dealing with respiratory 
concerns really developed from air particulate studies by Oberdorster and 
colleagues (Oberdorster et al., 2005b).  As such, impact of NPs on lung and 
respiratory diseases is one of the primary focuses of research in NP toxicity 
studies. There are several areas of concern regarding pulmonary health since the 
airways are also considered the first line of exposure to the environment and 
atmosphere. The cells lining the airways are the body’s first line of defence 
against pollutants. 
 
1.2.2 The Lung as Main Route of Entry 
The human lung is a vulnerable organ for nanotoxicity as there is 
approximately 2300 km of airways and 300 million alveoli, giving rise to a large 
surface area which is in contact with the environmental atmosphere and the 
ultrafine particulate pollutants present in it (Hoet et al., 2004). Even though nasal 
cilia and mechanical actions such as coughing could trap and expel larger size 
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particles from the airways, they may not be so effective with NPs. Their small size 
allows them to easily invade into the deep air spaces of the alveoli and readily 
taken up by lung epithelial cells and fibroblasts. 
In addition, there is just 0.5 micron of a single cell layer that separates 
inhaled air from the blood capillaries, which makes for a poor barrier against the 
entry of NPs from the alveolar lumen into the blood circulation. Because much of 
the concern regarding exposure to NP toxicity comes from either accidental or 
indirect release of NP as aerosols into the atmosphere during the manufacturing 
process, the respiratory system and lungs invariably becomes the first line of 
contact and main route of entry of atmospheric NP into the body. 
 
1.2.3 Translocation and Deposition of Nanoparticles in the Body 
After the respiratory system is exposed to ultrafine particles (UFPs), 
translocation to other organs is rapid and the particles may appear in the liver, 
heart and nervous system in a matter of hours (Brown et al., 2002; Kreyling et al., 
2002; Oberdorster et al., 2004). Stuart suggests that there are three main 
mechanisms of particulate matter (PM) deposition in the lungs, which are 
impaction, sedimentation and diffusion (Stuart, 1984), and for PM > 100µm, 
particles in the range of 0.1 µm and 50 µm, and ultrafine particles respectively.  
UFPs deposit themselves in the respiratory system by diffusional displacement. 
This deposition is dependent on the size of particles and this may occur in the 
nasal cavity, conducting airways, and the alveoli. Larger particles (with diameter 
greater than 1 µm) get deposited on the epithelial surface. These may however be 
cleared by bodily responses like coughing, or by mucociliary transport, and/or 
phagocytosis by macrophages (Gehr et al., 2000; Geiser et al., 2003; Schurch et 
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al., 1990). Conversely, UFPs seem to penetrate these boundary membranes 
rapidly (Geiser et al., 2003; Oberdorster et al., 2004; Schurch et al., 1990). 
Besides, there have been in vitro studies to prove that UFPs induce oxidative 
stress and mitochondrial damage via penetration into the mitochondria of 
epithelial cells; and that UFPs are more potent than PM2.5 and PM10 (Li et al., 
2003). 
 
1.2.4 Inflammation in Pulmonary Toxicity  
Among all the adverse effects caused by NP, inflammation appears to be 
the common factor. In fact, different types of NPs can induce different 
inflammatory reactions. For example, SWCNT (single-wall carbon nanotubes) 
were found to be more toxic in comparison to other NPs with regards to inducing 
dose-dependent epithelioid granuloma as well as interstitial inflammation in the 
lungs (Lam et al., 2004). The oxidative stress leads to activation of different 
transcription factorswhich subsequently induces up-regulation of pro-
inflammatory protein synthesis (Schins et al., 2000). Pulmonary inflammation 
may also result in changes in membrane permeability, which in turn can lead to 
particle distribution extending beyond the lung and indirectly affecting 
cardiovascular performance (Harder et al., 2005; Zhu et al., 2009). Moreover, NPs 
have the potential to enter the brain (Oberdorster et al., 2004) and blood 
circulation (Nemmar et al., 2001) and subsequently other major organs. However, 
as inhalation was not used as a mode of delivery of the NPs to the lungs in these 
animal studies, the relevance of these observations in humans is yet to be 
established. Moreover, for a clearer understanding of their potential for such 
effects, areas of study must encompass firstly, particle characteristics and dose 
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effects that influence the translocation processes and secondly, clearance 
mechanisms and kinetics. 
 
1.3 Nanotoxicology 
The study of the toxicity of NPs is a new and developing field. Only in the 
last three years or so has the number of published papers on the topic risen 
exponentially (Pumera, 2011). However, the toxicity profiles of many NPs are 
still yet to be determined. The difficulty is compounded by the fact that NPs are 
available in different sizes, shapes, elemental makeup and surface 
functionalization. However, there are a few factors that have been identified or 
predicted to be affecting NP toxicity in vitro and in vivo. 
 
1.3.1.1 Intrinsic Toxicity of Nanoparticles 
Literature on particulate matter (PM), especially work on PM with less 
than 10µm diameter (PM10), formed the basis for extensive studies into 
nanotoxicology and are the first proponents of the “NP hypothesis” (Borm et al., 
2006). The hypothesis suggests that NPs are the main drivers of pro-inflammatory 
effects in cases of PM toxicity because they are the main particulate type found in 
PM mixtures, thus implying that NPs may possess some intrinsic toxicity, 
meaning that the toxic effects could be attributed to NPs alone and not due to 
other external factors such as surface functionalizations.  
The small size of NP suggests a high surface area per unit mass, and from 
particle toxicology this is correlated to higher reactivity (Donaldson et al., 2005). 
In addition, the larger the surface area also leads to a higher possibility for the 
formation of free radicals (i.e, superoxide anions or hydroxyl radicals), which 
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consequently drives oxidative stress. This is especially so for metal based NPs and 
forms the underlying mechanism responsible for inflammatory responses to NP 
exposure (Byrne and Baugh, 2008). Certain heavy metal NPs like cadmium 
quantum dots (QDs) and silver NPs (AgNPs) are also known to be highly toxic 
(Hsin et al., 2008; Lovric et al., 2005). It should be noted that though most NP 
agglomerate readily, this agglomeration only reduces particle number without 
affecting the total surface area. Therefore while size does play a big part in 
particle toxicity, the shape of the NP as well as the surface modifications may also 
affect the uptake and risk of toxicity (Tsuji et al., 2006; Warheit et al., 2005).  
 
1.3.2 Size of Nanoparticles 
Size of the NPs affects the biodistribution and translocation of the NPs 
into the respiratory tract. Generally, the smaller the NP size, the easier it is to 
reach the deep air spaces in the lungs. In a model of the human respiratory system 
developed by the International Commission on Radiological Protection (ICRP), 
NPs in the 10-30 nm range showed the highest deposition fraction in the lung 
alveoli (Oberdorster et al., 2004). Hence, the 20 nm diameter size of the AuNPs 
used in this study is also of practical importance and more accurately reflect the in 
vivo situation.  
Many studies have attributed the size of the NPs to play an important role 
in regards to toxicity. The smaller the particle, the greater the surface area is to 
volume ratio will be and hence there may be a greater likelihood for biological 
reactions to take place. It is generally considered that 50 nm size particles are 
good enough to be easily taken up by cells (Alkilany and Murphy, 2010), particles 
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with diameters 20 nm and below start to display some toxic effects (Chen et al., 
2009) and those smaller than 2 nm show the greatest toxicity (Pan et al., 2009). 
 
1.3.3 Elemental Constituents of NPs 
Some elements are also intrinsically more toxic than others.  Heavy metals 
even in their bulk form, are already well known to be toxic in the human body. 
The metallic nature of the metal derived NPs and the presence of transition metals 
encourages the production of reactive oxygen species (ROS) leading to oxidative 
stress (MacNee and Donaldson, 2003). Elemental metal NPs like cadmium 
(quantum dots) and silver are known to induce oxidative stress and apoptosis in 
various cell types (Arora et al., 2008; Kirchner et al., 2005) as well as in vivo 
(Bar-Ilan et al., 2009). Silver nanoparticles (AgNPs) causes decreased 
proliferation and DNA damage in human cells (Asharani et al., 2009a; Asharani et 
al., 2009b). Cadmium NPs can also induce oxidative stress, genotoxicity (Choi et 
al., 2008; Gagne et al., 2008; Li et al., 2009b) and lung inflammation in rats 
(Jacobsen et al., 2009).  
 
1.3.4 Surface Functionalizations 
The addition of functional groups on NPs adds on another dimension to 
the diversity of NPs. These modifications can also change the behaviour or 
properties of the NPs.  Adding amine tags on AuNPs can make them less toxic 
than the naked NPs (Lee et al., 2008; Takahashi et al., 2006). Conjugation with 
immunogenic peptides can also ameliorate toxicity of AuNPs (Chen et al., 2009). 
Opsonization, in this case it is the coating of NPs with a protein (for example, 
fibronogen, serum or albumin), makes the NPs more attractive to be endocytosed 
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by cells or phagocytes (Nativo et al., 2008) thereby increasing the risk of NP 
toxicity within the cell. Applying different charges on the NP surface can also 
affect hydrophilicity of NP and subsequently the ease of uptake into the cell and 
type of cell death as well (Schaeublin et al., 2011).  
 
1.4 Manifestations of Nanoparticle Toxicity 
1.4.1 Cytotoxicity  
The most fundamental issue of any toxicity study is the question: does the 
drug (or NP in this case) cause cell death and to what extent? Some studies report 
an adverse reaction to AuNPs (Cho et al., 2009) while others showed little or 
limited toxicity (Connor et al., 2005). 
Many assays and experimental techniques have come out of the need to 
first measure the cell viability upon treatment of NP. Common assays in use are 
the colorimetric assays like MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) and MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) assays which give a 
colored formazan product upon reaction with reductase produced by living cells. 
The intensity of the dye is then measured with a spectrophotometer to determine 
the number of viable cells. The lactate dehydrogenase (LDH) assay is another 
popular cell viability test. LDH secretion into media is a direct measurement for 
non-viable cells due to disruption of the cellular membrane in dead cells (Kim et 
al., 2009). Another relatively simple method is to stain cells with propidium 
iodide (PI) for flow cytometry. Cells are counted and sorted whether they pick up 
the PI dye (for dead cells) or not (for viable cells). Microscopy options are also 
available for probing with fluorescence tagged cell cytoxic biomarkers. Lastly, the 
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trypan blue cell exclusion assay, which is based on the uptake of the trypan blue 
dye by dead cells,but not live cells. Cell counting and scoring of dead-live cells 
are done by hand and thus this method is more laborious and time-consuming than 
the others.  
Although these colorimetric and fluorimetric assays are useful and 
relatively simple to do, there are some disagreements on whether they are suitable 
to be used for all NPs (Worle-Knirsch et al., 2006). In some circumstances, the 
NP may interfere with the colorimetric readings leading to false positives and 
inaccurate results. AuNPs for example are able to absorb visible light (in the 350 
nm to 750 nm spectrum) and have a range of absorbance wavelengths from 450 
nm to about 550 nm, which could interfere with MTT and MTS assays. Moreover, 
it is also possible for AuNPs to quench fluorescent signals (Willets and Van 
Duyne, 2007). Caution is advised when performing such measurements; therefore 
in this study the trypan blue cell viability assay method was selected as the 
preferred method for assessing cell viability due to the interference of AuNPs in 
the colorimetric detection readings. 
 
1.4.2 Oxidative Stress 
The body system is constantly in a state of homeostasis and oxidative 
stress is simply a result of a disruption in that carefully maintained state of 
equilibrium. Exposure to NPs is known to cause an increase in reactive oxygen 
species (ROS). If the more ROS produced is more than what the system can cope 
with, it tips the balance towards a state of oxidative stress. ROS generation by 
NPs could be due to three factors as outlined by Knaapen et al. (Knaapen et al., 
2004):  
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(i) active redox cycling on the surface of NPs, particularly the metal-based NPs 
(Fahmy and Cormier, 2009; Lopez and Norskov, 2002), 
(ii) oxidative groups functionalized on NPs and  
(iii) particle-cell interactions, especially in the lungs where there is a rich pool of 
ROS producers like the inflammatory phagocytes, neutrophils and macrophages.  
Overproduction of ROS activates a series of cytokine cascades, which includes an 
upregulation of interleukins (IL), kinases and tumor necrosis factor α (TNF-α) 
pro-inflammatory signaling processes as a counter reaction to oxidative stress 
(Fujii et al., 2001) (Figure 1.2).  
 
 
Figure 1.2: Possible mechanistic pathway for pulmonary toxicity induced by 
exposure to NPs. Exposure to NPs may lead to oxidative stress due to increased 
production of reactive oxygen species (ROS) and downstream signaling responses 




Studies on titanium oxide NPs (TiO2NPs) and C60 fullerenes have shown 
that these NPs cause an up-regulation of pro-inflammatory enzymes such as IL-1, 
TNF-α, IL-6, MIP and MCP in rodent lungs (Park et al., 2010; Park et al., 2009). 
When receptor tyrosine kinases, mitogen-activated protein (MAP) kinases and 
transcriptional factors such as nuclear factor (NF)-κB and STAT-1 are activated, 
the genes involved in inflammation and fibrosis are transcribed and expressed 
(Bonner, 2002, 2007). Stimulation of interleukin IL-1β and TNF-α heightens 
expression of pro-fibrotic proteins. More specifically, the latter is known to up-
regulate the production of transforming growth factor (TGF)-β1, which 
potentiates collagen deposition by fibroblasts (Sime et al., 1998) while the former 
is associated with expression of platelet-derived growth factor (PDGF)-AA and its 
receptor, PDGF receptor-α, which increases proliferation of myofibroblasts, and 
subsequently promotes the formation of immature collagenous tissue within the 
lung (Bonner, 2002). 
The harmful effects of ROS and oxidative stress may be manifested 
through damage of DNA, oxidations of polydesaturated fatty acids in lipids and 
oxidations of amino acids in proteins (Limbach et al., 2007). Although these 
effects may be seen in varying degrees of severity in several nanomaterial studies, 
there is still no conclusive data for AuNP induction of oxidative stress.  
 
1.4.3 Nanogenotoxicity 
Nanogenotoxicity is another sub-branch in the field of nanotoxicity 
research which studies the genotoxic effects of nanomaterials both in vitro and in 
vivo. There is also an increasing amount of literature on this subject in recent 
years (Singh et al., 2009). Although there are no conclusive links with NP-induced 
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genotoxicity and lung cancer from past epidemiological studies and in vivo rodent 
experiments, some researchers have pointed out that long term inflammation and 
oxidative stress present in tissue environment eventually induces DNA damage in 
cells and tissues (Singh et al., 2009). This is of particular concern especially if the 
NPs continue to generate an oxidative environment in the cell that causes gene 
mutations/deletions. This can lead to larger scale mutagenesis and carcinogenicity, 
and subsequently development of tumours and cancer (Knaapen et al., 2004). 
Already, more evidence has emerged regarding the DNA damaging properties of 
certain classes of NPs, particularly the metal based NPs like AgNP, silica dioxide 
(SiO2) NPs and titanium oxide (TiO2) NPs (Asharani et al., 2009b; Schins et al., 
2002; Trouiller et al., 2009).  
One proposed mode of action for NP genotoxicity is the ability of 
signaling peptides functionalized on carbon nanotubes (CNTs) that enables them 
to enter the nucleus via nuclear pores (Pantarotto et al., 2004). It has yet to be 
shown that such CNTs are able to cause genotoxicity but it is thought that there is 
a greater risk of genotoxicity when NPs are able to get in close proximity to DNA. 
There are other different mechanisms that may be specific to the elemental 
composition and shape of NPs, which could lead to DNA damage such as single-
strand breaks, double-strand breaks, DNA deletions and genomic instability in the 
form of increase in 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels (Falck et al., 
2009; Yang et al., 2009). While some researchers have found that exposure to 
TiO2NPs in rats could cause formation of lung granulomas (Park et al., 2009), 
others have cautioned that appearance of granulomas does not necessarily mean 
that the tissue is cancerous as most tissues probably remain benign (Muller et al., 
2009). As most reports regarding NP toxicity reports have been deduced from 
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experiments involving UV or irradiation exposure, the clinical relevance of these 
mechanistic experiments are questionable (Roller, 2009). Nevertheless, a recent 
study has shown that TiO2 NPs may be able to switch on regressive cancer cells. 
Pre-implantation of TiO2NP in vivo and later co-culturing a regressive cancer cell 
line over the implantation site, was found to induce tumorigenic characteristics 
such as upregulation of tumor growth factor beta (TGF-β) and prostaglandin E2 
(PGE2) (Onuma et al., 2009). According to Mroz and colleagues, long term 
exposure to NPs, like nanoparticulates in PM10, can displayed genome instability 
under comet assay analysis, alter cell cycle kinetics in flow cytometry and induce 
protein expression of p53 and DNA repair related proteins, all of which are seen 
in irradiated cells (Mroz et al., 2008). Hence they postulate that these NPs could 
activate signaling pathways similar to ionizing radiation, resulting in 
carcinogenesis as a consequence of errors in DNA replication. DNA repair in 
ionizing radiation requires activation of ATM (Ataxia telangiectasia mutated), a 
serine/ threonine-specific kinase and subsequently, the ubiquitylation signaling 
cascade and sumoylation pathway. However, as cancer is a multifactorial disease, 
there may not be only one defining cause for an individual to develop neoplasm. 
Instead it may be more pertinent to place the risk factor from NP exposure 
alongside other risk factors for cancer as well. 
 
1.4.4 Autophagy 
Autophagy in the Greek simply refers to “self” (auto) and “eating” 
(phagy), may be described as a process of degradation of cellular components in 
the lysosomal pathway. The function of autophagy is still not clearly understood 
but it is generally thought to be a natural process to maintain cellular homeostasis 
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as well as a cellular response to metabolic stresses like starvation, infection or 
disease progression. It was only fairly recent that autophagy was recognized as a 
type II programmed cell death and a cell survival mechanism in times of stress 
(Kiffin et al., 2006; Tsujimoto and Shimizu, 2005). It is found to be implicated in 
several diseases and cellular stresses such as starvation, development, innate and 
adaptive immunity, aging, tumorigenesis and stress-induced differentiation 
(Galluzzi et al., 2008). This phenomenon is really a multi-faceted process. At the 
basal level it helps to maintain cell homeostasis, in the recycling and renewal of 
old cell organelles (Ebato et al., 2008). Under acute stress it protects and promotes 
cell survival by removing damaged organelles and providing much needed 
nutrients in times of starvation (Lum et al., 2005). However if the cell is subjected 
to a prolonged period under stressful conditions, it may exacerbate autophagy and 
drive the cell towards cell death (Levine and Yuan, 2005; Schweichel and Merker, 
1973). This dual role of autophagy is closely related as both pathways share some 
common cell-signaling proteins, for example the ATG6 protein Beclin-1, which 
play prominent roles in driving the cell towards either fate, cell survival or 
apoptosis and cell death (Scarlatti et al., 2009).  
The whole process is made up of multiple steps and is tightly regulated 
with a host of autophagy proteins and their complexes with other related 
molecules. In a general overview of this process, parts of the cytoplasm and 
organelles targeted for degradation are sequestered into double membrane vesicle 
forming an autophagosome. This eventually fuses with a lysosome or endosome 
for breakdown and the products subsequently recycled for use in the cell or 
exocytosed (Mehrpour et al., 2010). These events may be classified into 5 stages: 
1) nucleation, the assembling of the phagophore, 2) Expansion, the extension of 
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the phagophore and elongation of the autophagosome membrane, 3) Completion, 
the autophagosome is completed and characteristic double membrane is clearly 
seen, 4) Fusion, the autophagosome is fused with a lysosome forming an 
autolysosome and 5) Degradation, when the autolysosomal contents are degraded 
by the lysosomal hydrolases, after which they are later recycled in the cell 
cytoplasm or targeted for exocytosis. 
The consensus nomenclatures for autophagy proteins are ATG 
(AuTophaGy-related) and genes are denoted as Atg. Thus far, 31 ATG proteins 
have been identified as listed by Klionsky and co-workers (Klionsky et al., 2003; 
Yang and Klionsky, 2009). Out of these, there are about 3 or 5 subgroups of 
proteins involved in the formation of the autophagosome that make up the core 
machinery (Tanida, 2011; Yang and Klionsky, 2009). Some of the key players 
which are more critical to the autophagosome membrane elongation and 
maturation are ATG 12, ATG 8 (commonly known as microtubule-associated 
protein 1 light chain 3 (MAP-LC3), ATG 5, ATG 6 (Beclin 1) and ATG 7 in 
mammalian autophagy (Figure 1.3).  
Particularly for MAP-LC3, it exists as two forms LC3-I and LC3-II, the 
latter being a characteristic marker for the mature autophagosome and often used 
as a positive indication of the presence of autophagy (Kabeya et al., 2004).  
There are currently few studies on nanomaterial induced autophagy and none 
besides our study implicating AuNP in induction of autophagy. Stern and co-
workers were one of the first in describing this phenomenon, induction of 
autophagy in porcine renal cells treated with cadmium-selenium quantum dots 
(Stern et al., 2008). Subsequent studies into other nanomaterials such as rare earth 
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oxides NPs and fullerenes also found these to induce or mediate autophagy in 
other cell types (Li et al., 2009a; Yamawaki and Iwai, 2006).   
 
 
Figure 1.3: Mechanism of action for maturation and elongation of the 
autophagosome membrane. This diagram shows the major players in the 
formation of the autophagosome including ATG 8 (LC3) activation and 
recruitment to the growing autophagosome membrane and ATG 5, ATG 12, 
ATG16 forming key components of the membrane as well. ATG 4, ATG 3, ATG 
7 and ATG 10 are also essential catalysts for the activation and priming of the key 









1.5 Current Knowledge on the Toxicity of AuNPs 
1.5.1 Toxicity of Gold Nanoparticles 
Toxicity studies on AuNPs have been on the increase in recent years. 
While there is a general concensus that gold compounds are cytotoxic (Coronnello 
et al., 2005), it is not so clear in the case of AuNPs. Some have reported the 
biocompatibility of AuNPs (Connor et al., 2005; Shukla et al., 2005) and its 
suitability for use in biomedical applications yet others have have found AuNPs to 
affect dermal fibroblast cell proliferation and migration (Pernodet et al., 2006). 
The characteristics and surface functionalization of the AuNP in question do play 
a part in determining its toxicity profile. The smaller the AuNP diameter, the 
greater the toxicity, particularly those of diameter less than 10 nm seem to exert 
the most toxic effect, resulting in cell death by necrosis (Pan et al., 2007). 
Hydrophilicity and a cationic surface modification also renders the AuNP to be 
more cytotoxic (Chompoosor et al., 2010). Results from in vivo studies are also 
mixed. Generally, most have that found AuNPs are readily taken up and 
translocated to various organs systems relatively quickly upon exposure. 
However, there are few reported signs of toxicity in treated animals which 
developed adverse effects (Chen et al., 2009; Cho et al., 2009). The route of 
AuNP administration may also affect the extent of toxicity, for instance oral 
administration and intraperitonal injection of AuNPs in mice show- evidence of 
increased toxicity over tail vein injection (Zhang et al., 2010). 





1.5.2 Toxicity of AuNPs in vitro 
Some  available literature on AuNP-induced toxicity in vitro is listed in Table 1.1 
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1.5.3 Toxicity of AuNP in vivo 
Some available  literature on AuNP-induced toxicity in vivo is listed in Table 1.2 
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1.6 Scope of Study 
Nanotechnology as a new and emerging technology, standards of exposure and 
safety are yet to be established. The hypothesis of this study is that 20 nm 
AuNPs exert cytotoxic and genotoxic effects on human lung fibroblasts and 
epithelial cells in vitro. 
 
The objectives of this study are to: 
1. Evaluate the uptake of 20 nm AuNPs into the human MRC-5 lung fibroblast, 
and the human small airways epithelial cells (SAEC) and its biodistribution in the 
cell and morphological effects by light and electron microscopy. 
2. Assess the cell viability, oxidative stress, genotoxicity after treatment with 20 
nm AuNPs in MRC-5 lung fibroblasts  and SAECs. 
3. Analyse the cell cycle and oxidative stress pathway genes following exposure 
to 20 nm AuNPs treatment in MRC-5 lung fibroblasts.  
4. Proteomics analysis in 20 nm AuNP-treated MRC-5 lung fibroblasts. 
5. Investigate the differential gene expression in lung tissues of 20 nm AuNP 













Materials and Methods 
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2.1 Cell Culture 
MRC-5 fetal lung fibroblasts (ATCC No. CC-171) were cultured in RPMI 
1640 media supplemented with 10% FBS and 100 units/ml penicillin, 100 µg/ml 
streptomycin. Small airways epithelial cells (SAEC; Lonza) were cultured in 
Small Airway Basal Medium (SABMTM) supplemented with proprietary 
SingleQuots growth supplements which includes bovine pituitary extract (BPE), 
hydrocortisone, human epithelial growth factor (hEGF), epinephrine, insulin, 
tiiodothyronine, transferring, gentamicin/amphotericin-B and retinoic acid. Cell 
cultures were maintained in a in an atmosphere of 5% CO2 and 37˚C.  
Both cell line were routinely maintained through passaging of cell culture 
once or twice a week. Cells were washed in 1 x PBS and trypsinized by the 
addition of 0.5 x trypsin or 1 x trypsin for MRC-5 and SAEC cells respectively. 
 
2.2 AuNP Synthesis and Preparation 
Colloidial AuNPs is a wine red solution. To synthesize particles at average 
of 20 nm size in 2 nM concentration, 95 mL of an aqueous chlorauric acid 
solution containing 5 mg of Au was brought to a boil, and 5 mL of 1 % sodium 
citrate solution was added to this boiling solution. The solution first changed to a 
bluish color, then purplish, and eventually to wine red, further boiled for 30 min 
and was then left to cool to room temperature. 20 nm diameter size AuNPs were  
chosen for use in this study as they are stable in solution and the 20 nm size 
particles were found to be have the highest deposition fraction in the lung aveoli 
(as previously mentioned on pg 14).  
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2 nM concentration was used as it was a more efficient starting concentration to 
work on for the purpose of concentrating and coating the AuNPs with FBS to 
produce a stock solution of 10 nM AuNPs. 
Characterization analysis was done by Deny Hartono and Huang Shu-Ying 
from A/P Yung’s lab. Size distribution of the AuNP particles were found to be 
consistent with an average diameter of 20 nm through Dynamic Light Scattering 
(DLS) method (Figure 2.1). The zeta-potential which gives the surface charge of 
the AuNPs was measured at -16.8 mV. The AuNP solution was subsequently 
concentrated and coated with FBS through incubation in 37˚C water-bath for 6 
hours. The AuNPs were washed in 1 x PBS and reconstituted to give a 10 nM 
gold nanoparticle solution. This solution was then sterile filtered through a 0.2 µm 
pore-size sterile filter prior to treatment. 
 
Figure 2.1: Dynamic Light Scattering (DLS) graph of AuNP in solution. The % 
intensity measured peaked sharply at 20 nm diameter size showing that a large 
majority of the particles measured had a size distribution of about 20 nm in 
diameter. 
 
2.3 Treatment with AuNP 
The cells were seeded at a density of 8 x 104 cells/well in six-well plates 
(Nunc, Denmark) and cultured for 1 day before treatment. Concentrations of 1, 
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0.5 and 0.1 nM gold nanoparticles were prepared from 10 nM sterile-filtered stock 
solution of nanogold by dilution with culture media. The cells were washed twice 
with 1 x PBS before treatment with the different concentrations of AuNPs for 24, 
48 and 72 h. Control wells were replaced with fresh culture media. The 
experiment was repeated in triplicates. 
 
2.4 Transmission Electron Microscopy (TEM) 
 TEM images allows one to view high powered images of the cellular 
crosssection and visualize organelles and other cellular structures. This technique 
was employed in order to visualize the AuNPs inside the cells to evaluate AuNP 
uptake and localization within the cell. 
 
2.4.1 Sample Processing and Imaging for TEM 
MRC-5 cells were seeded on 4-chambered coverglass (Lab-tek Chambered 
Coverglass System) at a density of 2 x 104/ml (14000 cells/well). After 72 h of 
culture, cells were fixed with 2.5% glutaraldehyde and washed 3 times with 1 x 
PBS. Subsequently, post-fixation with 1% osmium tetroxide was performed 
followed by dehydration with ascending series of alcohol before being embedded 
in araldite for 24 h. Ultrathin sections of 99 nm thickness were cut with a glass 
knife on the Reichert Ultracut E ultramicrotome, mounted onto copper grids and 
doubly stained with uranyl acetate and lead citrate. Images were acquired using 
Olympus EM208S transmission electron microscope at voltage level of 100.0 
KeV. Duplicate samples per treatment were processed for TEM and only the 72 h 
1 nM treatment and control were repeated in a separate experiment in duplicates. 
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2.4.2 EDX Energy Dispersive X-ray (EDX) Analysis 
In order to verify the dense spots are AuNPs, TEM samples from the 
previous step were used for EDX analysis. The elemental composition of the TEM 
specimens was analysed on the CM120 BioTWIN by the Philips EDAX 
Microanalysis system and software.  
 
2.5 Scanning Electron Microscopy (SEM) 
2.5.1 Sample Processing for SEM 
Cells were seeded at a seeding density of 4 x 104 cells / ml on 12 mm 
diameter round cover glass slips and later treated with AuNPs following the steps 
as described in section 2.3. After 72 h, cells were fixed with 2.5% glutaraldehyde 
and washed 3 times with 1 x PBS. The samples were then dehydrated through the 
ethanol series dehydration method with 2 changes of 100 % ethanol at the last 
stage. Samples with AuNPs only did not undergo ethanol series dehydration steps. 
A drop from the 10 nM stock AuNP solution was dropped onto a 12 mm round 
glass cover slip coated prior with poly-L-lysine and allowed to dry in air. Samples 
after drying were used immediately for the next step. Samples were replicated in 
duplicates. 
 
2.5.2 Critical Point Drying (CPD) and Carbon Coating 
Samples on the glass cover slips were placed into a metal container and 
then into the chamber inside the critical point dryer (Balzers CPD 030, Bal-tec, 
Liechtenstein). The procedure was carried out as per the manufacturer’s 
instruction. The chamber was first cooled to 4˚C and then liquid carbon dioxide 
pumped in for 10 mins before the ethanol is drained out. This process is repeated 
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for about 3-4 times to remove the alcohol in the samples. The last step involves 
heating the chamber til about 42˚C and the pressure built up is slowly released by 
hand. The glass cover slips are removed and mounted onto metal stubs with silver 
paint. The samples were subsequently coated with a fine spray of carbon and oven 
dried overnight before viewing. 
 
2.5.3 Scanning Electron Microscopy 
Samples were viewed on the JEOL JSM-6701F, field emission scanning electron 
microscope at a voltage level of 10.0 KeV. Typical three-dimensional surface 
images of the cell and of the AuNPs were captured. In addition, a backscattered 
electron (BSE) imaging was produced to view the AuNPs on and under the cell 
surface. A composite photo of both views was overlaid to create the SEM photos.  
 
2.6 Cell Viability Assays  
2.6.1 Trypan Blue Cell Counting 
Cells (MRC-5 and SAEC cell lines) were cultured onto 4-well plates 
(NUNC, Denmark) at a seeding density of 4 x 104 cells/ml (or 8 x 104 cells/well). 
After treatment if AuNPs at specific time points of 24, 48 and 72 hours, the cells 
were trypsinized with 0.25% trypsin-EDTA (Invitrogen, US). The collected cells 
were centrifuged at 1000 rpm and resuspended in culture media. The cell 
suspension were resuspended in 0.4% Trypan Blue solution (Sigma, US) in a 1:1 
volume ratio and counted using the glass hemocytometer. For each treatment, 3 
replicates were performed. Cells that were stained blue by the Trypan Blue 
solution were counted as non-viable cells and the total number of cells, viable and 
non-viable cells were counted in person with the aid of a punch counter and 
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recorded. Subsequently, the percentage of non-viable cells were calculated with 
this data as such: 
 
% Cell Non-viability = Number of stained (non-living) cells x 100% 
   Total cells counted (stained + unstained) 
 
Total cell count was calculated as such: 
Cell concentration (cells/ml)     =  Average cell count per square of the 
four corner squares in the 
hemocytometer x dilution factor 
 
Total cell count  (cells) = cell concentration x total volume 
 
2.6.2 Cell Viability Assay with MTS assay 
Cells were seeded on to 96 well culture plate at 4000 cells / well. They 
were cultured for 1 day before treatment with the gold nanoparticles at 0, 0.1, 0.5 
and 1 nM concentrations. MTS assay was carried out on the fourth day, 72 h after 
nanogold treatment with the CellTiter 96® AQueous Non-Radioactive Cell 
Proliferation Assay kit (Promega, US). This assay measures the formazan product 
of metabolized MTS in living cells which is directionally proportional to the 
number of living cells in the culture. The absorbance of the formazan at 490 nm 
was measured with the Genois ELISA plate reader. Experiment was repeated in 5 
replicates. 
 
2.7 Gene Expression Profiling 
2.7.1 RT2 Profiler PCR Arrays  
Cells were seeded on 6-well plates and treated with 1 nM AuNP for 72 h 
as previously described  (Section 2.3). After the 72 h treatment timepoint, RNA 
 38 
extraction was performed with the Qiagen RNeasy Microkit (Qiagen, Germany). 
First strand cDNA synthesis (C-02) and realtime PCR were carried with 
proprietary kits and reagents from Superarray, Biosciences according to 
manufacturer’s instructions. Gene expression profiling of 84 key genes from 
selected pathways were simultaneously assayed with the RT2 Profiler PCR array 
plate (Superarray, Biosciences). There were 2 pathway arrays used in this thesis, 
Human Cell Cycle pathway (PAHS-020) and the Human Oxidative Stress and 
Antioxidant Defence pathway (PAHS-065). Triplicate samples of AuNP treated 
and control cells were prepared, one array plate for each sample, the PCR run was 
carried out on the 7000 Real-Time PCR from Applied Biosystems (ABI, USA), 
following manufacturer’s instructions. Statistical analysis was performed through 
t-tests in Excel (Microsoft) data analysis template also provided by the 
manufacturer. 
 
2.7.2 Extraction of Total RNA and First Strand cDNA synthesis 
Cell cultures were seeded and treated with AuNP as described above. Rat 
lung tissue samples were prepared as in section 2.10 and received frozen at -80°C. 
Total RNA was extracted from treated cells and/or from frozen rat lung tissue 
samples with the RNeasy Minikit using the proprietary reagents and spin column 
(Qiagen, Germany). Cell culture samples were homogenized by passing the lysate 
8 times through a 22-guage needle and syringe. Rat lung tissues were first 
weighed and them homogenased in lysis buffer (buffer RLT from RNeasy 
Minikit) with a rotor homogenizer for at least 40 secs. After the homogenization 
of each sample, 70% ethanol was added, mixed by pipetting and then alioquoted 
into a RNeasy Mini spin column. Subsequent steps were completed as directed in 
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the RNeasy Minikit protocol and the total RNA were eluted with RNase free 
water and used immediately for the next step.  
First strand cDNA synthesis was produced with the Superscript III™ first 
strand synthesis kit (Invitrogen) following the manufacturer’s instructions. 
Around 1 – 2 µl of total RNA extracted previously was mixed with the following 
reagents to form master mix 1: 
 1 µl Random Hexamer (50 ng/µl) 
 1 µl dNTPs (10 mM) 
 n µl total RNA sample (up to 8 µl of total RNA) 
 x µl DEPC water (to top up total volume to 10 µl) 
These samples were then incubated at 65 oC for 5 mins in a thermocycler (Thermo 
Hybaid, UK) followed by a cooling period of 1 mins at 4 oC.  
A second master mix is prepared and the total volume of 10 µl of master 
mix 2 was added to each sample. Each sample reaction is made up as follows: 
2 µl 10x RT buffer 
 4 µl 25 mM MgCl2 
 2 µl 0.1 M DTT 
 1 µl RNAseOUT (40 U/µl) 
 1 µl SuperScript III (200 U/µl) 
The cDNA synthesis master mixes were incubated in the thermocycler at the 
following conditions: 25 oC for 10 mins, 50 oC for 50 mins, 85 oC for 5 mins. The 





2.7.3 Real Time Reverse Transcription-Polymerase Chain Reaction  
(Realtime RT-PCR) 
Real time PCR was performed on the HT7900 FAST Realtime PCR 
system from Applied Biosystems (ABI, USA). The FAST system was used in all 
the PCR runs using the FAST SYBR green cocktail from Applied Biosystems 
(ABI, USA). Each sample of the real time RT-PCR reaction was prepared thus:  
 5 µl FAST SYBR Green Master Mix (ABI Biosystems) 
 0.5 µl each of forward and reverse primers 
 1 µl of cDNA template 
 3 µl top up with RNase free water 
A total volume of 10 µl of the reaction mixture was added into each well of a 96-
well reaction plate. The instrument is then set up for the run. The conditions of the 
FAST thermal cycling run are as follows: Initial activation 20 sec at 95 oC, 
followed by 40 cycles of melting at 95 oC for 1 sec, annealing of primer and 
extension at 60 oC for 20 sec. This is subsequently followed by a dissociation 
curve analysis to verify the specificity of the amplification process and detect the 
presence of primer-dimers. This portion of the run has been programmed to 
elevate the temperature of the samples over several minutes. During the run, the 
realtime PCR machine is able to monitor the decrease in SYBR Green dye 
fluorescence due to the dissociation of the dye from double stranded DNA. A 
single sharp peak in the dissociation curve plot represents specific amplification. 
Table 2.1 lists the primer sequences that were used in these experiments for the 
relevant in vitro and in vivo samples. Primers were designed using the Primer-
BLAST tool found on the National Center for Biotechnology Information (NCBI) 
website (http:// www.ncbi.nlm.nih.gov/). The primer design utilizes the PRIMER3 
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software and its specificity was verified by the NCBI’s Basic Local Alignment 
Search Tool (BLAST) program and database. 
 
Table 2.1: Primer Sequences used in Realtime RT-PCR 
Human cell cultures 





Protein disulfide isomerase 
associate 3 (PDIA3) 
CAGGCCTACCCTGGTGATTA TAGAACTGCACCCAGCAGTG 
V-type proton ATPase 
subunit B (VATB) 
GAGGGGCAGATCTATGTGGA GGCTTCTTCTCCAACGACAG 
Hetrogeneous nuclear 
ribonucleus protein C1/C2 
(hnRNP C1/C2) 
TGTGGAGGCAATCTTTTCGA TGATACACGCTGACGTTTCG 
Rat lung tissues 





Beta-actin CCCTGGCTCCTAGCACCAT ATAGAGCCACCAATCCACACAGA 
Cyclooxygenase 2 (Cox-2) GCACAAATATGATGTTCGCATTCT GAACCCAGGTCCTCGCTTCT 
Peroxiredoxin II (Prx II) GAGGGAAGTACGTGGTCCTCT GGTAGGTCATTGACTGTGATCTG 
Cyclin B1 TGATACTCCCTC TCCAAG AATGCACCATGTCGTATG 
Cyclin B2 GCAGTGCCTCGTCCGCACTT TGAGGTTTCTTAGCCACTTGAGCCG 
MAD2 AGAGGAGCCATTAGGGCGCCAT CCCGGCCCAGGCAGCTTATCT 
BRCA1 CCAAACAAAGGCGTCACCAGGC ATCCAGACGCCACTGAGTCCGG 
Cyclin F TGCCAGTGTGTGGGCATCTGC GCCTCATCCGACACAGACAAGCC 
HPxT CCCTCAGTCCCAGCGTCGTGATTA GGCCACAATGTGATGGCCTCCC 
Catalase (Cat) CCCGAGTCCAGGCTCTTCT CGGCCTGTACGTAGGTGTGA 
Glutathione peroxidase 1 
(Gpx 1) 
TAGGTCCAGACGGTGTTC GATACCAGGAATGCCTTAGG 




1 (Hmox 1) 
GGCTGTGAACTCTGTCTC GGCATCTCCTTCCATTCC 














2.8 Lipid Hydroperoxide Assay 
Lipid Hydroperoxide (LPO) Assay Kit (Caymen Chemical Company) 
measures the amount of hydroperoxides directly, utilizing the redox reactions with 
ferrous ions to give ferric ions. These ferric ions in turn are detected with 
thiocynante ion as the chromogen. Lipid hydroperoxides were extracted in 
chloroform from sonicated samples following manufacturer’s instructions. After 
addition of the chromogen for colour development, the samples were aliquoted 
onto 96-well glass plate and readings taken on a multi-well plate 
spectrophotometer. A positive control sample was included as a validation of the 
assay technique. Cells were treated with 10 nM hydrogen peroxide (H2O2) for 1 h 
prior to extraction. The LPO assay relies on colour development and absorbance 
of the dye to determine the amount of lipid hydroperoxide present in the samples. 
The presence of AuNPs in the samples may interfere the dye absorbance reading 
since AuNPs exhibit strong surface plasmon absorption from 480 to 590 nm 
region.  
 
2.9 Inductively coupled plasma mass spectrometry (ICP-MS) 
To ensure that there were no interference from AuNPs, the samples after 
lipid extraction were analysed with inductively coupled plasma mass spectrometry 
(ICP-MS) to evaluate the amount of AuNPs present in the sample and its potential 
effect on the LPO assay. Similarly, protein extracts for the 2-D electrophoresis 





2.9.1 Microwave Digestion of Biological Samples 
Triplicate samples of lipid extract in choloroform and protein extracts in 
water were used in this assay. Due to procedural loss during the performance of 
the assay, which includes variation in instrument performance, 200 µL of 1 ppm 
cadmium ions (Merck, Germany) was spiked into each tissue sample and serves as 
an internal standard. Nitric acid was first added to facilitate digestion, hence 2 mL 
of 69.5% HNO3 (Fluka, Switzerland) and 1.5 mL of 30% H2O2 (Merck, for trace 
analysis) were added to individual samples in the quartz inserts. Additionally, 
5 mL of ultrapure water and 1 mL of 30% H2O2 (Merck, Germany) were also 
added to the Teflon vessel in which the quartz inserts were placed into. The 
Teflon vessels were then placed into the rotor and then the rotor contraption is 
placed into the microwave system.  
The optimized digestion program for the closed-pressurized microwave digestion 
was set as follows: 
 
Table 2.2: Conditions for microwave digestion system. 
Step Microwave Power (W) Time (min) 
1 205 3 
2  0.5 
3 205 5 
4  0.5 
5 450 5 
6  0.5 
7 600 5 
8 650 5 
9  2 
10 Ventilation 15 
Total Time 41.5 
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The rotor with the quartz vessels were On completion of the microwave digestion, 
individual samples were diluted to 20 ml and transferred to a cleaned vial 
(Wheaton, USA), and stored in the dark at 4°C prior to ICP-MS analysis.  
 
2.9.2 ICP-MS Analysis 
Calibration standards of HAuCl4 (Sigma–Aldrich, USA) in five 
concentrations (0.2, 2, 4, 10, and 20 µg/L) were analysed with each batch of 
samples. Ultrapure water was used to blank instrument readings. ICP-MS 
instrument from Perkin Elmer, Massachusetts, USA. Readings were collected by 
the proprietary software from Perkin Elmer, USA and statistical analysis was 
performed to assess significance of AuNP quantity between samples. 
 
2.10 Proteomics Analysis 
2.10.1 Harvesting Cells & Protein Extraction 
Cells were washed once in PBS and twice in 0.35 M sucrose to minimize 
contamination from salt. The cells were then scraped in 0.35 M sucrose containing 
proteinase inhibitor mix (Amersham Biosciences). The cell pellets were collected 
after centrifugation at 2000 rpm for 5 min at 4°C and was subsequently 
resuspended in lyses buffer containing 7 M urea, 2 M thiourea, 4% CHAPS, 20 
mM dithiothreitol, 0.5% Pharmalyte pH 4-7, proteinase inhibitor mix and nuclease 
mix (Amersham Biosciences). Protein concentrations were determined using a 2-





2.10.2 Western Blotting 
The extracted proteins were resolved on SDS page gel and transferred onto 
PVDF membrane via semidry transfer (BioRad). Membranes were blocked in 5% 
non-fat milk and washed in Tris-buffered saline in 1% Tween. Membranes were 
incubated with primary antibody and then with corresponding secondary antibody, 
developed with chemiluminescence substrate (Pierce) and visualised on a XPress 
CL blue ray film (Pierce). Optical densities of bands were measured on the GS710 
Densitometer and band intensities were analysed with Quantity One image 
analysis software (Biorad, USA). 
Primary antibodies used were as follows: MAD2 (sc-28261), cyclin B2 
(sc-28303) were purchased from Santa Cruz (Santa Cruz, US). Malondialedhyde 
(MAD) (ab27642), PNK (ab4191), COX-2 (ab6665), PDIA3 (ab10287) and 
hnRNP C1/C2 (ab10294) were all obtained from Abcam (Cambridge, UK). 
Antibodies to autophagy proteins were purchased from Abgent (San Diego, US), 
MAP-LC3 (ATG 8) (AM1800a), BECN1 (ATG 6) (AP1818c), APG 5 
(AP1812b/a), APG 7 (AP1813d) and APG 12 (AP1816a).  
 
2.10.3 Two Dimensional Gel Electrophoresis (2D-GE) 
The 2D-GE technique is a useful tool for global proteomic analysis in 
toxicity research, and they play an increasingly important role in toxicity 
biomarker discovery and validation (Johnson et al., 2008; Sheehan, 2007). Studies 
which employ this proteomic technique have been used in experiments involving 
silica nanoparticles (Yang et al., 2010), multi-walled carbon nanotubes 
(Witzmann and Monteiro-Riviere, 2006), titanium dioxide nanoparticles (Liu et 
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al., 2010), airborne particulate matter (Jeon et al., 2011) and silver nanoparticles 
(Lok et al., 2006) but there are few on AuNPs (Tedesco et al., 2010a). 
The 18cm immobilized pH gradient (IPG) dry strip pH 4-7 (Amersham 
Biosciences) were rehydrated for 16 h in reswelling tray with 350 µl rehydration 
solution containing 7 M urea, 2 M thiourea, 4% CHAPS, 20 mM dithiothreitol, 
and 0.5% Pharmalyte pH 4-7 (Amersham Biosciences). For analytical and 
preparative gels, approximately 80ug and 240 µg, respectively, of protein was 
loaded into the rehydrated IPG strip pH 4-7 using the cup-loading method. The 
first dimensional isoelectric focusing (IEF) was carried out on IPG strips pH 4-7 
at 20°C with a maximum current setting of 50 µA/strip using Ettan IPGphor3 IEF 
unit (Amersham Biosciences). The IEF run was carried out under the following 
conditions: (i) 300V, 450 Vhr; (ii) 500 V, 250Vhr; (iii) 1000 V, 1000 Vhr; (iv) 
1000 - 8000 V, 3500 Vhr and (v) 8000 V, 32000 Vhr. Voltage increases for (i), 
(ii), (iii), and (v) were performed “stepwise”, while the increase for (iv) was 
carried out on a “linear gradient”. Prior to the transfer of the strips to the second 
dimensional SDS gel, equilibration of the strips were achieved in two steps; the 
first in an equilibration buffer made up of 6 M urea, 30% w/v glycerol, 2% w/v 
SDS, 75 mM Tris-HCl (pH 8.8), 0.002% BPB and 1% w/v dithiothreitol and the 
second in a similar buffer containing 2.5% w/v iodoacetamide in place of 
dithiothreitol. After being transferred onto the second dimensional SDS-PAGE 
gel, the strips were sealed with 0.5% w/v agarose. SDS-PAGE was performed on 
1.0 mm, 9%T polyacrylamide gels at a constant power of 10 W per gel at 16°C by 
using Ettan DALTsix electrophoresis system (Amersham Biosciences). All 
samples were run in triplicate to ensure reproducibility. 
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2.10.4 Protein Visualization and Image Analysis  
2-D gels were visualized by staining with PlusOne silver staining kit (GE 
Healthcare). The gels were fixed in 30% ethanol, 10% acetic acid in water 
overnight followed by twice washing in water for 5 min each. Then the gels were 
immersed in 30% ethanol, 0.2% w/v sodium thiosulfate and 6.8% w/v sodium 
acetate in water for 60 min. After the gels were rinsed four times with water for 15 
min each, they were incubated in chilled 0.25% w/v silver nitrate solution for 60 
min. After discarding the silver nitrate solution and rinsing with two changes of 
water for 1 min each, the gels were developed in 0.03% w/v formaldehyde in 
2.5% w/v sodium carbonate. When the desired intensity was attained, the 
developer solution was discarded and the gel incubated with 1.46% w/v EDTA 
disodium dihydrate for 60 min to halt the reaction. The staining procedure was 
completed by three rinses with water for 15 min each and the resultant silver 
stained gels were subsequently scanned by the Image Scanner (Amersham 
Biosciences). Firstly, the image analysis was done by selecting the best gels. 
These are gels that were chosen from triplicate experiments based on the highest 
image resolution and number of spots. Only spots that displayed obvious 
differences were analysed for differential expression. After which, all the best gels 
were collectively analysed and consistent spots, in which at least four out of six 
pairs of samples, were picked out and labeled on a master gel. All the triplicate 
gels were subsequently re-analysed with ImageMaster 2D Platinum 6.0 





2.10.5 In-gel Reduction, Alkylation and Trypsin Digestion of Protein Spots 
Selected silver-stained protein spots were manually excised and cut up into 
smaller pieces. These gel pieces were then washed in 100 µl of 50 mM 
ammonium bicarbonate in 50% acetonitrile, dehydrated in 100 µl of 100% 
acetonitrile and dried in a Speedvac for 20 min. After that, the gel pieces were 
reswelled in 20 µl of solution containing 10 mM dithiothreitol in 100 mM 
ammonium bicarbonate and incubated at 57°C for 1 h. This solution was 
subsequently replaced with 20 µl of solution containing 55 mM iodoacetamide in 
100 mM ammonium bicarbonate and incubated in the dark, at room temperature 
for 1 hr, with occasional vortexing. The liquid phase was aspirated and the gel 
pieces were then washed in 100 µl of 100 mM ammonium bicarbonate. The 
solution was removed and the gels were dehydrated in 100 µl of 100% 
acetonitrile. The above wash and dehydration steps were repeated twice. The final 
solution was removed and gel pieces were dried in a Speedvac for 20 min. The gel 
pieces were digested with 10 µl of 0.01 µg/µl sequencing grade modified trypsin 
(Promega) in 50 mM ammonium bicarbonate and incubated at 37°C for 14 h. To 
enhance peptide extraction, 10ul of 0.1% trifluoroacetic acid in 50% acetonitrile 
was added to the gel pieces for final extraction.  The extracts were dried in a 
Speedvac for 45 min.  
 
2.10.6 MALDI TOF/TOF MS and Protein Identification 
Dried extract was re-dissolved in 1 µL of matrix solution containing 5 
mg/ml of a-cyano-4 hydroxycinnamic acid (CHCA) in 0.1% trifluoroacetic acid 
and 50% acetonitrile. After which, the extract was spotted onto the MALDI target 
plate and allowed to dry in air. This is followed by the Mass Spectrometry 
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analysis on the Applied Biosystems 4800 Proteomics Analyser MALDI-TOF/TOF 
Mass Spectrometer (Framingham, MA, USA).  The GPS explorer™ software 
Version 3.6 (Applied Biosystems) was used to create and search files with 
MASCOT search engine (Version 2.1; Matrix Science) for peptide and protein 
identification. 
 
2.11 Measurement of DNA damage  
To ascertain if AuNPs could induce oxidative DNA damage, the quantity 
of 8 hydroxydeoxyguanosine (8-OHdG), an established marker for cellular 
oxidative stress (Valavanidis et al., 2009), was analysed. 8-OHdG causes 
mutagenicity through G·C to T·A transversions resulting in 8-OHdG·A mispaired 
bases. Its production is induced by reactive oxygen species (ROS), particularly the 
hydroxy radical which is primarily responsible for the hydroxylation of 
deoxyguanosine to 8-OHdG. After treating with 0 (control), 0.5 and 1 nM AuNPs 
for 72 h, DNAs were extracted from the MRC-5 fibroblasts by the method 
described by Huang et al. (Huang et al., 2001). The quantity of 8-OHdG was 
measured using a Shimadzu LC-10AD HPLC equipped with an autosampler. The 
amounts of 8-OHdG in the samples were expressed relative to the amounts of 
deoxyguanosine (dG) as calculated from the response on the electron capture 
detector (ECD) at 700 mV. 
 
2.11.1 DNA Extraction 
Cells were cultured and treated as described previously and incubated for 
72 h. The amounts of cells used for DNA extraction was about 1 x 107. It was 
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found that 1 nM nanogold could destroy DNA so that 20 flasks of cells (double of 
control) were used in DNA extraction. 
DNA was extracted from MRC-5 cells by the method described by Huang 
et al. (Huang et al., 2001). Cells (107 – 2 × 107) were washed in 3 ml ice-cold 
nuclei isolation solution [10 mM Tris⋅HCl, pH 8.0, 1% (v/v) Triton X, 0.32 M 
sucrose, 0.2 mM EDTA, 0.1 mM DTPA, and 5 mM MgCl2]. The nuclei were 
suspended in 1.5 ml RNase solution (10 mM Tris⋅HCl, pH 8.0, 5 mM EDTA, and 
0.1 mM DTPA). DNase-free RNase (1 µl) was then added and mixtures were 
incubated at 37°C for 0.5 h. The nuclei suspension was then mixed with 1.5 ml 
cell lysis solution [10 mM Tris⋅HCl, pH 8.0, 1%(v/v) SDS, 5 mM EDTA, and 0.1 
mM DTPA]. Proteinase K (20 µl of 20 µg/µl) was added and incubated at 55°C 
for 1 h, followed by an additional 10 µl proteinase K and incubation for 2 h more. 
After cooling the solution on ice, 1 ml protein precipitation solution was added 
and shaken vigorously. Precipitated protein was removed by centrifugation and 
the supernatants were extracted with equal volume of chloroform:isoamyl alcohol 
(24:1, v/v). The upper aqueous phase was treated again with 1 µl DNase-free 
RNase for 15min at 37°C. The aqueous phase was extracted once more with equal 
volume of chloroform: isoamyl alcohol. DNA was precipitated in the aqueous 
phase with equal volume of ice-cold isopropanol and stored at -20°C overnight. 
After centrifugation, DNA was washed twice with 70% ethanol and dissolved in 
HPLC grade water for immediate enzymatic digestion after measuring the ratio of 
260/280. In the enzymatic digestion, 20 µl of the 5 µg/µl concentrated 100µg 
DNA were diluted to 87 µl HPLC water. After addition of 10 µl 100 mM MgCl2 
and 1 µl 1M Tris⋅HCl (pH 7.4), 2 µl of 20 U/µl DNase I were added for 0.5 h 
incubation at 37°C. After adjusting the pH to 5.2 with 1 µl of 3 M sodium acetate 
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(pH 8.0), the fragmented DNA was digested with 1 µl of NP1 (1 U/µl) for 1 h. 
After bring the acidic pH back to neutral with 10 µl of 1 M Tris⋅HCl (pH 8.0), 1 
µl of AP (1 U/µl) was added, followed by 1 h incubation. 
 
2.11.2 HPLC analysis 
A spectra series HPLC (Shimadzu, LC-10AD) equipped with autosampler 
was used. Separations were performed using dual columns. First column (Gemini, 
C6, 50 × 3.00 mm, 5 µl) was to roughly separate dG and OHdG from the digested 
DNA solution. A divert valve was inserted to collect the part containing dG and 
OHdG and they were transfered to the second column (Waters, C18, 150 × 4.6 
mm, 5 µl) which coupled to an ECD (ESA, CoulArray 5600 A). The solvent 
system used was a mixture (pH 4.7, which adjusted by acetic acid) of 6% 
methanol, 20 mM sodium acetate. The flow rate on the first column was 0.4 
ml/min and followed with 1.0 ml/min of methanol to remove impurities. The flow 
rate on the second column was 1.0 ml/min. The amount of OHdG in the samples 
was expressed relative to the amounts of dG as calculated from the response on 
the ECD at 700 mV. 
 
2.11.3 Alkaline Single-Cell Gel Electrophoresis (Comet Assay)  
Cells were cultured in 6-well plates and treated with AuNP as previously 
described. After 72 h treatment, cells were harvested and washed twice in 1 x PBS 
before resuspending in PBS. Cell density was checked by pipetting 5 µl of cell 
suspension on microscope slides and noting the spread of the cells. Each well on 
the comet slide gel should contain approximately 2 x 104 cells. The cells were 
embedded in 0.8% low melting agarose (Pronadisa, Spain) on comet slides 
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(Trevigen, USA) and lysed in prechilled lysis solution (2.5 M NaCl, 0.1 M EDTA, 
10 mM Tris base, pH 10) with 1% Triton X (Trevigen, USA) for 1 h at 4 °C. Cells 
were then subjected to denaturation in alkaline buffer (0.3 M NaCl, 1 mM EDTA) 
for 40 min in the dark at room temperature. Electrophoresis was performed at 25 
V and 300 mA for 20 min. The slides were immersed in neutralization buffer (0.5 
M Tris-HCl, pH 7.5) for 15 min followed by dehydration in 70% ethanol. The 
slides were air-dried and stained with SYBR green dye. The tail moments of the 
nuclei were measured as a function of DNA damage. Analysis was done using 
comet imager v1.2 software (Metasystems GmbH, Germany), and 100 comets 
were analysed per concentration. 
 
2.11.4 Fluorescence In Situ Hybridisation (FISH) 
The FISH assay detects and identifies types of DNA damage and 
aberrations. MRC-5 cells were treated in the typical condition of 1 nM AuNP for 
72 h and allowed to grow for another 24 h in the absence of AuNPs. The cells 
were subsequently arrested at mitosis by treatment with colcemid (0.1 µg/ml) in 
media. Cells were then fixed in Carnoy’s fixative and then incubated with a 
hypotonic solution (0.075 M KCl) at 37 °C for 15 min. Subsequently, cells were 
stained with telomere specific peptide nucleic acid (PNA) probes labeled with 
Cyc3 and centromere specific PNA probes labeled with FITC. The cells were 
counterstained with 4′,6-diamidino-2-phenylindole (DAPI) to visualize the 
chromosomes. Metaphase spreads (50 per treatment) were captured on a Zeiss 
Axioplan 2 imaging fluorescence microscope (Carl Zeiss, Germany) and analysed 
using the in situ imaging software (Metasystems GmbH, Germany). 
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2.12 Rat Lung Tissues and AuNP Inhalation Exposure 
Male adult Wistar rats used in this experiment were subjected to inhalation 
exposure of AuNPs in a whole body exposure chamber following the protocol as 
described by Yu et al. (Yu et al., 2007). The aerosal generation system (TSI Inc. 
Minnesota, USA) introduced the aerosolized AuNP into the chamber, which 
housed 4 rats at a time. A total of 6 rats were used for the purpose of this 
experiment in this study. The rats were divided into 2 groups, (i) the exposure 
group were exposed to aerosolized AuNPs for 6 h per day for 5 consecutive days 
for 3 weeks (a total of 15 days exposure) and (ii) the control group of unexposed 
animals were kept away from the exposure chamber.  
These animals were sacrificed 2 days after the last exposure and the lungs 
organs harvested and snap frozen in liquid nitrogen for storage. Samples and 
instruments were washed thoroughly and care was taken to prevent contact of fur 
to tissues in order to prevent transfer of AuNP residues on the external surfaces of 
the rat body to the organ tissues. Associate Professor Yu Liya E. and Dr 
Balasubramanian Suresh Kumar from the Division of Environmental Science and 
Engineering, Faculty of Engineering performed the above in vivo procedures. The 









2.12 Statistical Analysis 
Statistical analysis of the values for all experiments are expressed as mean 
± standard deviation of two independent experiments. The data were analysed 
using Student’s t test or an unpaired t-test for two treatment samples or One-Way 
ANOVA (Graphpad Prism, USA) for data with 3 or more treatment groups 
together with a post-hoc Tukey’s Test to compare the statistical significance 
















3.1 Internalization and Biodistribution of AuNPs into MRC-5 cells 
3.1.1 Light Microscopy and Transmission Electron Microscopy (TEM) 
There were no visible alterations in the cell morphology between the 
treated and control groups (Figure 3.1). However, AuNPs taken up by the MRC-5 
lung fibroblasts may also under light microscopy as bright blue spots (Figure 3.1, 
B) as they become highly aggregated due to 72 h treatment with AuNPs. 
 
Figure 3.1: Control and AuNP treated MRC-5 cells as seen under light 
microscopy. Large aggregates of the gold particles may also be seen under light 
microscopy as bright blue spots in the cell cytoplasm, clustering around the 
nucleus (B), which were not observed in the untreated control (A). Scale bars = 
100 µm. Insets in both show a close-up view of the cells in the respective 
treatments. Black arrows point to AuNP aggregates in the cell cytoplasm. 
 
It was also observed that AuNP clusters accumulated in endosomes and 
lysozomes in the cytoplasm (Figure 3.2, E and F), which is not surprising as these 
are the eventual endpoints of ingested materials marked for degradation (Griffiths 
et al., 1988).  
The AuNPs mostly gathered in clusters inside cellular vesicles. In some 
cases, scattered AuNPs were found in the cytosol. The AuNP-treated fibroblasts 
appeared to be highly active with many of them exhibiting large numbers of 
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vacuoles in the cytoplasm (Figure 3.2 B) as compared with the untreated control 
(Figure 3.2 A), with many of which contained large clusters of AuNPs. 
 
Figure 3.2: Comparison of MRC-5 cells of control and 1 nM AuNP treatments. 
(A and B) Low magnification micrographs. Control cell in (A) shows a  healthy 
cell with intact cell organelles while in (B) the AuNP treatment caused formation 
of numerous large vacuoles in the cytoplasm of AuNP treated cells giving it an 
unhealthy perforated appearance. (A) Scale bar = 1 µm; (B) Scale bar = 5µm. (C 
and D) High magnification micrographs. Vacoules of control cells (C) do not have 
the appearance of the dark dense spots of AuNPs while in (D) there are many 
clusters of the AuNP in the vacuoles. Scale bar = 0.2 µm. (E and F) Cellular 
localization of AuNP in MRC-5 after 72h treatment with 1nM AuNP. Black 
arrows point to AuNP clusters inside the cell. (E) AuNP in cell cytoplasm 
enclosed within an endosome. Scale bar = 1 µm. (F) AuNPs found clustering in a 
lysosome. Scale bar = 0.2 µm.  
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vacuoles in the cytoplasm (Figure 3.2 B) as compared with the untreated control 
(Figure 3.2 A), with many of which contained large clusters of AuNPs. This is 
more clearly seen in the high magnification micrographs of the control and 1 nM 
AuNP treated cells, where the vacuoles contain large clusters of dark dense spots 
of AuNPs (Figure 3.2 D) which are absent in the vacuoles of the untreated control 
(Figure 3.2 C).  
 
 
Figure 3.3: Dose dependent uptake of AuNPs in MRC5 cells after 72 h treatment 
with (A) 0.1 nM, (B) 0.5 nM and (C) 1 nM concentration of AuNPs in culture 
media. Magnification x 44 000, Scale bar = 0.2 µm. (D) Micrograph taken at a 
lower magnification of cells treated with 1 nM concentration of AuNP for 72 h. 
Appearance of large vacuoles with AuNPs within in the cell cytoplasm is very 
pronounced. Magnification x 11 000, Scale bar = 1 µm. Red letter N indicates 
nucleus. Black arrows point to AuNP clusters. 
 
The quantity of AuNPs observed correlated with the concentration of nanogold 
treatment. 1 nM treated cells had the highest amount of AuNPs clustered in the 
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vesicles while the 0.1 and 0.5 nM treated cells had smaller clusters (Figure 3.3, A, 
B and C). Additionally, most of the vesicles containing the AuNPs were seen 
clustering around the nucleus (Figure 3.3, D) although some AuNPs clusters could 
be found in other areas of the cytoplasm as well. 
 
3.1.2 Scanning Electron Microscopy (SEM) 
The AuNP treated cells were prepared for scanning electron microscope 
(SEM) to observe any changes on the cell surface due to ingestion of the AuNPs. 
Using the back scattering technique, AuNPs were detected as bright white spots 
possessing an average diameter of 20 nm (Figure 3.4, A). They also typically 
appeared with a halo surrounding the clusters or individual particle due to the 
critical drying process and may also be indicative of the serum coating that were 
given to the particles prior to treatment in media. In contrast, such bright white 
spots were not detected in the control samples as can be seen in Figure 3.4 B. 
Additionally, the surface of the untreated control appear relatively smooth while 
the AuNP treated samples had typical “bumps”, which were identified as AuNP 
clusters (Figure 3.4 D) on the cell surface. What was interesting to see was the cell 
membrane in the act of engulfing a cluster of AuNPs (Figure 3.4 C). The 
invagination of the cell membrane and the attachments to the cluster of AuNPs to 
the mouth of the invagination suggests that the uptake process of AuNPs into the 
cell be endocytosed. Chithrani and Chan have demonstrated that transferrin coated 
AuNPs entered cells via the clathrin-mediated endocytosis pathway (Chithrani and 
Chan, 2007), which suggests that the serum coated AuNPs could also be taken up 
into lung fibroblast cells in a similar manner. 
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Figure 3.4: Scanning electron microscopy (SEM) of AuNP. (A) Serum coated 
AuNPs as they appear under SEM. The halo around the particles may be due to 
the critical drying process and the serum coating. (B) Control cells without AuNP 
treatment. (C) A cluster of AuNPs in the act of being engulfed on the cell surface. 
(D) Typical appearance of AuNP clusters on the cell surface. Scale bar = 100 nm. 
 
3.1.3 Time-point Tracking of AuNP Uptake 
In order to find out the time frame in which the cells ingests these 
particles, the fibroblast cells were treated with AuNPs over a range of time 
periods of 6 h, 12 h, 24 h and 48 h at the typical treatment concentration of 1 nM. 
However it was the 6 h and 12 h periods that gave the most contrast under TEM. 
At 6 h, barely any AuNPs, individual particles or clusters, could be detected while 
after 12 h treatment, multiple clusters of AuNP could be seen in vacuoles and in 
the cytoplasm (Figure 3.5, A and B).  
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Figure 3.5: TEM micrographs of MRC-5 cells after 6 h and 12 h treatment with 1 
nM AuNPs. (A) This series of micrographs show the absence of AuNPs at 6 h. 
Although there were dark spots observed (A’) in the cellular cytoplasm, they turn 
out to be dense cellular granules (A’’). (B) At 12 h, it was obvious that the AuNP 
had been taken up by the cells, accumulating mainly in vacuoles. (C) Also at 12 h, 
it was observed that the cells are also able to take up the AuNPs through the cell 
podia as seen in the series of magnified images of the cross section of the 
lamellopodia located away from the main cell body.  
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Another interesting observation is that the uptake process could also take 
place at the lamellopodia outside of the main cell body (Figure 3.5, C). Here, the 
invagination of the cell membrane on the podia in a cross sectional view around 
the cluster of AuNPs may be clearly seen 
 
3.1.4 Verification of AuNPs with EDAX Microanalysis  
In the midst of these interesting observations, there is a need to verify that 
the electron dense particles are AuNPs. TEM specimens were subjected for 
elemental analysis with a CM120 BioTWIN electron microscope coupled with a 
Philips EDAX Microanalysis system. The fibroblasts treated with AuNPs showed 
the presence of Au as indicated by the two peaks corresponding to the gold M 
shell (2.2 KeV) and L shell (9.7 KeV) (Figure 3.6). These peaks were absent in 
the control samples (Figure 3.6 B). The 1 nM treatment sample, registered a P/B 
ratio (ratio of the intensity of the detected element against the background) of 4.60 
while the P/B value of 1.10 in the control implies no difference from the 
background (for the element to be significantly present in the sample, the P/B 
ratio value needs to be 3.0 and above). Hence the electron dense dark spots in 




Figure 3.6: Verification of AuNPs with EDAX Microanalysis system. (A) The 
dense cluster of AuNPs was identified as gold as evidenced by the peaks on the 
graph corresponding to the Au M shell (2.2 KeV) and L shell (9.7 KeV). The 1nM 
treatment sample, registered a P/B ratio (ratio of the intensity of the detected 
element against the background) of 4.60 while the P/B value of 1.10 in the control 
implies no difference from the background (for the element to be significantly 
present in the sample, the P/B ratio value needs to be 3.0 and above). (B) 
However, no peaks were detected at these positions in the control sample. Inserts 
include the TEM micrographs of the section taken for EDAX microanalysis and 





3.2 Cell Viability on AuNP treatment 
3.2.1 Trypan Blue Exclusion Assay for Cell Viability 
To evaluate if AuNPs had an effect on cell proliferation and death, cell 
viability was determined with Trypan Blue exclusion together with One Way 
ANOVA with post hoc Tukey’s Test (Graphpad Prism). Cell viability assay with 
the trypan blue exclusion test show that MRC-5 cells are still viable at 24, 48 and 
72 hours of incubation with the gold nanoparticles in media (Figure 3.7). MTS 
assay at 72 hours treatment further confirmed that there was no loss in cell 
viability (Figure 3.8). This is inline with previous reports that these particles do 
not cause acute cytotoxicity and is relatively biocompatible (Connor et al., 2005).  
 
 
Figure 3.7: Percentage non-viability of MRC-5 cells after (A) 24 h, (B) 48 h and 
(C) 72 h AuNP treatment. There seems to be a dose dependent relationship with 
increasing percentage non-viability against increasing AuNP treatment 




Figure 3.8: MTS cell viability assay of MRC-5 cells treated with 0, 0.1, 0.5 and 1 
nM concentrations of AuNP for 72 h. Results were not significant for all 
concentrations on statistical analysis with One-way ANOVA, which indicates that 
there was no loss in cell viability on AuNP treatment. However, there is the 
possibility of interference from the AuNPs in photospectrometer absorbance 
readings resulting in higher than expected values. Hence the non-absorbance 
reliant method like the trypan blue assay is a better indicator of cell viability. 
 
However there was a significant difference in the total number of cells at 
72 hours following AuNP treatment and untreated cells (Figure 3.9; One way 
ANOVA p value < 0.05). Cells treated with 1 nM concentration of AuNPs had 
significantly lower total cell count than controls (Tukey’s test, p-value < 0.05). 
The significant decrease in cell numbers after 72 h of treatment with 1 nM AuNPs 
indicates that nanogold may inhibit cell proliferation.  
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Figure 3.9: Cell count after 72 h treatment with AuNP in MRC-5 cells. Only the 1 
nM concentration showed significantly lower cell count as compared to the 
control. Thus may indicate that AuNPs could possibly inhibit cell proliferation. 
 
 
3.2.2 Gene Profiling on the Cell Cycle Pathway 
To further evaluate the expression of cell cycle genes following exposure 
of AuNPs, expression profiling of 84 key cell cycle related genes from MRC 
fibroblasts (1nM AuNPs for 72 hours and control) was conducted using the 
Human Cell Cycle RT2 Profiler PCR Array System (SuperArray, Bioscience 
Corp., USA). Full listing of the genes is found in Table 3.1. Statistical analysis 
was performed using Student’s t-tests. All the genes were detected in both the 
treated and control samples, with expression of 19 genes significantly reduced in 





Table 3.1: Full listing of genes in the Human Cell Cycle pathway RT2 Profiler 
PCR array. Total of 90 genes (inclusive of 5 house keeping genes). Gene symbols 
and gene names together with a short description of the genes is as provided, 
based on the gene table in the manufacturer’s product specification sheet 
(Superarray, Bioscience Corporation, USA). The fold change results and the 




















ANAPC2 APC2 Anaphase promoting complex subunit 2 1.49 0.4882 
ANAPC4 APC4 Anaphase promoting complex subunit 4 0.92 0.3370 





Ataxia telangiectasia mutated (includes 





ATR FRP1/MEC1 Ataxia telangiectasia and Rad3 related 0.84 0.0214 
BAX Bax zeta BCL2-associated X protein 1.17 0.8350 
BCCIP TOK-1 BRCA2 and CDKN1A interacting protein 1.05 0.8802 
BCL2 Bcl-2 B-cell CLL/lymphoma 2 0.77 0.2432 
BIRC5 API4/EPR-1 Baculoviral IAP repeat-containing 5 (survivin) 0.63 0.1220 
BRCA1 
BRCAI/BRCC
1 Breast cancer 1, early onset 0.65 0.0018 
BRCA2 BRCC2/FACD Breast cancer 2, early onset 0.85 0.2302 
CCNB1 CCNB Cyclin B1 0.63 0.007 
CCNB2 HsT17299 Cyclin B2 0.57 0.0041 











CCND2 KIAK0002 Cyclin D2 2.59 0.4468 
CCNE1 CCNE Cyclin E1 1.28 0.5084 
CCNF FBX1/FBXO1 Cyclin F 0.67 0.0424 
CCNG1 CCNG Cyclin G1 0.88 0.1828 
CCNG2 Cyclin G2 Cyclin G2 1.01 0.0705 
CCNH CAK/p34 Cyclin H 0.73 0.0233 
CCNT1 CCNT/CYCT1 Cyclin T1 0.81 0.1355 









































CDK2 p33(CDK2) Cyclin-dependent kinase 2 0.97 0.2041 
CDK4 
CMM3/PSK-











































Cyclin-dependent kinase 7  











































Cyclin-dependent kinase inhibitor 2A (melanoma, 









Cyclin-dependent kinase inhibitor 2B  









Cyclin-dependent kinase inhibitor 3 (CDK2-





CHEK1 CHK1 CHK1 checkpoint homolog (S. pombe) 0.97 0.4697 











CKS2 CKSHS2 CDC28 protein kinase regulatory subunit 2 0.72 0.0418 
CUL1 Cul1 Cullin 1 1.33 0.2407 
CUL2 MGC131970 Cullin 2 0.71 0.4210 





DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 




































GTSE1 B99 G-2 and S-phase expressed 1 0.87 0.1464 
HERC5 CEB1 Hect domain and RLD 5 1.48 0.6718 
HUS1 Hus1 HUS1 checkpoint homolog (S. pombe) 0.85 0.0337 





Karyopherin alpha 2  





























MCM2 minichromosome maintenance deficient 2, 































MCM5 minichromosome maintenance deficient 5, 








MKI67 KIA/Ki-67 Antigen identified by monoclonal antibody Ki-67 0.92 0.2188 











NBN AT-V1/AT-V2 Nibrin 0.81 0.0297 
PCNA MGC8367 Proliferating cell nuclear antigen 0.92 0.4660 
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RAD51 homolog  
















RBBP8 CTIP/RIM Retinoblastoma binding protein 8 0.75 0.0059 
RBL1 CP107/PRB1 Retinoblastoma-like 1 (p107) 0.81 0.2668 
RBL2 P130/Rb2 Retinoblastoma-like 2 (p130) 0.89 0.6530 











SKP2 FBL1/FBXL1 S-phase kinase-associated protein 2 (p45) 2.14 0.4915 
SUMO1 GMP1/PIC1 SMT3 suppressor of mif two 3 homolog 1 (yeast) 1.00 0.4179 




Transcription factor Dp-2  


















Ubiquitin-activating enzyme E1 (A1S9T and 
















RPL13A RPL13A Ribosomal protein L13a 1.27 0.2241 
GAPDH G3PD/GAPD Glyceraldehyde-3-phosphate dehydrogenase 1.10 0.8865 

















Table 3.2: Results of the 19 significantly downregulated genes in cell cycle PCR 
array. Results expressed in fold change with its corresponding p-value. A 
description of each gene’s relevant protein function is also included in the table. 
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Rad3 related 
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Breast cancer 1,  
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CCNB Cyclin B1 Cell cycle regulation 0.63 0.007 
HsT17299 Cyclin B2  Cell cycle regulation 0.57 0.0041 
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CDC20 cell division cycle 
20 homolog  
(S. cerevisiae) 









homolog (S. pombe) 
Cell cycle checkpoint regulator, 
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MAD2 mitotic arrest 
deficient-like 1 (yeast) 
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(S. cerevisiae) 
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(S. cerevisiae) 













homolog A (S. cerevisiae) 
homologous recombination, 
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MAD2, Cyclin B2 (HsT17299) and Cyclin B1 (CCNB), which are associated with 
the cell cycle, were found to be the most downregulated. Expression of BRCA1, 
Hus1, ATLD/HNGS1, AT-V1/AT-V2 which are DNA damage response genes 
and involved directly with maintaining genomic integrity, were also significantly 
decreased. The remaining genes encode proteins that are associated with the 
above genes or support the functions of the aforementioned genes (Table 3.2). 
Western blot was next performed with antibody probes to MAD2 and Cyclin B2 
to track if these changes were reflected at the protein level. Both showed positive 
results in the detection of downregulation of protein expression in the treated 





Figure 3.10: Western Blot of MAD2 and Cyclin B2 in AuNP treated samples. A 
similar downregulation of protein expression was observed and correlated with 
the findings from the RT-PCR results.  
 
Cell cycle regulatory genes like MAD2, HsT17299 and CCNB were also 
found to be most significantly downregulated in mRNA transcripts of the treated 
samples. MAD2 is MAD2 mitotic arrest deficient-like 1 which regulates the 
mitotic spindle checkpoint while HsT17299 and CCNB are Cyclin B2 and Cyclin 
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B1 respectively, regulators of the cell cycle at the G2/M phase. A decrease in 
expression of these critical checkpoint proteins would significantly inhibit cellular 
proliferation. Moreover, the AuNPs were coated with FBS prior to use in 
treatment hence this decrease in cell numbers may not be due to reduction of 
serum in media. It is likely that nanogold may interact with the proteins in the cell 
cycle pathways however the connections and exact mechanisms are not clearly 
understood.  
 
3.3 Oxidative Stress 
3.3.1 Lipid Hydroperoxide Assay 
The hydroperoxide concentration was found to be significantly higher in 
treated cells than the control cells (Figure 3.11; p-value < 0.05). This provides 
evidence that AuNP treatment could generate oxidative stress in MRC-5 lung 
fibroblasts.  
 
Figure 3.11: Lipid hydroperoxide assay (LPO assay) of control, AuNP treated 
and hydrogen peroxide treated samples. AuNP treated cells produce significantly 
more hydroperoxide compared with control (* p-value < 0.05). Hydrogen 
peroxide treatment serves as positive control for assay (** p-value < 0.01 
compared with control). Error bars = SEM. 
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3.3.2 Inductively Coupled Plasma Mass Sepctormetry (ICP-MS) 
To allay the concern that the presence of AuNP in cells may interfere with 
the assay absorbance due to the strong surface plasmon effect, trace gold content 
in AuNP treated samples was analysed via inductively coupled plasma mass 
spectroscopy (ICP-MS). The result (Figure 3.12) showed that the gold 
concentration in treated samples was negligible (< 10ppb), implying that there 
was little interference from AuNP in the assays.  
 
Figure 3.12: Inductively coupled plasma mass spectroscopy (ICP-MS) analysis 
was done to quantify the amount of AuNPs carried over into the extraction 
samples after treatment. Two kinds of samples (A) lipid extract in chloroform and 
(B) protein extract in lysis buffer and water were used in two separate analysis 
experiments. Triplicate samples were used for each treatment group and triplicate 
readings were taken for each sample on the ICP-MS equipment.  Both the lipid 
and protein extract results showed that the amount of AuNP quantified in the 
samples is negligible (< 10 parts per billion), implying that there is little influence 
from AuNP in the colorimetric assays. 
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3.3.2 Malondialdehyde Adducts on Western Blots 
In addition, malondialdehyde (MDA) modified protein adducts were 
evaluated by western blotting as a further verification of the presence of lipid 
peroxidation. MDA is a byproduct of lipid oxidation by free radicals and ROS and 
this aldehyde reacts readily with protein or DNA forming adducts which are 
considered to be highly genotoxic. Clearly, the amount of proteins alkylated by 
MDA was significantly more in the AuNP treated samples than that in control 
samples (Figure 3.13; p-value < 0.05), particularly the 2 prominent bands at the 
70kDa and 75kDa regions. 
 
Figure 3.13: Whole cell lysate western blot against MDA protein adducts 
showing significant increase in OD values of AuNP treated cells (OD p-value < 




3.3.3 Oxidative Stress Pathway Gene Profiling 
Gene profiling was done on selected oxidative stress related molecules that 
were affected by AuNP treatment using the RT2 Profiler PCR array (oxidative 
stress pathway, full set of genes are listed in Table 3.3). There were 4 out of the 
84 genes found to be significantly upregulated in AuNP-treated lung fibroblasts 
(Table 3.4, p-value < 0.05).  
 
Table 3.3: Full listing of genes in the Human Oxidative stress and Antioxidant 
pathway RT2 Profiler PCR array. Total of 89 genes (inclusive of 5 house keeping 
genes). Gene symbols, gene names, together with a short description of the genes 
is as provided, based on the gene table in the manufacturer’s product specification 
sheet (Superarray, Bioscience Corporation, USA). The fold change results and 
their respective p – values are also listed. Statistically significant changes are 




Gene Name Description Fold 
Change 
p - value 














































BCL2/adenovirus E1B 19kDa interacting 















































DGKK CK1/EHK1 Diacylglycerol kinase, kappa  1.31 0.3837 






















EPHX2 SYM1 Epoxide hydrolase 2, cytoplasmic  1.31 0.3837 
EPX LOC389611 Eosinophil peroxidase  0.91 0.7729 
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Glutathione peroxidase 4  









Glutathione peroxidase 5 





GPX6 Nbla00307 Glutathione peroxidase 6 (olfactory)  1.10 0.8333 
















Glutathione transferase zeta 1 







































Mannose-binding lectin (protein C) 2,  















MPO 1-Cys/AOP2 Myeloperoxidase  0.73 0.5614 
MPV17 KIAA1415 MpV17 mitochondrial inner membrane protein  0.97 0.7168 

























Neutrophil cytosolic factor 1,  







Neutrophil cytosolic factor 2  
(65kDa, chronic granulomatous disease,  











Non-metastatic cells 5, protein expressed in 









Nitric oxide synthase 2A  









NADPH oxidase, EF-hand calcium binding 









Nudix (nucleoside diphosphate linked moiety 











































































































Prion protein (p27-30) (Creutzfeldt-Jakob 
disease, Gerstmann-Strausler-Scheinker 













Prostaglandin-endoperoxide synthase 1 














Prostaglandin-endoperoxide synthase 2 



















RNF7 PS1TP5BP1 Ring finger protein 7  1.12 0.3162 




































Sirtuin (silent mating type information 









Superoxide dismutase 1, soluble (amyotrophic 
lateral sclerosis 1 (adult))  1.07 0.5305 
















Serine/threonine kinase 25  





























Thioredoxin domain containing 2 
(spermatozoa)  3.74 0.1001 

















Hypoxanthine phosphoribosyltransferase 1 





RPL13A SYM1 Ribosomal protein L13a  1.12 0.0696 
GAPDH LOC389611 Glyceraldehyde-3-phosphate dehydrogenase  0.89 0.4809 
ACTB GIF/GIFB Actin, beta  1.08 0.6149 
 
 
Table 3.4: Results of the 4 significantly upregulated genes in the Oxidative stress 
and Antioxidant PCR Array. 
 







cytoskeleton and kinases 









Involved in DNA double-




















Polynucleotide kinase 3’-phosphatase (PNK) and the cyclooxygenase 2 
(COX-2) were the highest positively altered genes, followed by oxidative stress 
responsive 1 (OXSR1) and peroxiredoxin 2 (PRDX2) genes. Expression of PNK 
and COX-2 proteins were also concomitantly and significantly increased with 




Figure 3.14: Validation of RT2 Profiler PCR assay with western blot. Blots 
probed against (A) PNK and (B) COX-2 antibodies showing upregulation of PNK 
and COX-2 proteins in AuNP treated samples and their corresponding graphs of 
optical densities (OD p-values <0.05). Error bars = SEM. 
 
3.4 Proteomic Analysis 
3.4.1 Two Dimensional Gel Electrophoresis and Mass Spectrometry 
In this study, 16 proteins were found to be differentially expressed in the treated 
samples. The location of these proteins are indicated on a representative gel map 




























Figure 3.15: Representative map of silver-stained 2 dimensional electrophoresis 
from MRC-5 whole cell lysate focused on a non-linear pH 4-7 IPG strip. Sixteen 




Table 3.5: List of protein spots undergoing quantitative changes with AuNP 
treatment as identified by MALDI-TOF/TOF MS. 
 
Protein name a) Accession 
no. a) 
Protein score/  










P28331 664/45 80443/ 5.89 +12.1171 <0.0001 
Lysyl-tRNA synthetase Q15046 130/11 68461/ 5.94 +2.7730 0.0052 
440/25 54454/ 6.78 Not detected      
in control 
NA 






926/45 54454/ 6.78 +1.4547 0.0461 
V-type proton ATPase 
subunit B 
P21281 891/60 55708/ 5.40 +3.2155 0.0383 
Secernin-1 Q12765 141/13 47020/ 4.69 -1.5945 0.0041 
Vimentin P08670 794/66 49680/ 5.19 -1.8346 0.0023 
Ribonuclease inhibitor P13489 102/42 51766/ 4.71 +1.6793 0.0195 
Eukaryotic translation 
initiation factor 2 subunit 2  
P20042 84/15 38706/ 5.60 +1.5887 0.0031 
430/25 32375/ 4.94 -1.7400 0.0006 




55/12 32375/ 4.94 -1.6838 0.0061 
Erlin-2 O94905 216/51 38044/ 5.47 +1.5043 0.0004 
Protein kinase C delta-
binding protein 
Q969G5 429/38 27685/ 6.05 -1.5111 0.0013 
Thioredoxin-like protein 1 O43396 129/53 32630/ 4.84 -2.3040 0.0002 
C-terminal-binding protein 2 P56545 125/33 49427/ 6.47 -1.5745 0.0024 
Ubiquitin carboxyl-terminal 
hydrolase isozyme L1 
P09936 287/48 25151/ 5.33 +2.3386 0.0085 
Glutathione S-transferase P P09211 406/47 23569/ 5.43 +2.8476 0.0026 
Translationally-controlled 
tumor protein 
P13693 184/45 19697/ 4.84 +2.9485 0.0019 
a) Protein name and accession numbers were derived from Swiss-Prot  
b) Protein score, percentage of coverage and Mr (Da)/PI were derived from 
MASCOT 
c) Protein spots were quantified based on the normalized average percentage of 
volume derived from ImageMaster 2D Platinum 6.0 software analysis 
d) Approximate fold-changes of protein expression were derived from the ratio of 
normalized average percentage of volume of treatment to control protein spots or 
vice versa. A “+” indicates up-regulation in the nano gold particles treated 








The identities of these proteins were revealed by mass spectrometry as 
shown in Figure 3.16. Of particular interests are the proteins associated with the 
oxidative stress pathways. There was a 12 fold up-regulation of NADH 
ubiquinone oxidoreductase (NDUFS1) and a 2.7 fold up-regulation for disulfide 
isomerase associated 3 (PDIA3) protein (also known as ER60 or ERp57), an 
endoplasmic reticulum protein associated with cellular stress (Frickel et al., 2004) 
(Figure 3.16, Table 3.5; p-value < 0.05). The heterogeneous nuclear 
ribonucleoproteins C1/2 (hnRNP C1/2), an mRNA binding protein involved in 
mRNA export, localization, translation and stability (Dreyfuss et al., 2002) 
showed significant downregulation by almost 2-fold with AuNP treatment as 
compared to control (Table 3.5,  p-values < 0.01). Thioredoxin-like protein 
isoform 1 (TXNL1), a thioredoxin which is involved in regulating oxidative stress 
(JimÈnez et al., 2006) was observed to be down-regulated by more than 2-fold in 
the treated samples (Table 3.5, p-value = 0.0002). Western blotting also 
confirmed significant downregulation of hnRNP C1/2 expression (Figure 3.17; p-
value < 0.01) and increased PDIA3 protein expression in AuNP-treated samples 




Figure 3.16: Two-dimensional electrophoresis (2D-GE) of AuNPs treated cellular 
protein extracts. Arrows with respective labels indicate protein spots with 
significant differences in expression. Comparing control and AuNP treated 
samples reveal spot differences. Upon mass spectrometry analysis, protein spots 




Figure 3.17: Western blotting of oxidative stress related proteins hnRNP and 
PDIA3 proteins. (A) hnRNP antibodies probe for both C1 and C2 isoforms 
visualised as 2 bands at band size 41kDa and 43kDa. Optical density of band 
intensity of control compared with AuNP treated samples show down-regulation 
of hnRNP protein expression (p-value < 0.01). (B) Conversely, probing with 
PDIA3 antibodies reveal an upregulation in AuNP treated samples. Optical 
density of band intensity is significantly higher in AuNP treatment compared to 
control (p-value < 0.01). Error bars  = SEM. 
 
3.5.2 Real time RT-PCR 
The proteomic result was validated with real time RT-PCR for a few 
selected genes. Although the results were not significant, a trend was detected in 
the gene expression of PDIA3, VATB and hnRNP C1/C2 over 24 h and 48 h time 
period, which corresponded with the upregulation and downregulations in the 




Figure 3.18: Fold change of PDIA3, VATB and hnRNP C1/C2 genes from real 
time RT-PCR analysis at 24h and 48h post AuNP treatment. Although results 
were not significant, the trend in gene expression corresponds with the results in 
the proteomics assay. PDIA3 and VATB gene expressions showed an 
upregulation in fold change with time while hnRNP C1/C2 gene expression 
exhibited a downward trend that matched the decrease in the protein expression 
level. 
 
The 2D-GE proteomic technique was employed to uncover more of the 
cellular changes occurring within the MRC-5 fibroblasts during AuNP treatment. 
Proteins found to be differentially expressed were found to cover a range of 
functions including oxidative stress response as well as regulation of cell cycle 
and cytoskeleton. AuNP treatment also caused sustained DNA strand breaks and 
chromosomal breaks induced by oxidative stress (Section 3.3). The proposed 
conclusion from these experiments is that these changes reflect the state of 




3.5 DNA damage 
3.5.1 Measurement of 8-OHdG 
It was found that 8-OHdG/106dG value in 1 nM AuNP treated cells was 
significantly higher than the control (Figure 3.19, p-value < 0.05; Table 3.6). This 
provided clear evidence that there was oxidative DNA damage when MRC-5 
fibroblasts were treated at higher concentrations of AuNPs (1 nM concentration).  
 
 
Figure 3.19: Analysis of 8-hydroxydeoxyguanosine (8OHdG) DNA using HPLC 
in MRC fibroblasts treated with AuNPs for 72 hours. The ratio of 8OHdG/106dG 
is presented as the means ± standard error of the mean of 3 independent 
experiments. P-value = 0.0019 (One Way ANOVA); * p-value < 0.05 when 












Table 3.6: HPLC data from MRC-5 cells treated for 72 hours with 0.5 nM, 1 nM 
























control,1 42 30 2.37 340.84 1.37 12.61 37.0 
- 
MRC 5, 
control,2 50 30 2.47 355.43 - 10 28.1 
2LDL 
MRC 5, 
control,3 40 30 3.38 428.41 1.38 13.82 32.3 
- 
MRC 5, 
0.5nM,1 50 30 2.83 408.31 1.96 18.01 44.1  
MRC 5, 
0.5nM,2 50 30 2.72 392.48 - 10 25.5 
2LDL 
MRC 5, 
0.5nM,3 50 30 3.08 398.15 - 10 25.1 
2LDL 
MRC 5, 
1.0nM,1 50 30 2.07 298.55 5.70 52.44 175.7 
- 
MRC 5, 
1.0nM,2 50 30 2.48 356.60 5.51 50.68 142.1 
- 
MRC 5, 
1.0nM,3 50 30 3.08 398.03 10.13 102.29 257.0 
- 
 
1LOD (10nM): limit of detection of 10nM was determined as the two-times 
signal-to-noise ratio of a standard solution OHdG. 








3.5.2 Single-Cell Gel Electrophoresis (Comet Assay) 
The comet assays showed positive results for DNA damage in the AuNP 
treated MRC-5 lung fibroblasts. Comet tail moments were found to be 
significantly higher in the treated group than in the control (Figure 3.20, p-value  
< 0.05).  
 
Figure 3.20: Comet assay on control and AuNP treated MRC-5 lung fibroblasts. 
Cells were treated for 72h in 1nM AuNP and subsequently run on alkaline 
electrophoresis and stained in SYBR green which visualizes the comet “tail”, the 
length of which is an indicator of DNA damage. (A)Control cells show little to no 
tail. (B) AuNP treated cells display a comparatively longer tail, indicative of the 
presence of higher DNA damage, particularly strand breaks. (C) Analysis of 100 
cells per treatment captured by the software showed that AuNP treated cells have 
significantly higher DNA damage than control (p-value < 0.05). Tail moment is 




3.5.3 Fluorescence In Situ Hybridization (FISH Assay) 
As shown by FISH, AuNP treated cells had a significant > 4 fold increase 
in aberrations per cell as compared to the controls (Figure 3.21, A and Table 3.7; 
p-value < 0.0001). All aberrations observed were chromosomal breaks with the 
majority being undetectable telomeres (Figure 3.21, C). No chromosomal fusions 
were found. It would appear that that short-term AuNP treatment is likely to cause 
chromosomal breaks in MRC-5 fibroblasts that persist even after one population 
doubling. 
 
Table 3.7: Summary of chromosomal aberrations detected from FISH analysis. 













% of cells with 
chromosomal 
aberrations 
Control 50 27 3 0.6 42% 




Figure 3.21: Fluorescence In Situ Hybridization (FISH) analysis of control and 
AuNP treated MRC-5 lung fibroblasts (1nM concentration and 72h). 50 cells per 
treatment were analysed and found to have a higher incidence of chromosomal 
aberrations in the AuNP treated cells as compared with the untreated controls. Red 
arrows point to chromosomal aberrations. (A) Bar chart of average number of 
aberrations per cell (n=50). There is a significant >4 fold difference between 
control and treated cells (p-value < 0.0001). Error bars = SEM. (B) Metaphase 
spreads of control and AuNP treated cells respectively. (C) (i) undetectable 
telomeres and (ii) chromosomal breaks and were the aberrations detected. No 










3.6.1 Autophagosome Formation under TEM 
A number of AuNPs were found clustered in vesicles containing cell-
membrane like debris in the cytoplasm which are typical features of 
autophagosomes (Figure 3.22, A-E). Some of the cellular materials were found in 
characteristic double membrane vesicles (Figure 3.22, B and C).  
 
 
Figure 3.22: TEM images of autophagosomes and cellular structures in MRC-5 
cells treated with AuNPs for 72 h. Black arrows point to AuNP clusters. 
Autophagosome formations in AuNP treated cells as indicated by red letters AP. 
Lysosomes are labelled in white Ly. Scale bars as indicated in figure. (A, B and 
C) Autophagosomes contain large amounts of cellular debris within a double 
membrane. Some APs may contain AuNP clusters within (A) while others (B and 
C) do not. (D) High magnification view of a large vacuole containing large 
clusters of AuNPs and cellular debris, possibly an autolysosome, a fusion of an 
autophagosome with a lysosome. (E and F) Besides these large vacuoles, the 





3.6.2 ATG Protein Expression in Western Blotting 
In light of this finding, western blots on the protein extracts from control 
and AuNP treated cells, probing for autophagy protein microtubule-associated 
protein 1 light chain 3 (MAP-LC3) over 48 h and 72 h treatment with AuNPs. The 
conjugated MAP-LC3-II protein expression of the cells was significantly higher 
than the controls (Figure 3.23; p-value < 0.05) which correlates with 
autophagosome formation (Mizushima and Yoshimori, 2007).  
 
Figure 3.23: Western blots of MAP-LC3 protein expression after 48 h and 72 h 
treatment with 1nM AuNP. Significant upregulation in MAP-LC3 II protein 
expressions at both 48 h and 72 h treatment with AuNP, comparing control with 
treated samples (OD p-value < 0.05). Error bars = SEM. MAP-LC3 I refers to the 
cytosolic form of the protein while the MAP-LC3 II form is found on membranes 
of autophagosomes and serves as an indicator of autophagosome formation. 
 
Next, the protein expression of 4 other autophagy proteins associated with 
autophagosome formation were also evaluated. At 72 h, autophagy gene 7 (ATG 
7) protein was found to be significantly higher in AuNP treated samples than in 
control (Figure 3.24, p-value < 0.05). However, western blots of other proteins 
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like ATG 5, BECN1 (or ATG 6), ATG 12 protein expressions were slightly higher 
in treated and the OD values were not significant when compared with controls 
(Figure 3.24, C and D). 
 
Figure 3.24: Western blots of autophagy proteins at 72h AuNP treatment. (A) 
ATG 5 (B) ATG 7 (C) BECN1 (ATG 6) (D) ATG 12 showed similar upregulation 
in protein expression but only ATG 7 significantly so (OD p-value < 0.05). Error 
bars = SEM. 
 
Of the five autophagy proteins investigated, it was found ATG 7 and 
MAP-LC3-II to have significantly higher expression in treated samples. ATG 7 is 
known to be an essential enzyme in the 2 major autophagy conjugation systems 
(Tanida et al., 2001). It activates ATG 12 for downstream conjugation to ATG 5 
and catalyses MAP-LC3-I to the autophagosomal marker MAP-LC3-II; both 
proteins are key activators and constituents of the autophagosome membrane 
formation process (Geng and Klionsky, 2008; He and Klionsky, 2009). While 
higher expressions of ATG 7 could translate to an increase of autophagosome 
activation, not seeing a corresponding change in other ATG protein expression 
levels may imply that these proteins were transiently expressed.  
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3.7 Small Airways Epithelial Cells (SAEC) 
With regards to the results obtained from the MRC-5 cells, it is also 
important to look at lung epithelial cells, which are closely related often found in 
close proximity to the fibroblast cells. The primary cell line, small airway 
epithelial cells (SAEC, Lonza, US) were used in a few selected experiments to 
complement the work on the MRC-5 cells. 
 
3.7.1 Uptake of AuNP into SAEC  
Uptake of AuNP into SAEC is similar to MRC-5 cells. The cell 
morphology appears largely no different from the untreated controls. Also similar 
to the treated MRC-5 cells, when large aggregates of AuNP accumulates in the 
SAEC, they appear as bright blue spots in the cell cytoplasm (Figure 3.25, B).  
 
Figure 3.25: Light microscopy photos of SAEC. The cells were treated with 1 nM 
AuNP for 72 h. (A) Control and (B) AuNP treated. Similar to the MRC-5 
treatment, the treated cells appear to have large aggregates of AuNP clusters that 
appear blue under light microscopy. Insets are a magnified picture of the cells in 
each respective treatment. Scale bars = 200µm.  
 
The AuNP clusters are more clearly seen under TEM. Again, like the MRC-5 cells 
they are readily taken up by the SAEC and tend to accumulate in the cellular 
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vacuoles. While the control cells also possess large vacuoles in the cytoplasm, the 
vacuoles in the treated SAEC look larger and lend a perforated appearance to the 
cell (Figure 3.26, A and B). The large AuNP clusters also accumulate mainly in 
these vacuoles and tend to stick to the sides of the vacuoles or with the cell debris 
found inside (Figure 3.26, D). The cytoplasm may also contain smaller AuNP 
clusters or individual particles (Figures 3.26, C).  
 
Figure 3.26: Transmission electron micrographs of SAEC. (A) Untreated control. 
Magnification = 5600x. Scale bar = 1 µm  (B) Low magnification of the AuNP 
treated SAEC. Magnification = 2200x. Scale bar = 1 µm. Compared with the 
controls, the AuNP treated SAEC possess more and larger vacuoles in the 
cytoplasm surrounding the nucleus. Black arrows point to AuNP clusters. (C) 
However, clusters of AuNPs more typically accumulates in the vacuoles while 
some small individual clusters and particles may be found in the cytoplasm. 
Magnification = 28000x. Scale bar = 0.5 µm. (D) Larger clusters usually associate 
with cell debris in the vacuoles. Magnification = 28000x. Scale bar = 0.2 µm. 
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Similarly, as with the MRC5, the presence of AuNP was verified with 
EDX analysis and the results showed that indeed the small dense particles 
observed in the TEM samples were indeed gold. Both the M and L shells of gold 
reading in the AuNP treated samples showed a P/B value greater than 3.0 hence 
showing that gold is significantly present in the samples (Figure 3.27). 
 
Figure 3.27: Verification of elemental gold in AuNPs in SAEC cells with EDAX 
Microanalysis system. The dense cluster of AuNPs were identified as gold as 
evidenced by the peaks on the graph corresponding to the Au M shell (2.2 KeV) 
and L shell (9.7 KeV). The treated sample, registered a P/B ratio (ratio of the 
intensity of the detected element against the background) of 59.80. A P/B ratio 
value of 3.0 and above is indicative that the element is significantly present in the 
sample. Insert reflects the calculated values as processed by the software (EDAX 









3.7.2 Cell Viability Assay with Trypan Blue Cell Counting 
Cells were treated in the same manner as with the MRC-5 trypan blue 
experiments. The SAEC show more sensitivity towards AuNP treatment 
compared to the MRC-5 cells (Figure 3.28). At every timepoint of 24, 48 and 72 
h, the 1 nM AuNP treatment showed a significant increase in % non-viable cells 
(Figure 3.28; p-value < 0.05).  
 
Figure 3.28: Trypan blue cell viability assay on AuNP treated SAEC. Results of 
the percentage non-viability reflected in (A) 24 h (B) 48 h (C) 72 h time points. 
Each timepoint represents a separate and independent assay. For each assay, each 
treatment was repeated in triplicates. Only the 1 nM AuNP treatment at each 
timepoint was found to cause significant increase in the percentage of non-viable 
cells (p-value < 0.05).  
 
The total number of cells counted turned out to only be significant 
different at 72 h of AuNP treatment (Figure 3.29; p-value < 0.05). The cell 
numbers were significantly lower at 72 h for the 0.5 nM and 1 nM treatment 






Figure 3.29: Total cell count of the SAEC cells after 72 h of AuNP treatment. At 
72 h post AuNP treatment, both the 0.5 nM and 1 nM treatment show a significant 
decrease in total cell numbers (p-value < 0.05).  
 
Again these results indicate that SAEC may be more sensitive to AuNP 
treatment than MRC-5 cells since a lower concentration and shorter treatment 
period is able to bring about a significant difference. 
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3.7.3 Oxidative Stress 
3.7.3.1 Lipid hydroperoxide assay 
This is one of the two representative experiments for oxidative stress had 
been replicated with the SAEC. The results show a positive for oxidative stress in 
AuNP treated cells. There was a significant increase in hydroperoxide 
concentration in treated samples compared with the control (Figure 3.30; p-value 
< 0.05).  
 
 
Figure 3.30: Lipid hydroperoxide assay of SAEC. Graph of the hydroperoxide 
concentration after the typical treatment of 1 nM AuNP for 72 h. There is a 
significant increase in the hydroperoxide concentration after AuNP treatment 
compared to the untreated control (p-value < 0.05).  
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3.7.3.2 Real-time RT-PCR  
Four oxidative stress related genes, polynucleotide kinase 3’-phosphatase 
(PNK), cyclooxygenase 2 (COX-2), oxidative stress responsive 1 (OXSR1) and 
peroxiredoxin 2 (PRDX2), were selected based on the significant results in the 
oxidative stress gene profiling array with AuNP treated MRC-5. The SAEC cells 
were similarly treated with 1 nM AuNP for 72 h. Of these four, three were found 
to be significantly upregulated in AuNP treated SAEC cells compared to the 
untreated control (Figure 3.31; p-value < 0.05). Only the oxidative stress 
responsive 1 (OXSR1) gene did not show any significant difference in expression.  
 
 
Figure 3.31: Fold change of 3 significantly differentially expressed genes in 
SAEC upon AuNP treatment (p-value < 0.05). Cells were treated for 72 h at 1 nM 
AuNP concentration. (A) Cyclooxygenase 2 Cox-2 (B) Polynucleotide kinase 3’-




3.7.4 DNA damage 
The single cell gel electrophoresis experiment was the representative 
experiment for DNA damage replicated on the SAEC. The results for the assay 
showed a significant increased DNA damage in AuNP treated cells compared with 
untreated controls (Figure 3.30, p-value < 0.05). This indicated that AuNPs may 
also induce DNA breaks similar to those found in MRC-5 cells. 
 
 
Figure 3.32: Single cell gel electrophoresis (Comet assay) on SAEC. As with the 
MRC-5 cells, the SAEC were similarly treated for 72h in 1nM AuNP and 
subsequently run on alkaline electrophoresis and stained in SYBR green which 
visualizes the comet “tail”, the length of which is an indicator of DNA damage. 
(A) Analysis of 100 cells per treatment captured by the software showed that 
AuNP treated cells have significantly higher DNA damage than control (p-value < 
0.05). Tail moment is used as the comparative value. Error bars = SEM. (B) 
Control cells show little to no tail. (C) AuNP treated cells display a comparatively 




3.8. In Vivo Rodent Studies on Inhalation Exposure of AuNPs  
RNA extracted from frozen rat lung tissues were used for these next set of 
real time PCR experiments. The 9 oxidative stress genes of interests include: 
catalase, cyclooxygenase 2 (cox-2), glutathione peroxidase 1 (Gpx1), gluthathione 
peroxidase 3 (Gpx3), hemeoxygenase (cycling) 1 (Hmox1), peroxiredoxin 2 
(Prx2), superoxide dismutase 1 (SOD1), superoxide dismutase 2 (SOD2) and 
thioredoxin reductase 1 (Txnrd 1). Of the 9 oxidative stress pathway genes, only 
Cox-2 was found to be significantly upregulated (Figure 3.33; p-value < 0.05).  
 
Figure 3.33: Fold change of 9 selected oxidative stress genes on AuNP exposed 
rats compared with samples from the unexposed controls. Of these 9 genes, only 
Cox-2 expression was found to be significantly upregulated in AuNP exposed 
group which corresponded with our in vitro data (p-value <0.05). Error bars = 
SEM, n = 6. 
 
Following that, another set of 5 cell cycle genes were assayed with the 
same samples. These cell cycle genes were selected because they were the 5 most 
downregulated genes from the gene profiling array following the in vitro 
fibroblast data. These 5 genes are: breast cancer 1 (BRCA1), cyclin B2, cyclin F, 
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hypoxanthine (HPT) and MAD2 mitotic arrest deficient-like 1 (MAD2). Primers 
were constructed for the in vivo experiments based on the rat homologs of the 
human genes. With the exception of Cyclin F and MAD2, cell cycle genes largely 
showed a trend of downregulation in AuNP exposed mice, which also matches 
with our in vitro data (Section 3.2.2, 3.3.3 and 3.7.3.2). However, the mRNA 
expression levels for the AuNP exposed lung for all 5 genes tested were not 
significantly different from the control samples (Figure 3.34, p-value > 0.05). 
 
 
Figure 3.34: Fold change of 5 cell cycle related genes on AuNP exposed rats 
compared with samples from the unexposed controls. Although the results were 
not significant, the trend shows a downregulation of cell cycle genes (with the 
exception of Cyclin F and MAD2), which corroborated with our in vitro data. 















4.1 Uptake of AuNP in Lung Cells 
4.1.2 Appearance of AuNP upon cellular uptake 
 AuNPs were taken up easily by human embryonic MRC-5 lung fibroblast 
cell line as well as in the small airways epithelial cells (SAEC) primary culture. 
After 72 h of AuNP treatment, particles may become highly aggregated in the cell 
cytoplasm that they appear as bright blue spots under light microscopy. It may be 
reasoned that the plasmon resonance of the AuNPs is influenced by the size of the 
NPs and hence, the large clustering and aggregation changes the appearance of the 
NPs and the way light is scattered on the surface of the particles (Link and El-
Sayed, 2003). Therefore the clusters appear blue in colour instead of the original 
wine red colour of the 20 nm sized AuNPs.  
Other than the clustering of AuNPs in the cell cytoplasm, the two cell lines 
(MRC-5 lung fibroblasts and SAEC) do not have any observerable changes in 
morphology on AuNP treatment. However under TEM, the treated cells appear 
unhealthy, sporting large vacuoles containing large clusters of AuNPs and may be 
indicative of an adverse reaction to the presence of the AuNPs. This is also 
consistent with observations found in other NP studies, particularly in the lung 
macrophages (Takenaka et al., 2006). In addition, some double membranous 
vesicles containing cellular debris was observed in the cytoplasm of the MRC-5 
cells which is indicative of autophagy. This phenomenon will be discussed in the 
later chapter (Section 4.4). 
Uptake of the AuNP into cells may be influenced by a number of factors 
particularly the size, shape and surface functionalizations. Endocytosis of NPs are 
strongly size-dependent and on both theoretical models and practice, it has been 
shown that 50 nm is the optimal size of uptake of NPs (Wang et al., 2010b; Zhang 
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et al., 2009). Regarding shapes, spherical particles were found to be taken up more 
readily by cells compared with rod-shaped AuNPs (Chithrani et al., 2006). One 
reason could be that rods take up more receptor binding space hence reducing the 
efficiency and time taken for intracellular uptake into the cells. Lastly, different 
complex or modifiers on the AuNP surface, influences the path of uptake of the 
NPs into the cells (de la Fuente et al., 2006). In addition, coating the NP with 
serum or opsonization, also renders the particle more “appetizing” to cells as well. 
There is also growing interest about the particle-organism interactions as it is 
increasingly clear that issues on NPs uptake into cells are not dependant on just 
the characteristics listed above but also on the protein corona surrounding the NP 
and its interaction with the serum in media and on the cell surface (Chithrani and 
Chan, 2007). 
There are six known ways of internalization of materials into the cell. 
Besides passive permeation, there is phagocytosis (cell eating), micropinocytosis 
(cell drinking), caveolin dependent and clathrin dependent endocytosis as well as 
the caveolin and clathrin independent methods (Mukherjee et al., 1997). While it 
maybe possible for the AuNPs to enter into the cell through unassisted methods 
(Geiser et al., 2005), it is more likely that AuNPs would be taken into the cells 
through the process of endocytosis (Chithrani and Chan, 2007). This is due more 
to the surface charge on the NP, which would either facilitate or hinder the 
movement through the lipid double membrane. It is still debatable by which route 
of endocytosis AuNPs are taken up the cell, although most researchers do believe 
that clusters of NPs are most likely taken up through receptor-mediated 
endocytosis (RME).  
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The results from this study also correlate well with the above observations. 
SEM micrographs of the AuNP cluster being engulfed on the cell membrane 
surface suggests that an assisted form of endocytosis is at play. Formations of 
clarithin like structures attaching the cluster of AuNP to the cell surface 
membrane gives some indication that this is the method of choice of entry of 
AuNP into the cell. TEM micrographs also suggest that the AuNPs may be taken 
up by the cells’ filopodia. This interesting observation is also seen in another 
highly motile and invasive breast cancer cell line, MDA-MB-231 breast cancer 
cells. NPs endocytosed by the cells first show up in the lamelliapodia and 
filopodia of this breast cancer epithelial cell line thereby causing a delination in 
these cellular structures upon exposure to quantum dots (Parak et al., 2002). The 
paper also proposes that as the motile cells move, it may also adsorb NPs onto the 
cell surface and this initiates the uptake of NPs into the cell body.  
More studies on mechansim of cellular uptake of AuNPs  is called for and 
it would be interesting to observe the process of uptake and  rate, at more time 
points as well as introduce endocytic inhibitors to elucidate the exact mechanistic 
processes. 
 
4.1.2 Localisation of AuNPs in cells. 
The NPs are mainly located in clusters within cellular vesicles. Also, it is not 
uncommon for the NPs to be found located in the cytoplasm as well. The amount 
of AuNPs ingested into the cell is dependent on the time and concentration of the 
AuNP exposure. This is observed in other AuNP studies as well and appears to be 
a generic behaviour of NP uptake into cellular compartments (Chithrani et al., 
2006; Mironava et al., 2010). Similar observations of AuNPs residing mainly in 
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the vesicles of macrophages after the NPs have been taken up had also been 
reported (Shukla et al., 2005). Although individual particles of AuNPs has been 
sighted in the nucleus, it is a rare observation. Further investigation is needed to 
ascertain that it is not an artifact.  
Additionally, AuNP clusters tend to be accumulated in endosomes and 
lysozomes in the cytoplasm, which is not surprising as these are the eventual 
endpoints of ingested materials marked for degradation (Griffiths et al., 1988). 
The AuNP treated fibroblasts appear to be highly active with many of them 
exhibiting large numbers of vacuoles in the cytoplasm, containing large clusters of 
AuNPs. The fact that the NPs were taken up by the cells provide weightage that 
the effects observed in later experiments may be due to interaction of these 
particles with the various organelles and biological molecules inside the cells. 
Whatever impact that AuNP treatment has on the cells could at least be be in part 
due to the direct contact of the AuNP present in the cellular compartments. 
 
4.2 AuNP Treatment and Cell Viability  
In this study, AuNP treatment was found to be not significantly 
detrimental to cell viability. However, MRC-5 fibroblast cell numbers after 72 h 
treatment was significantly lower than untreated cells, therefore suggesting that 
AuNP treatment could affect cell proliferation as well as cell survival. SAEC 
primary epithelial cells appear to be more sensitive to AuNP treatment, where 
even at 24 h post treatment, AuNP treatment the % non-viability is significantly 




4.2.1 AuNP Treatment Effect on Cell Cycle Genes 
In the cell viability assays, there were no significant increase in % non-
viable cell counts between the control and AuNP treated lung fibroblast cells. 
However, there was a significant decrease in cell count after 72 h of treatment 
with 1nM AuNPs, showing that AuNPs inhibited cell proliferation. This is most 
likely be explained by downregulation of specific cell cycle genes. MAD2 
regulates the mitotic spindle checkpoint while Cyclin B2 and Cyclin B1 are 
regulators of the cell cycle at the G2/M phase. It is likely that AuNPs influence 
cell cycle pathways, inducing a reduction in the expression of critical checkpoint 
proteins that significantly inhibit cellular proliferation. 
The detection of DNA damage and downregulation of DNA repair genes 
suggest that AuNPs at 1 nM concentration may interact directly or indirectly with 
regulators of genomic integrity. It is currently not certain how the AuNPs are 
involved in DNA damage as the particles were not found in the nucleus but 
mainly located in cytoplasmic vesicles. It has also been shown that AuNPs 
localized to membranous structures can non-specifically interact with proteins in 
vitro leading to abnormal protein production in cells (Khan et al., 2007; Pernodet 
et al., 2006). Another possible mechanism causing the DNA damage could be 
ROS since other known toxic NPs like cadmium have been reported to induce 
cytotoxicity and DNA damage through production of excessive ROS (Che et al., 
2003; Lovric et al., 2005; Papageorgiou et al., 2007). Interestingly, 
downregulation of DNA repair genes was also observed. In fact, tumour 
suppressor genes like BRCA1 are also known to have some measure of control 
over DNA non-homologous end joining (NHEJ) and knockdown of this gene 
could lead to carcinogenesis (Bruun et al., 2003; Zhang and Powell, 2005).  
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4.2.2 Effect of AuNP Treatment on Cell Cycle-Related Proteins 
It was not only on the mRNA level where differential expression of cell 
cycle genes was detected. Information obtained from the 2D-GE results also 
reflected a change in the protein expression of certain cell cycle-related proteins. 
These proteins are mainly involved as cell cycle regulators or have involvement in 
the cell cytoskeleton or even possibly tumorigenesis. Vimentins (Vim) are 
intermediary filaments found abundantly in fibroblast cells (Perreau et al., 1988). 
Secernin-1 (SCN1) is a cytosolic protein with roles in the regulation of exocytosis 
in mast cells and recently found to be a prognostic marker for gastric cancer 
(Miyoshi et al., 2010; Way et al., 2002). Translationally-controlled tumour protein 
(TCPT) stablizes microtubules and has calcium binding properties (Yarm, 2002). 
Early translation factor proteins are the eukaryotic translation intiation factor 2 
(eIF2-beta) (Price and Proud, 1994) and lysyl-tRNA sythase (lysRNA), the latter 
also has roles as a proinflammatory signaling molecule and can cause cell toxicity 
when bound to mutant form of superoxide dismutase (Kawamata et al., 2008; Park 
et al., 2005). The upregulation of these proteins in our study signals the role of 
these proteins in AuNP-induced oxidative stress in fibroblasts.  
For other cell cycle proteins, the C terminal-binding protein II (CtBP2) is 
known as a co-repressor of transcription (Castet et al., 2004) with important 
regulatory roles in development and oncogenesis (Chinnadurai, 2002). V-type 
proton ATPase subunit B2 (VATB2) is part of a larger complex of V-ATPases 
proton pumps that acidify endocytic and exocytic organelles (Beyenbach and 
Wieczorek, 2006). Erlin 2 (SPFH2) belongs to a family of prohibitin proteins on 
the endoplasmic reticulum that degrade Inositol triphosphate (IP3) receptors on 
the ER membrane (Pearce et al., 2007), dysregulation of this protein could disrupt 
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cellular signaling pathways. Glutathione S transferase P (GSTP1-1) is a 
detoxification enzyme that catalyzes the conjunction of various hydrophilic 
compounds and electrophillic compounds with glutathione (Kolwijck et al., 2009). 
Ribonuclease inhibitor (RNH) in tissues has strong affinity binding to 
ribonucleases and recent studies show that it may have anti-tumor effects in 
hematopoietic cells (Fu et al., 2005). Not much is known about protein kinase C 
delta-binding protein (hSRBC) however it may possess some tumor suppressor 
properties in primary lung cancers (Zochbauer-Muller et al., 2005). The ubiquitin 
carboxyl terminal hydrolase isozyme L1 (UCH-L1) is a thiol protease that has 
been reported to possess tumor suppressor characteristics in nasopharyngeal 
carcinomas (Li et al., 2010). 
Taken together, these results indicate the vast complexicity of AuNP 
treatment on human fibroblast and epithelial cells and may be particularly 
affecting the cell cycle regulation and transcription regulators thereby resulting in 
an overall decrease in cell proliferation. AuNPs may therefore induce some degree 
of cytotoxicity in human lung fibroblasts. It is shown in this present study that 
AuNPs inhibit cell proliferation by downregulating cell cycle genes. Furthermore, 
AuNPs not only cause oxidative damage but also affect genes associated with 
genomic stability and DNA repair. 
 
 112 
4.3 Oxidative Stress  
Having shown that oxidative stress is present in cells treated with AuNPs, 
it may be possible that oxidative stress induced by AuNPs could be the underlying 
mechanism for the other effects of toxicity such as decrease in cell cycle 
dysregulation and DNA damage (Figure 4.1). Oxidative stress is often found to 




Figure 4.1: Possible oxidative stress pathway upon AuNP treatment and the 
regulatory effects and interactions of significantly upregulated oxidative stress 
genes with selected pathways, signal transduction, DNA-nucleotide excision 
repair, cell survival, apoptosis and proliferation. DNA repair protein XRCC1, was 
identified by the program to have direct protein-protein interaction with the 3’ 
polynucleotide kinase (PNKP) protein as well as direct regulatory influence on 
Cox-2. This pathway map was constructed with the genes that were differentially 
regulated in the oxidative stress gene profiling array and generated with the 
Pathway Studios software (Ariadne Genomics, US).  
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4.3.1 Lipid Peroxidation 
Oxidative stress in vitro caused by AuNP treatment is not an isolated phenomenon 
and it has been seen in other cell types such as HeLa cells (Pan et al., 2009), with 
other kinds of NPs,  for example copper oxide, silica oxide and ferric oxide 
(Fahmy and Cormier, 2009) and is also reported in in vivo studies on fish 
(Tedesco et al., 2010b). Oxidation reactions are naturally occurring processes are 
important to maintain the homeostatic balance in cells, where an imbalance on 
either end will be detrimental to the normal functioning of the cell. Imbalances 
such as the overproduction of ROS could cause an environment of stress within 
the cell and damage manifested in the oxidative damage of protein, lipids and 
DNA (Camhi et al., 1995). Oxidative damage to lipids (lipid peroxidation) is due 
to the degradation of polyunsaturated fatty acids by peroxides. Many of the 
products of these reactions are highly reactive aldehydic intermediates which 
readily form adducts with macromolecules such as proteins and phospholipids 
(Uchida, 2000). These products also then generate a chain reaction on their own, 
producing even more free radicals that could acerbate the oxidative stress 
environment.  
There are a variety of ways how oxidative stress may be assessed and 
measured in in vitro situations. Two assays were used to evaluate the presence and 
extent of damage caused by oxidative stress due to AuNP treatment; measurement 
of the lipid hydroperoxide, one of the initial products from lipid peroxidation and 
the other detects the adducts in on lysine residues caused by malondialdehyde 
(MDA), the most abundant aldehyde produced from the peroxidation reactions 
(Requena et al., 1997). Both these assays proved positive for the presence of 
oxidative damage. Particularly MDA, a toxic molecule, is known to be elevated in 
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various diseases and is implicated in mutagenesis and carcinogenesis (Marnett, 
2002; Niedernhofer et al., 2003) verifying that ROS induce genotoxicity. MDA 
modified proteins can also alter cellular functions and decrease cell proliferation 
(Rittie et al., 2002), adding onto the evidence for changes in cell cycle regulation 
seen in the AuNP treated cells. 
However, it is interesting to note that MDA was also found to be 
negatively influencing lysosomal proteins and autophagy (Krohne et al., 2010) but 
these pathways may be cell-specific and influenced by other factors. More still 
needs to be done to elucidate the effect AuNP treatment has on lipid peroxidation 
in the cell and how the MDA and other products of lipid peroxidation influences 
cellular responses within the cell. 
 
4.3.2 Upregulation of Oxidative Stress Genes 
Among the oxidative stress genes evaluated, two genes stood out from the 
rest. Expression of PNK and COX-2 genes were upregulated and the protein 
expressions were also concomitantly and significantly increased with AuNP 
treatment compared to control. The protein is induced upon stress and the 
functions are well known. The PNK protein is known to function in DNA double 
strand break repair (Jilani et al., 1999). COX-2 a stress inducible enzyme, is 
expressed only in certain cell types and is an indicative marker of inflammation 
(Vane et al., 1994). Its association with oxidative stress has only been recently 
established as 4-hydroxynonenal, another aldehydic product of lipid peroxidation, 
was found in combination with oxidized low-density lipoprotein (LDL), to be 
potent inducers of COX-2 (Kumagai et al., 2004). It is likely that MDA could 
induce COX-2 expression in a similar manner to 4-hydroxynonenal as MDA 
 115 
adducts are present in LDL (Requena et al., 1997). The increase in aldehydic 
products of lipid peroxidation together with the oxidative modification of LDL 
could contribute to induction of COX-2 expression (Uchida, 2008). On the other 
hand, MDA is  known to be a product of prostaglandin biosynthesis (Smith et al., 
1976), therefore setting up a feedback loop by which the production of MDA 
further induces expression of COX-2.  
The results validate the notion that AuNP induces oxidative stress in 
human lung fibroblast cells. However, the repair mechanism for damaged DNA in 
the lung fibroblasts may be functionally intact as upregulation of PNK in treated 
cells may be indicative of the response by the cellular repair system reacting to the 
oxidative DNA damage induced by the AuNP treatment. However, upregulation 
of genes such as peroxiredoxin 2 (PRP), another antioxidant and OSR1, a MAP4 
Kinase activated by osmotic stresses (Chen et al., 2004), conferred protection 
against oxidative stress. 
 
4.3.3 Differential Expression of Oxidative Stress-Related Proteins 
In this present study, the NDUFS1 protein, which is the core and largest 
subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase 
(also known as complex I), was found to be highly upregulated in AuNP treated 
lung fibroblasts. NDUFS1 is the most basic unit required for catalysis reactions. 
Complex I functions in the transfer of electrons from NADH to the respiratory 
chain with ubiquinone as the immediate electron acceptor. It has an iron-sulfur 
protein (IP) component that forms part of the active site crevice where NADH is 
oxidized. Hence, complex 1 is known to be the major source of superoxide O2 and 
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ROS in human fibroblasts (Iuso et al., 2006) which correlates with induction of 
oxidative stress in AuNP treated cells.  
AuNP treatment also affects other oxidative stress related proteins, 
particularly the antioxidant proteins. PDIA3, better known as ER60 or ERp57, is 
known to display protective ability against H2O2 toxicity (oxidative stress) and 
upon binding to protein Ref-1, are involved in activation of a number of 
transcription factors (Grillo et al., 2006). Not surprisingly, the upregulation of this 
protein is also accompanied by a similar upregulation of various transcription and 
translation factors in the 2D-GE results. This same complex has also been 
implicated in DNA repair, as cellular sensors for DNA damage mismatch repairs 
(Jin et al., 1997; Krynetski et al., 2003). Increased expression of PDIA3, which 
has an antioxidant function, is also an appropriate cellular response to oxidative 
stress and DNA damage caused by AuNP treatment. TXNL1, which is reported to 
be protective against glucose deprivation cytotoxicity (JimÈnez et al., 2006) was 
also down-regulated. Both PDIA3 and TXNL1 are part of the thioredoxin 
superfamily of which is also known to regulate cellular redox potential and 
prostaglandin synthase (Daiyasu et al., 2008). 
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4.4 Autophagy  
The act of ”self-cannibalization”, as autophagy may be described, may not 
be a unique response of NPs but this study is one of the first to report this 
phenomenon in relation to AuNPs. The function of autophagy is still not clearly 
understood but it is generally thought to be a natural process to maintain cellular 
homeostasis as well as a cellular response to starvation, infection or disease 
progression. It was only until recently that this has been recognized as a type II 
programmed cell death and a cell survival mechanism in times of stress (Kiffin et 
al., 2006; Tsujimoto and Shimizu, 2005). However, few works have demonstrated 
that NPs could induce autophagy. The more prominent ones include cadmium-
selenium (Cd-Se) NPs in porcine kidney cells (Stern et al., 2008),  quantum dots 
in human mesenchymal stem cells (Seleverstov et al., 2006), fullerenes in cancer 
cells (Wei et al., 2010) and here in this study, AuNPs induces the formation of 
autophagosomes in human lung fibroblast cells (Figure 4.2). Many papers have 
also reiterated that this phenomenon is very likely a common reaction of NP 
treatment in vitro as it is also observed across different cell types and with 
different kinds of NPs. It is, however, dependent on the NP size and the speed of 
metabolic clearance of the NP from the cell (Zabirnyk et al., 2007). In other 
words, the smaller NP diameter size and the longer NP exposure inside the cell 




Figure 4.2: Induction of autophagy after AuNPs treatment in cells. Presence of 
AuNPs in cell cytoplasm causes increased ROS formation which in turn causes 
oxidative damage to cell constituents. Autophagy is induced to clear and degrade 
damaged organelles and protect the cell from oxidative cell death. AuNPs may be 
subsequently engulfed by autophagosomes and along with the products of 
lysosomal degradation be excreted out of the cell or retained in the cell. 
 
4.4.1 Significance of ATG Proteins Upregulation after AuNP treatment 
Of the five autophagy proteins investigated, ATG 7 and MAP-LC3-II were 
found to have significantly higher expression in treated samples. ATG 7 is known 
to be an essential enzyme in the 2 major autophagy conjugation systems (Tanida 
et al., 2001). It activates ATG 12 for downstream conjugation to ATG 5 and 
catalyses MAP-LC3-I to the autophagosomal marker MAP-LC3-II; both proteins 
are key activators and constituents of the autophagosome membrane formation 
process (Geng and Klionsky, 2008; He and Klionsky, 2009). While higher 
expressions of ATG 7 could translate to an increase of autophagosome activation, 
not seeing a corresponding change in other ATG protein expression levels may 
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imply that these proteins were transiently expressed. Interestingly, when ATG 7 is 
deleted or knocked down, it impairs cell survival and causes fatality in irradiated 
mice, showing how essential this gene is in the protection of cell viability towards 
environmental stresses (Mortensen et al., 2011). 
 
4.4.2 Oxidative Stress as Autophagy Inducer 
One of the leading causes of autophagy is oxidative stress and this 
association has been well established (Chen et al., 2008). ROS is the main player 
in the autophagy response to oxidative stress (Kaushik and Cuervo, 2006; Scherz-
Shouval and Elazar, 2011). This group of small, highly reactive molecules such as 
superoxide, hydroxyl radicals arising from oxygen, nitrogen oxides, peroxide free 
radicals from hydrogen peroxide capable of oxidizing a variety of cell components 
including lipids, proteins and DNA. Under normal circumstances, ROS is 
produced as by-products of oxidative metabolism and maintained at a low level 
useful for cell signaling purposes.  In times of stress, the regulation of ROS level 
is disrupted resulting in wide-spread damage to cell constituents and prolonged 
exposure to such a situation often leads to diseases like cancer or cell death (Azad 
et al., 2009). 
The hypothesis is that while AuNP treatment induces oxidative stress, the 
cell may be able to avoid cell death through autophagic pathways. Organelles, 
proteins or lipids damaged by ROS may be efficiently cleared by internalization 
into and subsequent digestion in autophagosomes (Kiffin et al., 2006) thereby 
rescuing the cell from apoptosis. It is also likely that the oxidative environment, 
caused by the presence of AuNP in the cell media, could trigger off the autophagic 
process (Huang and Shen, 2009; Moore, 2008), rather than a direct cellular 
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reaction to AuNP presence in the cell. Others suggest that there may be localized 
sites of oxidative stress around clusters of metal-based NPs, therefore containing 
the extent of damage in the cells (Funnell and Maysinger, 2006). The lung is the 
especially susceptible to oxygen toxicity as it comes in contact with oxygen in 
atmospheric air all the time. Hence, it does possess some endogenous anti-oxidant 
defence against such occurrences (Ryter and Choi, 2010). However, at times when 
the first tier of defence cannot restore cell homeostasis, cells enter into a stress 
situation which calls for the induction of autophagy to arrest and contain the 
damage inflicted by ROS (Moore, 2008).  
On another note, NPs may be able to induce autophagy through an 
oxidative stress independent pathway (Johnson-Lyles et al., 2010). Therefore, not 
all autophagy processes are initiated by oxidative stress. The mechanism for this 
mode of action is still unclear and requires for more in-depth studies into this area.  
 
4.4.3 Other Factors Contributing to Autophagy 
DNA damage or sustained loss of genomic integrity may also induce 
autophagy. The HPLC, comet and FISH assays have shown that AuNPs are able 
to induce DNA damage through oxidative stress. Some recent papers suggest that 
in such cases, DNA damage induced by oxidative stress activates poly(ADP-
ribose) polymerase 1 (PARP-1) which in turn activates autophagy through a novel 
LKB1-AMPK (Liver Kinase B1-AMP-activated protein kinase) signalling 
pathway (He and Klionsky, 2009; Huang et al., 2009; Munoz-Gamez et al., 2009). 
On the other hand, knocking down ATG 5 and ATG 7 causes cells to be more 
susceptible to oxidative stress induced cell death (Huang et al., 2009). This may 
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be a possible explanation why cells continue to thrive despite the harsh treatment 
with NPs.  
With regard to COX-2, a previous study showed that when celecoxib, a 
COX-2 inhibitor is applied, it promoted cell growth arrest and autophagy in 
glioblastoma cells (Kang et al., 2009). Yet others report no difference in COX-2 
expression when autophagy is inhibited (Bauvy et al., 2001). It appears that there 
may be more than one autophagy signalling pathway involved and thus regulation 
of these could be controlled by other signalling proteins or factors wich are yet 
unknown. 
 
4.4.4 Implications for NP Induced Autophagy 
The topic of autophagic cell death and survival induced by NPs is still an 
under developed field and there is much to understand about the processes of the 
cellular response to these changes in exposure to AuNPs. Implications for the NP 
autophagic response does not only concern the lung but also various organ 
systems as it may also have an impact on neurodegenerative diseases as well as 





4.5.1 Genotoxicity of AuNPs 
Many genotoxic research on NPs are centered on metal-based NPs as they 
are found to possess DNA-damaging effects in vitro. Silver, titanium oxide, cobalt 
and iron oxide are just some of the examples of these. There are currently only a 
handful of studies reported on the genotoxicity of AuNP both in vitro and in vivo 
and the general consensus is that AuNP may possess little or weak genotoxicity 
abilities. One of the few studies on NP genotoxicity investigated the effect of 
various common NPs in the lungs of ApoE knockout mice. It described AuNPs as 
possessing the least inflammatory and DNA-damaging ability in comparison with 
carbon black, QDs (cadmium-selenium NP) and CNT (Jacobsen et al., 2009).  
In contrast, this study showed that AuNP can have potent DNA damaging 
ability with the onset of oxidative stress upon AuNP treatment. However, the 
cytotoxicity and genotoxicity potential of AuNP can be enhanced by modifying 
surface functionalisation on the AuNP, such as putting on a positive charge on the 
particle and making it more hydrophobic (Chompoosor et al., 2010). Another in 
vivo study yielded some positive results to the presence of genotoxicity including 
the modulation of genes related to DNA repair in AuNP fed zebrafish (Geffroy et 
al., 2011). 
AuNPs appear to be popularly employed in many novel cancer therapies 
targeting DNA damage of cancer cells together with routine cancer drugs (such as 
cisplatin), radiation or other photothermal therapy (Atkinson et al., 2010; Jain et 
al., 2011; Zheng and Sanche, 2009). Most have reported that while AuNP does not 
necessarily induce DNA damage, it acts to enhance the treatment of anti-cancer 
drugs or radiation therapy administered. In addition, the action of the 
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photomutagenicity may not necessarily be due to AuNP but to the Au3+ ions 
residues after AuNP synthesis (Wang et al., 2011). Light irradiation on these Au3+ 
ions may induce formation of superoxide radicals, which would also add on to the 
oxidative stress and DNA damage. On the other hand, some researchers have made 
use of the colorimetric properties of AuNPs to develop an assay for the detection 
of oxidative DNA damage (Shen et al., 2009). The exact mechanism of action for 
DNA damage effect is yet to be clearly elucidated in AuNP treated cells. 
 
4.5.2 Other Factors Affecting DNA Damage Response in AuNP treatment 
Gathering the results from realtime PCR gene profiling assays and 2D-GE, 
there were quite a few significant differential expression of genes and proteins in 
the AuNP treated samples.  
The downregulation of heteogeneous nuclear ribonucleus protein C1/C2 
(hnRNP C1/C2) expression provides further evidences to its contribution to AuNP 
toxicity and its role in times of cellular stresses. The main function of this protein 
is binding to pre-mRNA and nucleates the assembly of 40S hnRNP particles 
(Huang et al., 1994). They also modulate the stability and the level of translation 
of bound mRNA molecules. Interestingly, downregulation of hnRNP C1/C2 also 
sensitizes cells to stress (Hossain et al., 2007). Moreover, a number of studies 
have linked hnRNP C1/C2 with repair of DNA strand breaks (Haley et al., 2009; 
Lee et al., 2005), together with its role in coordinating DNA repair mechanisms in 
the cell. HnRNP C1/C2 also has close association with telomerase and thereby 
influences repair and maintenance functions (Ford et al., 2000). 
These findings seem to indicate that AuNP involvement in the NHEJ 
pathway of DNA damage repair in the treated lung cells. The comet and the FISH 
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assays in this current study also showed evidence of DNA and chromosomal 
breaks. Therefore, it is plausible that AuNPs can induce DNA damage and impair 
DNA repair responses through the dysregulation of DNA repair genes involved in 
the NHEJ pathway leading to persistent DNA damage. Moreover, there was also 
an upregulation of PNK gene, another gene known to be involved with the NHEJ 
pathway (Chappell et al., 2002; Jilani et al., 1999) from the oxidative stress 
pathway gene profiling studies, thereby corroborating the results from these 
different studies. 
 
4.5.3 Tumorigenicity of Nanomaterials (NM) 
While it has been shown in many in vitro experiments that NMs are able to 
induce DNA damage and some form of mutagenesis, there is still a lack of 
evidence for tumorigenicity of NPs. Of note, in vivo studies involving MWCNT 
has demonstrated formation of mesotheliomas in rodents (Sakamoto et al., 2009; 
Takagi et al., 2008). Widespread deposition of MWCNT was observed in the 
peritoneal cavity where the nanotubes were injected. In the study by Sakamoto, 
they have even found mesotheliomas in the peritoneal cavity away from the 
original site of injection, suggesting that MWCNTs may easily translocate and 
also exert effects away from organ of exposure. Both studies emphasized on the 
persistency, size and shape on the carcinogenic potential of MWCNTs. While 
such studies may provide some insight into the outcome of NM toxicity, one must 
take into account the differences in how the nanotubes were prepared as well as 
the experimental design. Muller et al. conducted similar tests on MWCNT but 
reported no carcinogenicity after a 2-year period of exposure (Muller et al., 2009). 
They speculate that tumour formation could be dependant on size and length of 
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the nanotubes administered and the p53 knockout mice used in the Takagi study 
produced a more sensitive carcinogenic reaction (Takagi et al., 2008). However, 
NMs can induce oxidative stress and trigger inflammatory responses, which could 
form the starting point for carcinogenesis to occur. Nanomaterials that are highly 
reactive are also more likely to absorb endogenous substances, react with proteins 
and enzymes, triggering cytokine release. This would mediate inflammatory 
responses and potentially initiate a series of toxic responses far from the initial site 
of deposition (Bergamaschi et al., 2006; Borm and Kreyling, 2004). C60 fullerene, 
for example, was reported to cause photo-induced DNA damage by interacting 
with biological reducing agents such as NADH to cleave supercoiled DNA 
(Wang et al., 2009). Similarly, exposure to CNT in atmospheric air pollution has 
been associated with adverse cardiovascular effects by causing aortic DNA 
damage, platelet aggregation and enhances vascular thrombosis through 
inflammatory events (Radomski et al., 2005). 
 
4.5.4 Limitations of Current Research  
There are also certain shortcomings in the current research field. The 
short-term nature of toxicology tests in the treatment period of NMs generally 
lasts only up to three days, which implies that testing is limited to acute toxicity. 
In vitro and in vivo genotoxicity testing will have to be conducted for longer 
periods to observe if there are long-term effects of NMs such as tumour formation 
and carcinogenesis. Treatment intervals will have to go beyond days to weeks or 
even months in animal studies. It will also be useful to look at the clearance of 
NMs from the body and to study if there is a preference for accumulation in 
certain organs and any effect from biopersistence of such NMs.  
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Currently, there is a sore lack of studies reported on the gentoxic ability of 
AuNPs. More needs to be known and the mechanisms of action understood as 
AuNPs may have the potential and capability to be used as potent cytotoxic and 
gentoxic agents in cancer therapies. 
 
4.6 Response of Fibroblast vs Epithelial Cells to AuNPs 
Two cell lines were used in this study. MRC-5 is a human lung fibroblast 
cell line while SAEC is a primary cell line of small airways epithelial cells. 
Epithelial cells are the cells that line the airway vessels. As such, these cells are 
constantly exposed to many stress-inducing elements from atmospheric air 
breathed into the body. Fibroblast cells are the cells in connective tissue located in 
the interstitial space. These two cell lines are different and also behave differently 
from one another (Gadbois and Lehnert, 1997). However, comparing the reactions 
and response from one cell line to the other would lead us to understand more on 
how cells would behave in vivo. In this study, it appears that the epithelial cells 
also take up AuNP readily and are more sensitive to AuNP toxicity than the 
MRC-5 fibroblasts. This presents certain issues of concern and what it pertains to 
inhalation exposure of AuNPs. Issues like clearance and retention time of the NPs 
are also worth looking into as the extent of NP toxicity in these cells depends on 
these factors.  
Currently, there are few studies which look into different cell-cell 
interactions with regards to NP toxicity. However, there are surprising results in 
certain fibroblast-epithelial cell interactions. In the case of a study done on breast 
cancer carcinomas, autophagy induced in tumour-associated fibroblast cells may 
also protect the surrounding cancerous epithelial cells from cell death (Martinez-
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Outschoorn et al., 2010). This suggests that not just the cell condition but also the 
cellular microenvironment may play a part in cellular toxicity as well. A 
suggestion for future studies would be to look at co-culture studies of epithelial 
cells and fibroblasts to look at cell-cell interactions and cross-talk on exposure to 
AuNPs. 
 
4.7 In Vivo Study 
There is an increasing call for toxicological in vitro data to be backed up 
by in vivo data (Fischer and Chan, 2007). Therefore, rat lung tissue samples were 
obtained to conduct a complementary study to the in vitro results. Evalutating the 
gene expression levels of several selected cell cycle, oxidative stress and anti-
oxidant associated genes, a similar trend of gene expression levels were observed 
although results are not significant for a large number of the genes studied. 
By and large, the trend observed in the mRNA gene expression studies of  
in vitro and in vivo data does correlate fairly well although they were found not to 
be significant after statistical analysis. The only gene that turned out to be 
significant in both the in vitro and in vivo data is Cox-2. This suggests that 
exposure to AuNPs may create a stressful environment in the tissues hence the 
upregulation of such stress inducible genes to counteract its effects. It is also 
possible that such mechanisms are mediated through oxidative stress in the 
tissues. Although results were not significant, many of the cell cycle genes were 
downregulated, correlating with the gene profile array results taken from lung 
fibroblast cells. On the other hand, the oxidative stress related genes showed 
mostly a trend of downregulation, which is the opposite of the gene profiling 
results. Majority of the genes showing a downward trend in the in vivo samples 
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are anti-oxidants but it is the stress response genes which were upregulated in 
vitro. Perhaps, a more rigorous study with a larger sample size is needed to make 
a more valid conclusion. 
While in vitro allows the researcher to study into greater depths into the 
mechanisms and signaling pathways upon AuNP treatment, in vivo data is also 
important for study into the reactions and interactions in the tissue or organ 
system. Despite the advancement in NP toxicological research in the past few 
years, little is still known about the pharmacokinetics of NPs (Fischer and Chan, 
2007). The path of the NP through the body is dependant on several factors: 
(1) Route of entry 
The six main routes of entry of NPs into the body are: inhalation, intraperitonal, 
dermal, subcutaneous, oral and intraveneous. Depending on the application and 
the administration of the AuNPs, into the body is also as varied. How NPs enter 
also directly affects how quickly they are distributed around the body and issues 
of persistence and clearance from the body. 
(2) Interactions 
There are a few issues that affect pharmacokinetics of NPs in the body but most 
particularly with regards to the protein-NP interactions. Protein corona coating 
affects the uptake, biodistribution and interactions in the body (De et al., 2007). 
Different kinds of serum proteins may preferentially adsorbed onto NPs hence 
modifying the surface functionalization (Cedervall et al., 2007). Moreover, 
adsorption onto NP surface can also change the protein conformation (Lundqvist 




(3) Biopersistance and Clearance 
Biopersistence of NMs, whether in cells or tissues, do pose a certain degree of 
adverse health effect and could be a major contributing factor to nanotoxicity 
(Sanchez et al., 2009). For instance, when the clearance rate is slower than the 
accumulative rate of the inhaled NMs, the NMs will tend to remain in the lungs, 
thereby increasing the exposure to the potentially mutagenic substances and 
increasing the risk of toxicity and disease development. This is especially 
worrisome when a couple of papers have shown that AuNPs are able to persist in 
vivo for a period up to 4 months with preferential accumulation in the liver and 
spleen (Balasubramanian et al., 2010; Goel et al., 2009).  More study is required 
especially in the area of renal clearance and fecal excretions to better understand 
how NPs may be safely applied in therapeutic applications. 
 
4.8 Conclusion 
This study has shown that AuNP does induce some cytotoxic effects on lung cells 
in vitro as well as in AuNP exposed lung tissue in vivo. Treatment with AuNP 
decreases cell proliferation, induces DNA damage, autophagy as well as 




Figure 4.3: Overview of the major areas of interest regarding AuNP cytotoxicity 
covered in thesis. Based on previous published literatures, AuNPs may be first 
taken into the cell via clarithin-mediated endocytosis, hence the presence of large 
numbers of vacuoles with AuNP clusters as seen in the TEM photos. The presence 
of AuNP in the cell is likely to trigger off generation of ROS leading to oxidative 
stress and subsequent cytotoxicity effects include lipid peroxidation, DNA 
damage, differential expression of cell cycle genes and various proteins. Oxidative 
stress also triggers the phenomenon of autophagy which could be the cell survival 
mechanism aiding the cell to escape cell death in times of stress. This could be the 
reason why, in the face of such oxidative damage within the cell, there is still high 
cell viability upon AuNP treatment. These results are useful for the nanotoxicolgy 






 As the field of nanotechnology grows and develops, the health and safety 
aspects of this field should also be growing and developing alongside it. For every 
new and emerging technology, the risks and hazards of such should also be 
adequately evaluated. AuNP is just one of the many NMs in such a situation and 
hence there has been a growing concern worldwide for the use of AuNPs in both 
medical applications as well as safety concerns in workplace exposure. This study 
has looked at the some of the cytotoxic effects of AuNPs on lung cells through in 
vitro situation as well as the cellular response of the cells to AuNP treatment. 
These results are a valuable addition to the growing knowledge of AuNP toxicity 
and also useful for the nanotoxicology scientific community for the continued 
development of safe and effective therapeutic, diagnostics medical applications. 
 
4.9 Future Studies in the field of Nanotoxicology 
This study has opened up new avenues of study and contributed to the 
cumulative  data on the toxicological profile of AuNPs. The mechanics and 
intricacies of the signaling pathways involved upon AuNP treatment and the 
cellular response, AuNP effects and cellular reactions in epigenetics and wider 
cell-cell interactions are areas yet to be explored. Global gene expression studies 
like microarray analysis could be carried out to elucidate the differential gene 
expression changes upon AuNP treatment. In addition, the toxicological profile of 
AuNPs in other types of cell lines such as cancer cell lines and stem cell lines may 
also be interesting avenues of investigation. Other possibilities include 
establishing a co-culture system of two or more cell types to further explore the 
cell-cell interactions. Such systems may include a layer of lung epithelial cell 
culture over the lung fibroblast cells and investigate how treatment of the 
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epithelial layer affects the fibroblast layer, simulating the in vivo environment. 
More indepth in vivo studies can be carried out with regard to the toxicity of acute 
and chronic administration of  AuNPs 
The mode of uptake of these NPs into the cell is also another possible area 
of study. Cells may be treated with a variety of drugs that hinder endocytosis prior 
to AuNP treatment, the results will establish if uptake process is dependent or 
independent on endocytosis. These experiments are not limited to AuNPs alone. 
Silver NPs and silica NPs are also viable materials to explore their cytotoxic 
effects as they are also widely used in many applications. Engineers are producing 
many novel and rare earth based NPs, like ceria oxide NP, neodymium NP and 
gadolinium NP, which may also be interesting NPs to look into as their 
toxicological profiles are still not well-known. 
Besides investigations on the adverse effects of NMs, the field of 
nanotoxicology also encompasses continuous monitoring and risk assessment of 
NMs. Despite the many nanotoxicological studies that are ongoing, there are 
questions that need to be answered and concerns addressed. There is difficulty in 
interpreting data in view of variable parameters utilized in studies for example, the 
sizes of the NMs and its composing materials. The most critical research gap is 
the lack of studies on real-time NM exposure. Moreover, there is a need for long-
term NM exposure assessment in establishing the potential linkage of NMs with 
tumourigenesis. At the industry level, close monitoring and follow-up on the 
levels of emissions from NMs production industries are essential in protecting 
public health and our environment. However, there still exists a lack of 
appropriate epidemiological studies and equipment for accurate collection of data 
in assessing the real risk of NM exposure in the workplace. Despite the promising 
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applications of NMs, there are still doubts regarding their safety. There is some 
certainty that NMs do pose a certain degree of health risk that would require 
further investigation. A proper guideline on NM usage is imperative to ensure the 
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Gold Nanoparticles Induce Oxidative Damage in Lung Fibroblasts
In Vitro**
By Jasmine J. Li, Li Zou, Deny Hartono, Choon-NamOng, Boon-Huat Bay, and Lin-Yue Lanry Yung*
Nanomaterials, defined as any materials possessing at least
one dimension in the nanometer scale, are found to have
many uses and potential applications in the fields of biology
and medicine. Gold nanoparticles (AuNPs) in particular are
being developed as novel gene and drug delivery agents,[1,2]
transfection vectors, DNA-binding agents as well as various
imaging systems[3] because of the inertness of bulk gold.[4] Re-
cent research findings have brought to light concerns over the
safety of nanomaterials and long-term adverse effect of their
use. In this study, we demonstrate that AuNPs can induce
DNA damage and inhibit cell proliferation in human embryo-
nic lung fibroblasts. Furthermore, we found downregulation
of genes associated with regulation of the cell cycle and DNA
repair. The results shown here are substantially different from
the general perception that AuNPs only possess limited cyto-
toxicity.
Most gold complexes, for example gold(III) porphyrins and
gold(III) polyamines, are known to be cytotoxic[5,6] and have
been found to cause DNA damage and be cytotoxic to leuke-
mic cells.[7] However, AuNPs at zero-valency state have gener-
ally been considered to be biocompatible owing to the relative
inertness of gold in bulk form.[8,9] At nanometer-size, how-
ever, many metals are known to display very different charac-
teristics and reactivity than their bulk counterparts.[10] As
more applications for nanomaterials products are developed
and brought into regular use, there is an increasing concern
on the risk of toxicity of these nanomaterials to humans. Re-
cent research has brought to light concerns over the safety
and long-term adverse effect of use of these nanomateri-
als.[11,12] Various reports have highlighted the potential toxici-
ty caused by NPs, particularly in organs at the frontline of ex-
posure such as respiratory organs and skin. Carbon nanotubes
have been found to cause formation of lung granuloma in
mice.[13] Citrate-stabilized AuNPs have also been found to af-
fect dermal fibroblast cell proliferation and migration.[14]
Furthermore, AuNPs functionalized with quaternary amine
have been shown to be moderately toxic to mammalian cells
and Escherichia coli.[4] Inhalation of air-borne NPs also poses
a risk to human health through possible damage not only to
the respiratory organs, but also that these NPs are able to
translocate to the central nervous system and the brain.[15]
Hence, it is essential to establish the toxicity of these NPs as
well as the safety and risks involved in the use of these NPs in
therapeutics and research.
To assess the potential cytotoxicity of AuNPs, we selected
the MRC-5 human fetal lung fibroblast cell line (ATCC
No. CC-171) and exposed them to different concentrations of
20 nm AuNPs. The AuNPs were synthesized from aqueous
chlorauric acid solution via citrate reduction.[16,17] The AuNP
solution was subsequently passivated with fetal bovine serum
(FBS) at 37 °C for 6 h to mimic the real event, since protein
adsorption is known to occur when foreign materials enter hu-
man body. MRC-5 lung fibroblasts at a density of 8 × 104 cells
well–1 in six-well plates were exposed to 0.1, 0.5, and 1 nM
AuNPs for 24, 48, and 72 h. Control wells were incubated only
with fresh culture media, and experiments were repeated in
triplicates. To assess if the AuNPs were taken up by the fibro-
blast cells, the cells were examined by transmission electron
microscopy (TEM). There were no visible alterations in the
cell morphology between the treated and control groups at
different time points (Fig. 1A and B; additional images of cell
culture can be found in the Supporting Information). How-
ever, AuNPs taken up by the fibroblasts could be identified,
and they showed up as dark dense clusters under TEM
(Fig. 1D). In contrast, no cluster was found in the control
group (Fig. 1C). The AuNPs mostly gathered in clusters inside
cellular vesicles. In some cases, scattered AuNPs were found
in the cytosol (circled in Fig. 1E). The quantity of AuNPs ob-
served correlated with the concentration of AuNP treatment.
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in the vesicles, while the 0.1 and 0.5 nM treated cells had
smaller clusters. Additionally, most of the vesicles containing
the AuNPs were seen clustering around the nucleus (Fig. 1E).
Recently, Chithrani and Chan have demonstrated that trans-
ferrin coated AuNPs entered cells via the clathrin-mediated
endocytosis pathway,[18] which suggests that the serum-coated
AuNPs could be taken up by the lung fibroblasts in a similar
manner.
To verify that the electron-dense particles were AuNPs, the
TEM specimens were subjected to elemental analysis with a
CM120 BioTWIN electron microscope coupled with a Philips
EDAX Microanalysis system. The fibroblasts treated with
AuNPs showed the presence of Au as indicated by the two
peaks corresponding to the gold M shell (2.2 KeV) and L
shell (9.7 KeV). The 1 nM treatment sample, registered a P/B
ratio (ratio of the intensity of the detected element against
the background) of 4.60, while the P/B value of 1.10 in the
control implied no difference from the background (for the
element to be significantly present in the sample, the P/B ratio
value needs to be 3.0 or above). Magnified TEM images and
EDAX analysis results can be found in the Supporting Infor-
mation.
We further evaluated if AuNPs had an effect on cell prolif-
eration and death. Cell viability was determined with Trypan
Blue exclusion together with one-way analysis of variance
(ANOVA) with post hoc Tukey’s Test (Graphpad Prism). The
result showed that there was no significant difference in the
percentage of non-viable cells (i.e., no difference in cell death)
between the treatment and control groups after 24, 48, and
72 h incubation with the AuNPs (Fig. 2A to C). However,
there was a significant difference in the total number of cells
at 72 h following AuNP treatment (Fig. 2D; one way ANOVA
p value < 0.05). Cells treated with 1 nM concentration of
AuNPs had a significantly lower total cell count than controls
(Tukey’s test, p value < 0.05). The decrease in total cell num-
ber with no increase in non-viable cells in the 1 nM treated
case may imply that cell proliferation was inhibited at this
concentration. Since the AuNPs were coated with FBS, this
decrease in cell numbers was probably not due to depletion of
serum protein in media.
To ascertain if AuNPs could induce oxidative DNA dam-
age, we analyzed the quantity of 8 hydroxydeoxyguanosine
(8OHdG), which is an established marker of cellular oxidative
stress.[19] 8OHdG causes mutagenicity through G·C to T·A
transversions, resulting in 8OHdG·A mispaired bases.[20] Its
production is induced by reactive oxygen species (ROS), par-
ticularly the hydroxy radical which is primarily responsible for
the hydroxylation of deoxyguanosine to 8OHdG.[21,22] After
treating with 0 (control), 0.5, and 1 nM AuNPs for 72 h,
DNAs were extracted from the MRC 5 fibroblasts by the
method described by Huang et al.[23] The quantity of 8OHdG
was measured by using a Shimadzu LC-10AD high-perfor-
mance liquid chromatography (HPLC) instrument equipped
with an autosampler. The amounts of 8OHdG in the samples
were expressed relative to the amounts of deoxyguanosine
(dG) as calculated from the response on the electron capture
detector (ECD) at 700 mV. We found that the 8OHdG/106dG
value in 1 nM AuNP treated cells was significantly higher
than the control (Fig. 2E, p value < 0.05). This provided clear
evidence that there was oxidative DNA damage when MRC-
5 fibroblasts were exposed to AuNPs at 1 nM concentration.
To further evaluate the expression of cell cycle genes fol-
lowing exposure of AuNPs, expression profiling of 84 key cell
cycle related genes from MRC fibroblasts (1 nM AuNPs for
72 h and control) was conducted using the Human Cell Cycle
RT2 Profiler PCR Array System (SuperArray, Bioscience
Corp., USA). Statistical analysis was performed using Stu-
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Figure 1. A,B) Optical microscopy images of MRC-5 lung fibroblasts at 72 h after seeding. A) Untreated cells, and B) cells treated with 1 nM AuNPs.
C–E) Transmission electron microscopy images of lung fibroblasts after 72 h culture. C) Untreated cells, (D) 1 nM AuNP treatment, and (E) 1 nM
AuNP treatment showing the presence of AuNPs in vesicles which cluster around the nucleus (N). Arrows indicate AuNP clusters in vesicles. Circles
indicate AuNP clusters in cytosol. For (A–B) 10× magnification, bar = 190 lm, (C–D) 44000× magnification, bar = 0.2 lm, and (E) 11000× magnifica-
tion, bar = 1.0 lm.
and control samples, with expression of 19 genes significantly
reduced in the treated cells (Table 1; p value < 0.05). MAD2,
Cyclin B2 (HsT17299) and Cyclin B1 (CCNB), which are as-
sociated with the cell cycle, were found to be the most down-
regulated. Expression of BRCA1, Hus1, ATLD/HNGS1,
AT-V1/AT-V2, which are DNA damage response genes and
involved directly with maintaining genomic integrity, was also
significantly decreased. The remaining genes encode proteins
that are associated with the above genes or support the func-
tions of the aforementioned genes, and are provided in Sup-
porting Information Table S1.
The significant decrease in cell count after 72 h of treat-
ment with 1 nM AuNPs (showing that AuNPs inhibited cell
proliferation) could most likely be explained by downregula-
tion of specific cell cycle genes. MAD2 regulates the mitotic
spindle checkpoint while Cyclin B2 and Cyclin B1 are regula-
tors of the cell cycle at the G2/M phase. It is likely that AuNPs
influence cell cycle pathways, inducing a reduction in the ex-
pression of critical checkpoint proteins which significantly in-
hibit cellular proliferation.
The detection of DNA damage and downregulation of
DNA repair genes suggest that AuNPs at 1 nM concentration
may interact directly or indirectly with regulators of genomic
integrity. It is currently not certain how the AuNPs are in-
volved in DNA damage as the particles were not found in the
nucleus but mainly located in cytoplasmic vesicles. Pernodet
et al. have shown that AuNPs localized to membranous struc-


















































































































Figure 2. A–C) Cell count of non-viable MRC lung fibroblasts with different concentrations and duration of exposure to AuNPs. A) 24 h, B) 48 hm, and
C) 72 h. Error bar = standard error of the mean. D) Total cell count in the lung fibroblasts after 72 h treatment with AuNPs versus control. Error bar =
standard error of the mean. E) Analysis of 8-hydroxydeoxyguanosine (8OHdG) DNA using HPLC in MRC fibroblasts treated with AuNPs for 72 h. The
ratio of 8OHdG/106dG is presented as the means ± standard error of the mean of three independent experiments. p value = 0.0019 (One Way ANO-
VA); * p value < 0.05 when comparing 1 nM treatment with control and 0.5 nM treatment.
Table 1. Genes downregulated following exposure to 1 nM 20 nm size
AuNPs, showing fold difference and p values.




















ing to abnormal protein production in cells.[14,24] Another
possible mechanism causing the DNA damage could be the
generation of ROS caused by AuNPs, as other known toxic
NPs like cadmium have been reported to induce cytotoxicity
and DNA damage through production of excessive
ROS.[5,25–27] Interestingly, we also observed that there was
downregulation of DNA repair genes. In fact, Zhang et al.
have recently reported that knockdown of DNA damage re-
sponse genes in human cells could lead to carcinogenesis.[28]
In conclusion, AuNPs may induce some degree of cytotoxic-
ity in human lung fibroblasts. We have shown that AuNPs in-
hibit cell proliferation by downregulating cell cycle genes.
Furthermore, AuNPs not only cause oxidative damage but
also affect genes associated with genomic stability and DNA
repair.
Experimental
Cell Culture: MRC-5 fetal lung fibroblasts (ATCC No. CC-171)
were cultured in RPMI 1640 media supplemented with 10% FBS and
100 units mL–1 penicillin, 100 lg mL–1 streptomycin in an atmosphere
of 5% CO2 and 37 °C. Only cell cultures with passage 20 or less were
used in these experiments.
AuNP Synthesis and Preparation: To synthesize particles at average
of 20 nm size in 2 nM concentration, 95 mL of an aqueous chlorauric
acid solution containing 5 mg of Au was brought to boiling point, and
5 mL of 1% sodium citrate solution was added to this boiling solution.
The solution which first changed to a bluish color, then purplish, and
eventually to wine red, was further boiled for 30 min and then left to
cool to room temperature. The AuNP solution was subsequently con-
centrated and coated with FBS by incubating in a 37 °C water-bath for
6 hours. The AuNPs were washed in phosphate buffer saline (PBS) to
remove excess FBS, residual gold salt, and citrate, and were subse-
quently reconstituted to give a 10 nM nanoparticle solution. This solu-
tion was then sterile filtered through a 0.2 lm pore-size sterile filter
prior to treatment.
Treatment of MRC-5 Cells with AuNPs: MRC-5 cells were seeded
at a density of 8 × 104 cells/well in six-well plates (Nunc, Denmark)
and cultured for 1 d before treatment. Concentrations of 0.1, 0.5, and
1 nM AuNPs were prepared from 10 nM sterile-filtered stock solution
of AuNPs by dilution with culture media. The cells were washed twice
with PBS before treatment with the different concentrations of
AuNPs for 24, 48, and 72 h. Control wells were replaced with fresh
culture media without AuNPs (see Cell Culture for media composi-
tion). The experiment was repeated in triplicates.
Trypan Blue Cell Viability Assay: Cells were trypsinized with 0.25%
trypsin-EDTA (Invitrogen, USA), centrifuged at 1000 rpm and subse-
quently resuspended in culture media. The cells were stained with
0.4% Trypan Blue solution (Sigma, USA) and counted with a glass he-
mocytometer.
DNA Extraction from MRC-5 Cells: Cells were cultured and treat-
ed with AuNPs as described previously and incubated for 72 h. The
number of cells used for DNA extraction was about 107. We found
that 1 nM AuNPs could destroy DNA so twice the numbers of cells
compared to control were used in DNA extraction. Cells (1–2 × 107 in
number) were washed in 3 mL ice-cold nuclei isolation solution
(10mM Tris·HCl, pH 8.0, 1% (v/v) Triton X, 0.32 M sucrose, 0.2 mM
EDTA, 0.1 mM diethylene triamine pentaacetic acid (DTPA), and
5 mM MgCl2). The nuclei were suspended in 1.5 mL RNase solution
(10 mM Tris·HCl, pH 8.0, 5 mM EDTA, and 0.1 mM DTPA. 1 lL
DNase-free RNase was then added and the mixtures were incubated
at 37 °C for 0.5 h. The nuclei suspension was then mixed with 1.5 mL
cell lysis solution (10 mM Tris·HCl, pH 8.0, 1% (v/v) SDS, 5 mM
EDTA, and 0.1 mM DTPA). Proteinase K (20 lL of 20 lg lL–1) was
added and incubated at 55 °C for 1 h, followed by an additional 10 lL
proteinase K and incubation for 2 h more. After cooling the solution
on ice, 1 mL protein precipitation solution was added and shaken vig-
orously. Precipitated protein was removed by centrifugation and the
supernatants were extracted with equal volume of chloroform : isoa-
myl alcohol (24:1, v/v). The upper aqueous phase was treated again
with 1 lL DNase-free RNase for 15 min at 37 °C. The aqueous phase
was extracted once more with equal volume of chloroform : isoamyl
alcohol. DNA was precipitated in the aqueous phase with equal vol-
ume of ice-cold isopropanol and stored at –20 °C overnight. After cen-
trifugation, DNA was washed twice with 70% ethanol and dissolved
in HPLC-grade water for immediate enzymatic digestion after
measuring the A260/280 ratio. In the enzymatic digestion, 20 lL of
5 lg lL–1 (making a total of 100 lg) DNA were diluted to 87 lL in
water. After addition of 10 lL of 100 mM MgCl2 and 1 lL of 1 M
Tris·HCl (pH 7.4), 2 lL of 20 U lL–1 DNase I were added for 0.5 h
incubation at 37 °C. After adjusting the pH to 5.2 with 1 lL of 3 M
sodium acetate (pH 8.0), the fragmented DNAwas digested with 1 lL
of Nuclease P1 (1 U lL–1) for 1 h. The acidic pH was titrated to neu-
tral with 10 lL of 1 M Tris·HCl (pH 8.0), 1 lL of AP (1 U lL–1) was
added, followed by 1 h incubation.
HPLC Analysis: A spectra series HPLC (Shimadzu, LC-10AD)
equipped with an autosampler was used. Separations were performed
using dual columns. First column (Gemini, C6, 50 × 3.0 mm) was to
roughly separate dG and 8OHdG from the digested DNA solution. A
divert valve was inserted to collect the part containing dG and
8OHdG and they were transferred to the second column (Waters, C18,
150 × 4.6 mm) which was coupled to an electrochemical detector
(ECD) (ESA, CoulArray 5600A). The solvent system used was a mix-
ture with pH 4.7 (adjusted by acetic acid) comprising 6% methanol
and 20 mM sodium acetate. The flow rate on the first column was
0.4 mL min–1 and followed with 1 mL min–1 of methanol to remove
impurities. The flow rate on the second column was 1 mL min–1. The
amounts of 8OHdG in the samples were expressed relative to the
amounts of dG as calculated from the response on the ECD at
700 mV.
Gene Expression Profiling: Expression profiling of 84 key cell cycle
related genes in 72 h 1 nM AuNPs treated MRC-5 cells against un-
treated MRC-5 cells, was performed using the Human Cell Cycle RT2
Profiler PCR Array System (SuperArray, Bioscience Corp., USA) fol-
lowing the manufacturer’s instructions.
Transmission Electron Microscopy: MRC-5 cells were seeded on
4-chambered coverglass (Lab-tek Chambered Coverglass System) at a
density of 2 × 104 cells mL–1 (14000 cells/well). After 72 h of culture,
cells were fixed with 2.5% glutaraldehyde and washed three times
with PBS. Subsequently, post-fixation with 1% osmium tetroxide was
performed followed by dehydration with ascending series of alcohol
before embedding in araldite. Ultrathin sections were cut and doubly
stained with uranyl acetate and lead citrate. Images were acquired
using the Olympus EM208S transmission electron microscope.
Energy Dispersive X-ray (EDX) Analysis: The elemental composi-
tion of the TEM specimen was analyzed by the CM120 BioTWIN
electron microscope and Philips EDAXMicroanalysis system.
Statistical Analysis: Graphpad Prism statistical analysis software
was used in all statistical analysis, except for the PCR array data
which was analyzed with Student’s t-test in Microsoft Excel.
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a b s t r a c t
Elemental metal nanoparticles like cadmium and silver are known to cause oxidative stress and are
also highly toxic. Yet for gold nanoparticles (AuNPs), it is not well established whether these
particles are biologically toxic. Here we show that AuNPs, which were taken up by MRC-5 human
lung ﬁbroblasts in vitro, induce autophagy concomitant with oxidative stress. We also observed
formation of autophagosomes together with the uptake of AuNPs in the lung ﬁbroblasts as well as
upregulation of autophagy proteins, microtubule-associated protein 1 light chain 3 (MAP-LC3) and
autophagy gene 7 (ATG 7) in treated samples. AuNP treated cells also generated signiﬁcantly more
lipid hydroperoxides (p-value< 0.05), a positive indication of lipid peroxidation. Veriﬁcation with
western blot analysis for malondialdehyde (MDA) protein adducts conﬁrmed the presence of
oxidative damage. In addition, AuNP treatment also induced upregulation of antioxidants, stress
response genes and protein expression. Exposure to AuNPs is a potential source of oxidative stress in
human lung ﬁbroblasts and autophagy may be a cellular defence mechanism against oxidative stress
toxicity.
 2010 Elsevier Ltd. All rights reserved.
1. Introduction
Nanotoxicity is an emerging ﬁeld of research, a response to
growing uses of nanosized materials in a slew of technological
applications and consumer products [1]. Early research into toxic
effects of ultraﬁne carbon particles and carbon nanotubes high-
lighted the potential health risks from exposure of these particles in
our environment [2]. These particulates are potentially hazardous
when it comes in contact with the human body, especially the
respiratory system being the most vulnerable route of entry. In vivo
studies in rats exposed to aerosols of gold nanoparticles (AuNPs)
revealed that the nanoparticles were rapidly taken into the system
with the highest accumulation in the lungs, aorta, oesaphagus and
olfactory bulb [3]. Moreover, particles of nano-dimension are
believed to be more biologically reactive than their bulk counter-
parts due to their small size and larger surface area to volume
ratio [1].
Gold in its bulk form has long been considered an inert,
noble metal with some therapeutic and even medicinal value,
hence gold nanoparticles (AuNPs) are thought also to be rela-
tively non-cytotoxic [4]. Yet there are differing reports of the
extent of the toxic nature of these particles owing to the
different modiﬁcations of the AuNP, surface functional attach-
ments and the shape and diameter size of the nanospheres [5,6].
Moreover, the metallic nature of the metal derived NPs and the
presence of transition metals encourages the production of
reactive oxygen species (ROS) leading to oxidative stress [7e9].
Elemental metal NPs like cadmium and silver are known to
induce oxidative stress and apoptosis in various cell types
[10,11]. In spite of this, the link between AuNP and oxidative
stress is not well established. Most often, the harmful effects of
ROS may be manifested through damage of DNA, oxidations of
polyunsaturated fatty acids in lipids and oxidations of amino
acids in proteins [12]. Previously, we have shown that DNA
damage occurs in AuNP treated lung ﬁbroblast cells [13]. In this
study, we evaluated the presence of oxidative damage in lipids
and proteins of AuNP treated lung ﬁbroblast cells, as well as
gene proﬁling of oxidative stress markers and found evidence of
autophagosome formation.
2. Materials and methods
2.1. Cell culture
MRC-5 human fetal lung ﬁbroblast cells (ATCC No.: CCL-171) were cultured in
RPMI media supplemented with 10% fetal bovine serum (FBS) in 100 mg/ml peni-
cillin/streptomycin in 37 C 5% CO2 incubator.
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2.2. AuNP synthesis and preparation
Gold nanoparticles (AuNPs), 20 nm in diameter, were prepared in citrate
reduction of gold salts as previously described [13]. The citrate buffer was removed
and the nanoparticles were coated with fetal bovine serum, washed and recon-
stituted in phosphate buffer saline (PBS) solution. The size and zeta potential of
resultant AuNPs were measured using dynamic light scattering (Zetasizer NanoZS,
Malvern, UK) at 25 C. With FBS coating, the size of AuNPs increased from
22.11.9 nm to 35.5 3.9 nm, and the zeta potential changed from 40.6 2.1 mV
to11.31.1 mV. These values were in agreement with the literature values [14,15].
The AuNP solution was then sterile ﬁltered before addition into treatment media.
2.3. AuNP treatment
MRC-5 lung ﬁbroblasts were seeded in 6 wells cell culture plates (NUNC,
Denmark) at a seeding density of 4104 cells/ml and treated with 1 nM concen-
tration of AuNP in growth media the following day. Control cells were cultured in
growth media. Treated and control cells were then incubated for 72 h before
harvesting.
2.4. Transmission electron microscopy (TEM)
MRC-5 lung ﬁbroblasts were seeded onto 4-chambered coverglass (Lab-tek
Chambered Coverglass System) at a density of 2104 cells/ml (14,000 cells/well).
After 72 h of culture, cells were ﬁxed with 2.5% glutaraldehyde and washed 3 times
with PBS. Subsequent post-ﬁxation with 1% osmium tetroxide followed by dehy-
dration with ascending series of alcohol before embedding samples in araldite.
Ultrathin sections were cut and doubly stained with uranyl acetate and lead citrate.
Images were acquired using the Olympus EM208S transmission electron
microscope.
2.5. Oxidative stress PCR array
RNA from samples was extracted with the RNeasy Microkit (Qiagen). Reverse
transcription and realtime PCR were carried with proprietary kits and reagents from
Superarray, Biosciences according to manufacturer’s instructions. 84 key genes from
oxidative stress pathway were simultaneously assayed with the RT2 Proﬁler PCR
array plate (Superarray Biosciences).
Fig. 1. Cellular localization of AuNP in MRC-5 after 72 h treatment with 1 nM AuNP. Black arrows point to AuNP clusters inside the cell. (A and B) Control and AuNP treated MRC-5
cells as seen under light microscopy. Large aggregates of the gold particles may also be seen under light microscopy as bright blue spots in the cell cytoplasm, clustering around the
nucleus (B) which were not observed in the untreated control (A). Scale bars¼ 100 mm. Insets in both show a close-up view of the cells in the respective treatments. (C) AuNP in cell
cytoplasm enclosed within an endosome. Scale bar¼ 0.5 mm. (D) AuNPs found clustering in a lysosome. Scale bar¼ 0.2 mm. (E) Low magniﬁcation TEM shows numerous large
vacuoles found in the cytoplasm of AuNP treated cells. Scale bar¼ 5 mm.
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2.6. Lipid hydroperoxide assay
Lipid Hydroperoxide (LPO) Assay Kit from Caymen Chemicals. Lipid hydroper-
oxides were extracted in chloroform from sonicated samples following manufac-
turer’s instructions. A positive control sample was included as a validation of the
assay technique. Cells were treated with 10 mM hydrogen peroxide (H2O2) for 1 h
prior to extraction. To ensure that there were no interference from AuNPs, the
samples after lipid extraction were analysed with inductively coupled plasma mass
spectrometry (ICP-MS, Perkin Elmer) to evaluate the amount of AuNPs present in the
sample and its potential effect on the LPO assay.
2.7. Western blotting
Cells were washed in PBS and in 0.35 M sucrose solution. Samples were then
scraped and collected in 0.35 M sucrose containing protease inhibitor mix (Amer-
sham Biosciences). The cell pellets were collected and resuspended in lyses buffer
Fig. 2. TEM images of autophagosomes and cellular structures in MRC-5 cells treated with AuNPs for 72 h. Black arrows point to AuNP clusters. Autophagosome formations in AuNP
treated cells as indicated by red label “AP”. Lysosomes are indicated by white label “Ly”. Scale bars as indicated in ﬁgure. (A, B and C) Autophagosomes contain large amounts of
cellular debris within a double membrane. Some APs may contain AuNP clusters within (A) while others (B and C) do not. (D) High magniﬁcation view of a large vacuole containing
large clusters of AuNPs and cellular debris, possibly an autolysosome, a fusion of an autophagosome with a lysosome. (E and F) Besides these large vacuoles, the treated cells also
contain large numbers of dense endosomes and lysosomes.
Fig. 3. Western blots of MAP-LC3 protein expression after 48 h and 72 h treatment with 1 nM AuNP. Signiﬁcant upregulation in MAP-LC3-II protein expressions at both 48 h and 72 h
treatment with AuNP, comparing control with treated samples (OD p-value< 0.05). Error bars¼ SEM. MAP-LC3-I refers to the cytosolic form of the protein while the MAP-LC3-II
form is found on membranes of autophagosomes and serves as an indicator of autophagosome formation.
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containing 7 M urea, 2 M thiourea, 4% CHAPS, 20 mM dithiothreitol, 0.5% Pharmalyte
pH 4e7, proteinase inhibitor mix and nuclease mix (Amersham Biosciences). Protein
concentrations were determined using a 2-D Quant Kit (Amersham Biosciences).
The proteins were resolved on SDS page gel and transferred onto PVDF membrane
via semidry transfer (BioRad). Membranes were blocked in 5% non-fat milk and
washed in Tris-buffered saline in 0.1% Tween. Membranes were incubated with
primary antibody and then in corresponding secondary antibody with 3 washing
step in between. Protein bands were developed with chemiluminescence substrate
(Pierce) and visualised on XPress CL blue ray ﬁlm (Pierce). Optical densities of bands
weremeasured on the GS710 Densitometer and band intensities were analysed with
Quantity One image analysis software (Biorad).
2.8. Statistical analysis
Graphpad Prism statistical analysis software was used in all statistical analysis,
except for the PCR array data which was analysed with Student’s t-test in Microsoft
Excel.
3. Results and discussions
3.1. Internalization of AuNPs in cells
After 72 h of AuNP treatment, particles may be so highly
aggregated in the cell cytoplasm that they appear as bright blue
spots under light microscopy (Fig. 1A and B). Additionally, we
noticed that AuNP clusters accumulated in endosomes and lyso-
zomes in the cytoplasm (Fig. 1C and D), which is not surprising as
these are the eventual endpoints of ingested materials marked for
degradation [16]. The AuNP treated ﬁbroblasts appeared to be
highly active with many of them exhibiting large numbers of
vacuoles in the cytoplasm (Fig. 1E), with many of which contained
large clusters of AuNPs.
3.2. Autophagosome formation induced by AuNPs
A number of AuNPs were found clustered in vesicles containing
cell-membrane like debris in the cytoplasm which are typical
features of autophagosomes (Fig. 2AeE). Some of the cellular
materials were found in characteristic double membrane vesicles
(Fig. 2B and C). In light of this ﬁnding, we performed western blots
in protein extracts from the cells to probe for autophagy protein
microtubule-associated protein 1 light chain 3 (MAP-LC3) over 48 h
and 72 h treatment with AuNPs. The conjugated MAP-LC3-II
protein expression of the cells was signiﬁcantly higher than the
controls (Fig. 3, p-value< 0.05) which correlates with
autophagosome formation [17]. Next, we looked at the 4 other
autophagy proteins associated with autophagosome formation. At
72 h, autophagy gene 7 (ATG 7) protein was found to be signiﬁ-
cantly higher in AuNP treated samples than in control (Fig. 4B,
p-value< 0.05). However, western blots of other proteins like ATG
5, BECN1 (or ATG 6), ATG 12 protein expressions were slightly
higher in treated and the OD values were not signiﬁcant when
compared with controls (Fig. 4A, C and D).
While the link between oxidative stress leading to autophagy is
quite established [18], few works have demonstrated that nano-
particles could cause autophagy. The function of autophagy is still
not clearly understood but it is generally thought to be a natural
process to maintain cellular homeostasis as well as a cellular
response to starvation, infection or disease progression. It was only
until recently that this has been recognized as a type II pro-
grammed cell death and a cell survival mechanism in times of stress
[19,20]. The hypothesis is that while AuNP treatment induces
oxidative stress, the cell may be able to avoid cell death through
autophagic pathways. It is also likely that the oxidative
Fig. 4. Western blots of autophagy proteins at 72 h AuNP treatment. (A) ATG 5 (B) ATG 7 (C) BECN1 (ATG 6) (D) ATG 12 showed similar upregulation in protein expression but only
ATG 7 signiﬁcantly so (OD p-value< 0.05). Error bars¼ SEM.
Fig. 5. Lipid hydroperoxide assay (LPO assay) of control, AuNP treated and hydrogen
peroxide treated samples. AuNP treated cells produce signiﬁcantly more hydroper-
oxide compared with control (*p-value< 0.05). Hydrogen peroxide treatment serves as
positive control for assay (**p-value< 0.01 compared with control). Error bars¼ SEM.
J.J. Li et al. / Biomaterials 31 (2010) 5996e6003 5999
Author's personal copy
environment could trigger off the autophagic process [21,22],
rather than a direct cellular reaction to AuNP presence in the cell.
Others like Funnell and Maysinger suggest that there may be
localized sites of oxidative stress around clusters of metal-based
nanoparticles, therefore containing the extent of damage in the
cells [23].
Of the 5 autophagy proteins investigated, we found ATG 7 and
MAP-LC3-II to have signiﬁcantly higher expression in treated
samples. ATG 7 is known to be an essential enzyme in the 2 major
autophagy conjugation systems [24]. It activates ATG 12 for
downstream conjugation to ATG 5 and catalyses MAP-LC3-I to the
autophagosomal marker MAP-LC3-II; both proteins are key acti-
vators and constituents of the autophagosome membrane forma-
tion process [25,26]. While higher expressions of ATG 7 could
translate to an increase of autophagosome activation, not seeing
a corresponding change in other ATG protein expression levels may
imply that these proteins were transiently expressed. We had
previously found AuNPs to induce DNA damage possibly through
oxidative stress [13]. Some recent papers suggest that in such cases,
DNA damage induced by oxidative stress activates poly(ADP-
ribose) polymerase 1 (PARP-1) which in turn activates autophagy
through a novel LKB1-AMPK signalling pathway [26e28]. On the
other hand, knocking down ATG 5 and ATG 7 causes cells to be
more susceptible to oxidative stress induced cell death [27]. This
may be a possible explanation why cells continue to thrive despite
harsh treatment with nanoparticles.
3.3. Oxidative stress induced by AuNPs
With regards to our previous ﬁndings on oxidative DNA damage
induced by AuNPs, [13] here we further attempted to validate the
presence of oxidative stress in cells by measuring the hydroper-
oxide concentration in lipid extracts of treated and control samples.
We found that the hydroperoxide concentration was signiﬁcantly
higher in treated cells than the control cells (Fig. 5; p-value< 0.05).
This provides evidence that AuNP treatment could generate
oxidative stress in MRC-5 lung ﬁbroblasts. To allay the concern that
the presence of AuNP in cells may interfere with the assay absor-
bance due to the strong surface plasmon effect, trace gold content
in AuNP treated samples was analysed via inductively coupled
plasma mass spectroscopy (ICP-MS). The result (Fig. S1 in
Supplementary Information) showed that the gold concentration
in treated samples was negligible (<10 ppb), implying that there
was little interference from AuNP in the assays. In addition, we
evaluated malondialdehyde (MDA) modiﬁed protein adducts by
western blotting as a further veriﬁcation of the presence of lipid
peroxidation. MDA is a byproduct of lipid oxidation by free radicals
and ROS and this aldehyde reacts readily with protein or DNA
forming adducts which are considered to be highly genotoxic.
Clearly, the amount of proteins alkylated by MDA was signiﬁcantly
more in the AuNP treated samples than that in control samples
(Fig. 6; p-value< 0.05), particularly the 2 prominent bands at the
70 kDa and 75 kDa regions.
3.4. Gene proﬁling of AuNP treated MRC-5 cells
We investigated other oxidative stress related molecules that
were affected by AuNP treatment using the RT2 Proﬁler PCR array
(oxidative stress pathway, full set of genes are listed in Table 2). We
found 4 out of the 84 genes to be signiﬁcantly upregulated in AuNP
treated lung ﬁbroblasts (Table 1, p-value< 0.05). Polynucleotide
kinase 30-phosphatase (PNK) and the cyclooxygenase 2 (COX-2) were
the highest positively altered genes, followed by oxidative stress
responsive 1 (OXSR1) and peroxiredoxin 2 (PRDX2) genes. Expression
of PNK and COX-2 proteins was also concomitantly and
signiﬁcantly increased with AuNP treatment compared to control
(Fig. 7A and B, p-value< 0.05). The PNK protein is known to
function in DNA double strand break repair [29]. COX-2 a stress
inducible enzyme, is expressed only in certain cell types and is an
indicative marker of inﬂammation [30]. Its association with
oxidative stress has only been recently established as 4-hydrox-
ynonenal, another aldehydic product of lipid peroxidation was
found, in combination with oxidized low density lipoprotein (LDL),
to be potent inducers of COX-2 [31]. It is likely that MDA could also
induce COX-2 expression in a similar manner to 4-hydroxynonenal
Fig. 6. Whole cell lysate western blot against MDA protein adducts showing signiﬁcant
increase in OD values of AuNP treated cells (OD p-value< 0.05). Error bars¼ SEM.
Table 1
PCR Array RT2 Proﬁler results showing genes that were signiﬁcantly upregulated.
Gene Fold regulation p value (<0.05)
OXSR1 Oxidative-stress responsive 1 1.30 0.0373
PNK Polynucleotide kinase 30-phosphatase 1.59 0.0386
PRDX2 Peroxiredoxin 2 1.29 0.0414
COX-2 Cyclooxygenase-2 1.45 0.0379
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as MDA adducts are also present in LDL [32]. The increase in
aldehydic products of lipid peroxidation together with the oxida-
tive modiﬁcation of LDL could contribute to induction of COX-2
expression [33]. On the other hand, MDA is also known to be
a product of prostaglandin biosynthesis [34], therefore setting up
a feedback loop by which the production of MDA in turn further
induces expression of COX-2.
The results put together validate the notion that AuNP induces
oxidative stress in human lung ﬁbroblast cells. However, the repair
mechanism for damaged DNA in the lung ﬁbroblasts may be
functionally intact as upregulation of PNK in treated cells may be
indicative of the response by the cellular repair system reacting to
the oxidative DNA damage induced by the AuNP treatment.
However, there was upregulation of such genes such as
Table 2
Gene Table of the 84 genes assayed with Human Oxidative Stress pathway PCR array RT2 Proﬁler.
Gene Description Fold change p-value Gene Description Fold change p-value
ALB Albumin 1.10 0.5909 MTL5 Metallothionein-like 5, testis-speciﬁc (tesmin) 1.22 0.1046




ANGPTL7 Angiopoietin-like 7 1.47 0.3951 NCF2 Neutrophil cytosolic factor 2 (65 kDa, chronic
granulomatous disease, autosomal 2)
1.20 0.2147
AOX1 Aldehyde oxidase 1 1.23 0.2245 NME5 Non-metastatic cells 5, protein expressed in
(nucleoside-diphosphate kinase)
1.07 0.4729
APOE Apolipoprotein E 1.42 0.2483 NOS2A Nitric oxide synthase 2A (inducible,
hepatocytes)
1.48 0.5759
ATOX1 ATX1 antioxidant protein 1 homolog (yeast) 1.00 0.9764 NOX5 NADPH oxidase, EF-hand calcium binding
domain 5
1.10 0.8791
BNIP3 BCL2/adenovirus E1B 19 kDa interacting
protein 3
1.11 0.6041 NUDT1 Nudix (nucleoside-diphosphate linked
moiety X)-type motif 1
1.14 0.0713
CAT Catalase 1.13 0.4883 OXR1 Oxidation resistance 1 1.10 0.8328
CCL5 Chemokine (CeC motif) ligand 5 1.52 0.1072 OXSR1 Oxidative-stress responsive 1 1.30 0.0373
CCS Copper chaperone for superoxide dismutase 1.20 0.4568 PDLIM1 PDZ and LIM domain 1 (elﬁn) 1.09 0.7943
CSDE1 Cold shock domain containing E1, RNA-binding 1.17 0.1914 PIP3-E Phosphoinositide-binding protein PIP3-E 1.31 0.5485
CYBA Cytochrome b-245, alpha polypeptide 1.27 0.2839 PNKP Polynucleotide kinase 30-phosphatase 1.59 0.0386
CYGB Cytoglobin 1.38 0.3042 PRDX1 Peroxiredoxin 1 1.00 0.9737
DGKK Diacylglycerol kinase, kappa 1.31 0.3837 PRDX2 Peroxiredoxin 2 1.29 0.0414
DHCR24 24-dehydrocholesterol reductase 1.48 0.1174 PRDX3 Peroxiredoxin 3 2.00 0.3388
DUOX1 Dual oxidase 1 1.04 0.9268 PRDX4 Peroxiredoxin 4 1.01 0.9018
DUOX2 Dual oxidase 2 1.31 0.3837 PRDX5 Peroxiredoxin 5 1.14 0.2322
DUSP1 Dual speciﬁcity phosphatase 1 1.29 0.2056 PRDX6 Peroxiredoxin 6 1.26 0.1177




EPX Eosinophil peroxidase 1.10 0.7729 PRG3 Proteoglycan 3 1.31 0.3837





GLRX2 Glutaredoxin 2 1.13 0.3527 PTGS1 Prostaglandin-endoperoxide synthase 1
(prostaglandin G/H synthase and
cyclooxygenase)
1.34 0.1879
GPR156 G protein-coupled receptor 156 1.01 0.9317 PTGS2 Prostaglandin-endoperoxide synthase 2
(prostaglandin G/H synthase and
cyclooxygenase)
1.47 0.0379
GPX1 Glutathione peroxidase 1 1.10 0.5627 PXDN Peroxidasin homolog (Drosophila) 1.23 0.0679
GPX2 Glutathione peroxidase 2 (gastrointestinal) 1.30 0.5481 PXDNL Peroxidasin homolog (Drosophila)-like 1.24 0.5688
GPX3 Glutathione peroxidase 3 (plasma) 1.11 0.5260 RNF7 Ring ﬁnger protein 7 1.12 0.3162
GPX4 Glutathione peroxidase 4 (phospholipid
hydroperoxidase)
1.24 0.3008 SCARA3 Scavenger receptor class A, member 3 1.39 0.0569
GPX5 Glutathione peroxidase 5 (epididymal
androgen-related protein)
1.11 0.8053 SELS Selenoprotein S 1.34 0.0647
GPX6 Glutathione peroxidase 6 (olfactory) 1.10 0.8333 SEPP1 Selenoprotein P, plasma, 1 1.17 0.3312
GPX7 Glutathione peroxidase 7 1.03 0.8865 SFTPD Surfactant, pulmonary-associated protein D 1.70 0.1395
GSR Glutathione reductase 1.18 0.7512 SGK2 Serum/glucocorticoid regulated kinase 2 1.40 0.3661
GSS Glutathione synthetase 1.15 0.3164 SIRT2 Sirtuin (silent mating type information
regulation 2 homolog) 2 (S. cerevisiae)
1.35 0.1520
GSTZ1 Glutathione transferase zeta 1
(maleylacetoacetate isomerase)
1.13 0.2953 SOD1 Superoxide dismutase 1, soluble (amyotrophic
lateral sclerosis 1 (adult))
1.07 0.5305
GTF2I General transcription factor II, i 1.32 0.0719 SOD2 Superoxide dismutase 2, mitochondrial 1.10 0.3821
KRT1 Keratin 1 (epidermolytic hyperkeratosis) 1.31 0.3837 SOD3 Superoxide dismutase 3, extracellular 1.01 0.9787
LPO Lactoperoxidase 1.31 0.3837 SRXN1 Sulﬁredoxin 1 homolog (S. cerevisiae) 1.46 0.0818
MBL2 Mannose-binding lectin (protein C) 2, soluble
(opsonic defect)
1.31 0.3837 STK25 Serine/threonine kinase 25 (STE20 homolog,
yeast)
1.10 0.6343
MGST3 Microsomal glutathione S-transferase 3 1.04 0.7765 TPO Thyroid peroxidase 1.35 0.5574
MPO Myeloperoxidase 1.37 0.5614 TTN Titin 1.29 0.5276
MPV17 MpV17 mitochondrial inner membrane protein 1.03 0.7168 TXNDC2 Thioredoxin domain containing 2
(spermatozoa)
3.74 0.1001
MSRA Methionine sulfoxide reductase A 2.91 0.3895 TXNRD1 Thioredoxin reductase 1 1.10 0.7870
MT3 Metallothionein 3 1.99 0.3063 TXNRD2 Thioredoxin reductase 2 1.04 0.8400
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peroxiredoxin 2 (PRP), another antioxidant and OSR1, a MAP4Kinase
activated by osmotic stresses [35], which conferred protection
against oxidative stress.
With regard to COX-2 and autophagy, a previous study showed
that when celecoxib, a COX-2 inhibitor, is applied, it promoted cell
growth arrest and autophagy in glioblastoma cells [36]. Yet others
report no difference in COX-2 expression when autophagy is
inhibited [37]. It appears that there may be more than one autoph-
agy signalling pathway involved and thus regulation of these could
be controlled by other signalling proteins or factors yet unknown.
4. Conclusion
We surmise that the effect of the treatment of AuNP induces
oxidative damage in lung ﬁbroblast cells, pulling together a myriad
of antioxidants and stress response proteins in a defence pathway.
While the presence of AuNP could create an oxidative environment,
it also affects the regulation of cellular stress response mechanisms
and at the same time induces the formation of autophagosomes,
possibly to protect the cell from succumbing to oxidative stress.
Acknowledgement
This work was supported by research funding from the
Singapore Ministry of Education Academic Research Fund Tier 1 via
grant R279-000-205-112 and Tier 2 via grant MOE2008-T2-1-046,
and the National University of Singapore (NUS) Environmental
Research Institute (NERI) via grant R706-000-002-646.
Appendix. Supplementary material
Supplementary material associated with this article can be
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Figures with essential color discrimination. Fig. 2 in this article
has parts that are difﬁcult to interpret in black and white. The full
color images can be found in the on-line version, at doi:10.1016/j.
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Gold nanoparticles (AuNPs) are one of the most versatile and widely researched materials for novel
biomedical applications. However, the current knowledge in their toxicological proﬁle is still incomplete
and many on-going investigations aim to understand the potential adverse effects in human body. Here,
we employed two dimensional gel electrophoresis to perform a comparative proteomic analysis of AuNP
treated MRC-5 lung ﬁbroblast cells. In our ﬁndings, we identiﬁed 16 proteins that were differentially
expressed in MRC-5 lung ﬁbroblasts following exposure to AuNPs. Their expression levels were also
veriﬁed by western blotting and real time RT-PCR analysis. Of interest was the difference in the oxidative
stress related proteins (NADH ubiquinone oxidoreductase (NDUFS1), protein disulﬁde isomerase asso-
ciate 3 (PDIA3), heterogeneous nuclear ribonucleus protein C1/C2 (hnRNP C1/C2) and thioredoxin-like
protein 1 (TXNL1)) as well as proteins associated with cell cycle regulation, cytoskeleton and DNA
repair (heterogeneous nuclear ribonucleus protein C1/C2 (hnRNP C1/C2) and Secernin-1 (SCN1)). This
ﬁnding is consistent with the genotoxicity observed in the AuNP treated lung ﬁbroblasts. These results
suggest that AuNP treatment can induce oxidative stress-mediated genomic instability.
 2011 Elsevier Ltd. All rights reserved.1. Introduction
The current knowledge of the toxicological proﬁle of gold
nanoparticles (AuNPs) is incomplete and this is inhibiting their
use in many clinical applications including diagnostic imaging [1],
drug delivery [2,3] and photothermal therapy [4]. Bulk gold is
a yellow solid and relatively inert, while AuNPs at nanosize appear
wine red in solution and their biological activity is still not entirely
understood. The unique characteristics and properties of the
nanosized particles also make it hard to predict their biological
reactivity. Some studies have suggested that AuNPs may cause
toxicity in vitro, citing oxidative stress and DNA damage as results
of AuNP treatment [5,6,7]. In vivo studies also reﬂect similar
observations; AuNPs exhibited pulmonary toxicity and genotox-
icity in mice as well as oxidative stress in aquatic species [8,9]. One
study on inhalation exposed rats to AuNPs also showed. Bay), cheyly@nus.edu.sg
All rights reserved.
, Genomic instability of gold ndifferential expression in global gene analysis in various organ
tissues [10]. As we had previously reported, AuNP treatment also
induces oxidative stress, autophagy and DNA damage in vitro
[5,11]. It would seem that, there is still a need to perform in depth
investigations on the toxicity proﬁle of AuNPs for its use in bio-
applications to be safe and meaningful.
Proteomic techniques, such as two dimensional gel electro-
phoresis (2D-GE), are useful tools in the ﬁeld of drug and
toxicity studies. In 2D-GE, proteins are separated according to 2
measures, ﬁrstly by their isoelectric points and secondly by
molecular weight through SDS-PAGE gel electrophoresis. It is
one of the most common tools currently used in toxicity studies
today. Coupling it with mass spectrometry, speciﬁcally the
matrix-assisted laser desorption/ionization time-of-ﬂight mass
spectrometry (MALDI TOF MS), allows the identiﬁcation of
protein biomarkers of disease progression or predictive markers
of toxicogenesis [12]. The use of proteomic techniques in toxi-
cological studies is steadily growing as the ﬁeld relies more
heavily on molecular data to identify critical protein changes
and pathways to provide a reliable predictive platform for drug
development and toxicological proﬁling [13,14]. A number ofanoparticle treated human lung ﬁbroblast cells, Biomaterials (2011),
J.J. Li et al. / Biomaterials xxx (2011) 1e92researches have classiﬁed the use of proteomics in toxicity
studies into two levels. Tier I analysis refers to global protein
mapping and proﬁling for differential expression while Tier II
involves elucidating the protein functions and interactions as
well as how speciﬁc post-translational modiﬁcations and their
threedimensional structure affect these processes [14].
The primary focus of the current study was on the quantiﬁ-
cation and identiﬁcation of proteins (Tier I analysis) and its
differential expression upon AuNP treatment since nanomaterial-
induced toxicological proﬁles are still largely unknown. We per-
formed a comparative analysis of the protein expression proﬁle of
AuNP treated and control human fetal MRC-5 lung ﬁbroblasts. To
conﬁrm the proteomic ﬁndings, selected protein expression results
were veriﬁed by western blotting and real time RT-PCR analysis. In
addition, we further correlated the above investigations with the
alkaline single-cell gel electrophoresis assay (comet assay) and the
ﬂuorescence in situ hybridization (FISH) assay to assess DNA
damage and chromosomal aberrations caused by in vitro exposure
to AuNPs.Fig. 1. Representative map of silver-stained two dimensional electrophoresis from MRC-5 w
were labeled with their respective Swiss-Prot accession numbers.
Please cite this article in press as: Li JJ, et al., Genomic instability of gold n
doi:10.1016/j.biomaterials.2011.04.0232. Materials & methods
2.1. Cell culture
The cells used were MRC-5 human fetal lung ﬁbroblast cells (ATCC No.: CCL-171)
cultured in RPMI 1640 media and supplemented with 10% fetal bovine serum (FBS)
in 100 mg/ml penicillin/streptomycin in a 37 C, 5% CO2 incubator.
2.2. AuNP synthesis and preparation
Gold nanoparticles (AuNPs) of 20 nm in diameter, were prepared in citrate
reduction from gold salts. The nanoparticles were spun down to remove the citrate
buffer and subsequently coated with fetal bovine serum, washed and reconstituted
in phosphate buffer saline (PBS) solution to form the stock solution. The AuNP stock
solution was then sterile ﬁltered before addition into treatment media.
2.3. AuNP treatment
MRC-5 cells were seeded in 6 wells cell culture plates (NUNC) at a seeding
density of 4  104 cells/ml and treated with 1 nM concentration of AuNP in growth
media the following day. Control cells were cultured in growth media. Treated and
control cells were then incubated for 72 h before harvesting.hole cell lysate focused on a non-linear pH 4e7 IPG strip. Sixteen proteins identiﬁed
anoparticle treated human lung ﬁbroblast cells, Biomaterials (2011),
Table 1
List of protein spots undergoing quantitative changes with AuNP treatment as identiﬁed by MALDI-TOF/TOF MS.
Protein namea Accession no.a Protein score/%
coverageb




NADH ubiquinone oxidoreductase P28331 664/45 80,443/5.89 þ12.1171 <0.0001
Lysyl-tRNA synthetase Q15046 130/11 68,461/5.94 þ2.7730 0.0052
Protein disulﬁde isomerase associated 3 P30101 440/25 54,454/6.78 Not detected in control NA
428/36 54,454/6.78 Not detected in control NA
926/45 54,454/6.78 þ1.4547 0.0461
V-type proton ATPase subunit B P21281 891/60 55,708/5.40 þ3.2155 0.0383
Secernin-1 Q12765 141/13 47,020/4.69 1.5945 0.0041
Vimentin P08670 794/66 49,680/5.19 1.8346 0.0023
Ribonuclease inhibitor P13489 102/42 51,766/4.71 þ1.6793 0.0195
Eukaryotic translation initiation factor 2 subunit 2 P20042 84/15 38,706/5.60 þ1.5887 0.0031
Heterogeneous nuclear ribonucleoproteins C1/C2 P07910 430/25 32,375/4.94 1.7400 0.0006
54/15 32,375/4.94 1.8196 0.0007
55/12 32,375/4.94 1.6838 0.0061
Erlin 2 O94905 216/51 38,044/5.47 þ1.5043 0.0004
Protein kinase C delta-binding protein Q969G5 429/38 27,685/6.05 1.5111 0.0013
Thioredoxin-like protein 1 O43396 129/53 32,630/4.84 2.3040 0.0002
C-terminal-binding protein 2 P56545 125/33 49,427/6.47 1.5745 0.0024
Ubiquitin carboxyl terminal hydrolase isozyme L1 P09936 287/48 25,151/5.33 þ2.3386 0.0085
Glutathione S-transferase P P09211 406/47 23,569/5.43 þ2.8476 0.0026
Translationally-controlled tumor protein P13693 184/45 19,697/4.84 þ2.9485 0.0019
a Protein name and accession numbers were derived from Swiss-Prot.
b Protein score, percentage of coverage and Mr (Da)/PI were derived from MASCOT.
c Protein spots were quantiﬁed based on the normalized average percentage of volume derived from ImageMaster 2D Platinum 6.0 software analysis.
d Approximate fold-changes of protein expression were derived from the ratio of normalized average percentage of volume of treatment to control protein spots or vice
versa. A “þ” indicates upregulation in the nano gold particles treated samples while “e” indicates downregulation.
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Cells were washed once in PBS and then twice in 0.35 M sucrose to minimize
contamination with salts. The cells were then harvested with a cell scrapper in
0.35 M sucrose containing proteinase inhibitor mix (Amersham Biosciences). The cell
pellets were collected after centrifugation at 2000 rpm for 5 min at 4 C and was
subsequently resuspended in lyses buffer containing 7 M urea, 2 M thiourea, 4%
CHAPS, 20 mM dithiothreitol, 0.5% Pharmalyte pH 4e7, proteinase inhibitor mix and
nuclease mix (Amersham Biosciences). Protein concentrations were determined
using a 2 D Quant Kit (Amersham Biosciences).2.5. Two dimensional gel electrophoresis (2D-GE)
For analytical and preparative gels, approximately 80 ug and 240 ug respectively,
of proteins were loaded into the rehydrated 18 cm non-linear Immobilized pH
gradient (IPG) strip (pH 4e7) using the cup-loading method. The ﬁrst dimensional
isoelectric focusing (IEF) run was carried out using the following conditions: (i)
300 V, 450 V h; (ii) 500 V, 250 V h; (iii) 1000 V,1000 V h; (iv) 1000e8000 V, 3500 V h
and (v) 8000 V, 32,000 V h. Voltage increases for (i), (ii), (iii), and (v) were performed
on a “stepwise” basis, while the increase for (iv) was on a “linear gradient”. This was
followed by the second dimensional SDS-PAGE, performed on 1.0 mm 9% poly-
acrylamide gels at a constant power of 10 W per gel at 16 C by using Ettan DALTsix
electrophoresis system (Amersham Biosciences). All samples were run in triplicate
to ensure reproducibility.2.6. Protein visualization and image analysis
2 D gels were visualized by staining with PlusOne silver staining kit (GE
Healthcare) according to manufacturer’s instructions. Silver-stained gels were
scanned by an image scanner and all the triplicate gels were then analyzed with
ImageMaster 2D Platinum 6.0 (GE Healthcare).2.7. In-gel reduction, alkylation and trypsin digestion of protein spots
Silver-stained protein spots were excised manually and cut into small pieces.
The gel pieces were dehydrated in 100 ml of 100% acetonitrile, dried and rehydrated
in 20 ul of solution containing 10 mM dithiothreitol in 100 mM ammonium bicar-
bonate. Further preparation involved repeated wash and dehydration steps with
ammonium bicarbonate and acetonitrile. The gel pieces were subsequently digested
with 10 ml of 0.01 mg/ml sequencing grade modiﬁed trypsin (Promega) in 50 mM
ammonium bicarbonate and incubated at 37 C for 14 h. To enhance peptide
extraction, 10 ml of 0.1% triﬂuoroacetic acid in 50% acetonitrile was added to the gel
pieces for ﬁnal extraction. The extracts were dried in a Speedvac before mass
spectrometry analysis.Please cite this article in press as: Li JJ, et al., Genomic instability of gold n
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Dried extract was re-dissolved in 1 ml of matrix solution containing 5mg/ml of a-
cyano-4 hydroxycinnamic acid (CHCA) in 0.1% triﬂuoroacetic acid and 50% aceto-
nitrile. The extract was spotted onto the MALDI target plate, and allowed to dry in
air, prior to mass spectrometry analysis using an Applied Biosystems 4800 Proteo-
mics Analyzer MALDI-TOF/TOF Mass Spectrometer (Framingham). For the purposes
of peptide and protein identiﬁcation, the GPS explorer software Version 3.6
(Applied Biosystems) was used to create and search ﬁles with the MASCOT search
engine (Version 2.1; Matrix Science).
2.9. Western blotting
Protein extracted from cell lysates as described abovewas resolved on SDS-PAGE
gel and transferred onto PVDFmembrane via semidry transfer (BioRad). Membranes
were blocked in 5% non-fat milk andwashed in Tris-buffered salinewith 0.1% Tween.
Membranes were incubated with primary antibody, followed by the corresponding
secondary antibodywith 3washing steps in between. Protein bands were developed
with chemiluminescence substrate (Pierce) and visualized on XPress CL blue ray ﬁlm
(Pierce). Optical densities of bands were measured on the GS710 Densitometer and
band intensities were analyzed with Quantity One image analysis software (Biorad).
Primary antibodies usedwere as follows: PDIA3 (ab10287, Abcam) and hnRNP C1/C2
(ab10294, Abcam).
2.10. Real time RT-PCR
MRC-5 cells were treated with AuNPs for 48 h prior to RNA extraction with
RNeasy Mini kit (Qiagen). Total RNA was then converted to cDNA with the Super-
script III First Strand cDNA Synthesis kit (Invitrogen). Subsequently, real time PCR
was carried out on an ABI 7900HT system using the FAST format and SYBR green
mastermix (Applied Biosystems). Primer sequences for the genes of interest are
listed as follows: Protein disulﬁde isomerase associate 3 (PDIA3/ERp57) AAG CTC
AGC AAAGAC CCA AA (forward), CAC TTA ATT CAC GGC CAC (reverse); V-type proton
ATPase B2 (VATB) GAG GGG CAG ATC TAT GTG GA (forward), GGC TTC TTC TCC AAC
GAC AG (reverse); heterogeneous nuclear ribonucleus protein C1/C2 (hnRNP CI/C2)
TGT GGA GGC AAT CTT TTC GA (forward), TGA TAC ACG CTG ACG TTT CG (reverse);
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) GAA GGT
GAA GGT CGG AGT CAA CG (forward), TGC CAT GGG TGG AAT CAT ATT GG (reverse).
Fold change was calculated with the DD2CT method.
2.11. Alkaline single-cell gel electrophoresis (comet assay)
Treated cells were harvested and washed twice in PBS before resuspending in
phosphate buffer saline solution (PBS). The cells were embedded in 0.8% low
melting agarose (Pronadisa, Spain) on comet slides (Trevigen) and lysed in pre-
chilled lysis solution (2.5 M NaCl, 0.1 M EDTA, 10 mM Tris base, pH 10) with 1%
Triton  (Trevigen) for 1 h at 4 C. Cells were then subjected to denaturation inanoparticle treated human lung ﬁbroblast cells, Biomaterials (2011),
Fig. 2. Two dimensional gel electrophoresis (2D-GE) of AuNPs treated cellular protein extracts. Arrows with respective labels indicate protein spots with signiﬁcant differences in
expression. Comparing control and AuNP treated samples reveal spot differences. Upon mass spectrometry analysis, protein spots were identiﬁed as indicated.
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ature. Electrophoresis was performed at 25 V and 300 mA for 20 min. The slides
were immersed in neutralization buffer (0.5 M Tris-HCl, pH 7.5) for 15 min fol-
lowed by dehydration in 70% ethanol. Subsequently they were air-dried and
stained with SYBR green dye. The tail moments of the nuclei were measured as
a function of DNA damage. Analysis was done using comet imager v1.2 software
(Metasystems GmbH). 50 comets were analyzed per concentration. Experiments
were done in duplicates.Please cite this article in press as: Li JJ, et al., Genomic instability of gold n
doi:10.1016/j.biomaterials.2011.04.0232.12. Florescence in situ hybridization assay (FISH assay)
The FISH assay detects and identiﬁes types of DNA damage and aberrations.
MRC-5 cells were treated in the typical condition of 1 nM AuNP for 72 h and allowed
to grow for another 24 h in the absence of AuNPs. The cells were subsequently
arrested at mitosis by treatment with colcemid (0.1 mg/ml) in media. Cells were then
ﬁxed in Carnoy’s ﬁxative and then incubated with a hypotonic solution (0.075 M KCl)
at 37 C for 15 min. Subsequently, cells were stained with telomere speciﬁc peptideanoparticle treated human lung ﬁbroblast cells, Biomaterials (2011),
Fig. 2. (continued).
J.J. Li et al. / Biomaterials xxx (2011) 1e9 5nucleic acid (PNA) probes labeled with Cyc3 and centromere speciﬁc PNA probes
labeled with FITC. The cells were counterstained with 40 ,6-diamidino-2-phenyl-
indole (DAPI) to visualize the chromosomes. Metaphase spreads (50 per treatment)
were captured on a Zeiss Axioplan 2 imaging ﬂuorescence microscope (Carl Zeiss)
and analysed using the in situ imaging software (Metasystems GmbH).
2.13. Statistical analysis
All statistical analyses were performed on the Graphpad Prism 4.0 software.
Statistical analyses of the values for all experiments are expressedasmean standard
deviation. The data were analyzed using Student’s t test or One-Way ANOVA
(Graphpad Prism, USA). Those with p < 0.05 are considered as signiﬁcant.
3. Results
3.1. Two dimensional gel electrophoresis
Sixteen proteins were found to be differentially expressed in the
treated samples (Fig. 1, Table 1, p < 0.05). The identities of these
proteins were revealed by mass spectrometry as shown in Fig. 2. Of
particular interests are many of the proteins associated with theFig. 3. Western blotting of oxidative stress related proteins hnRNP and PDIA3 proteins. (A) h
41 kDa and 43 kDa. Optical density of band intensity of control compared with AuNP trea
Conversely, probing with PDIA3 antibodies reveal an upregulation in AuNP treated samples.
control (p-value < 0.01). Error bars ¼ SEM.
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NADH ubiquinone oxidoreductase (NDUFS1) and a 2.7 fold upre-
gulation for disulﬁde isomerase associated 3 (PDIA3) protein (also
known as ER60 or ERp57), an endoplasmic reticulum protein
associated with cellular stress [15] (Fig. 2 & Table 1; p < 0.05). The
heterogeneous nuclear ribonucleoproteins C1/2 (hnRNP C1/2), an
mRNA binding protein involved in mRNA export, localization,
translation and stability [16] showed signiﬁcant downregulation by
almost 2 fold with AuNP treatment as compared to control (Table 1,
p < 0.01). Thioredoxin-like protein isoform 1 (TXNL1), a thio-
redoxin which is involved in regulating oxidative stress [17] was
observed to be down-regulated by more than 2 fold in the treated
samples (Table 1, p ¼ 0.0002). Western blotting also conﬁrmed
signiﬁcant downregulation of hnRNP C1/2 expression (Fig. 3,
p < 0.01) and increased PDIA3 protein expression in AuNP treated
samples (Fig. 3, p < 0.01). In addition, several proteins associated
with cell cycle regulation, cytoskeleton and DNA repair were also
affected (Table 1). They include heterogeneous nuclear ribonucleus
protein C1/C2 (hnRNP C1/C2) and Secernin-1 (SCN1).nRNP antibodies probe for both C1 and C2 isoforms visualised as 2 bands at band size
ted samples show downregulation of hnRNP protein expression (p-value < 0.01). (B)
Optical density of band intensity is signiﬁcantly higher in AuNP treatment compared to
anoparticle treated human lung ﬁbroblast cells, Biomaterials (2011),
Fig. 4. Fold change of PDIA3, VATB and hnRNP C1/C2 genes from real time RT-PCR
analysis at 24 h and 48 h post AuNP treatment. Although results were not signiﬁ-
cant, the trend in gene expression corresponds with our results in the proteomics
assay. PDIA3 and VATB gene expressions showed an upregulation in fold change with
time while hnRNP C1/C2 gene expression exhibited a downward trend that matched
the decrease in the protein expression level.
Fig. 5. Comet assay on control and AuNP treated MRC-5 lung ﬁbroblasts. Cells were treated
SYBR greenwhich visualizes the comet “tail”, the length of which is an indicator of DNA dam
longer tail, indicative of the presence of higher DNA damage, particularly strand breaks. (C)
cells have signiﬁcantly higher DNA damage than control (p-value < 0.05). Tail moment is u
colour in this ﬁgure legend, the reader is referred to the web version of this article).
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We further validated our proteomic results with real time RT-
PCR for a few selected genes. Although the results were not
signiﬁcant, we detected a trend in the gene expression of PDIA3,
VATB and hnRNP C1/C2 over time, which corresponded with the
upregulation and downregulations in our proteomic results
(Fig. 4).3.3. Genomic instability assays
The comet assays showed positive results for DNA damage in the
AuNP treated MRC-5 lung ﬁbroblasts. Comet tail moments were
found to be signiﬁcantly higher in the treated group than in the
control (Fig. 5C, p< 0.05). As shown by FISH, AuNP treated cells had
a signiﬁcant> 4 fold increase in aberrations per cell as compared to
the controls (Fig. 6A, p < 0.0001). All aberrations observed were
chromosomal breaks with the majority being undetectable telo-
meres (Fig. 6C). No chromosomal fusions were found. It would
appear that that short-term AuNP treatment is likely to cause
chromosomal breaks in MRC-5 ﬁbroblasts that persist even after
one population doubling.for 72 h in 1 nM AuNP and subsequently run on alkaline electrophoresis and stained in
age. (A) Control cells show little to no tail. (B) AuNP treated cells display a comparatively
Analysis of 100 cells per treatment captured by the software showed that AuNP treated
sed as the comparative value. Error bars ¼ SEM (For interpretation of the references to
anoparticle treated human lung ﬁbroblast cells, Biomaterials (2011),
Fig. 6. Fluorescence In Situ Hybridization (FISH) analysis of control and AuNP treated MRC-5 lung ﬁbroblasts (1 nM concentration and 72 h). 50 cells per treatment were analyzed
and found to have a higher incidence of chromosomal aberrations in the AuNP treated cells as compared with the untreated controls. Red arrows point to chromosomal aberrations.
(A) Bar chart of average number of aberrations per cell (n ¼ 50). There is a signiﬁcant > 4 fold difference between control and treated cells (p-value < 0.0001). Error bars ¼ SEM. (B)
Metaphase spreads of control and AuNP treated cells respectively. (C) Chromosomal breaks and undetectable telomere were the aberrations detected. No fusion was observed (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this articl).
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The 2D-GE technique is a useful tool for global proteomic
analysis in toxicity research, and they play an increasingly impor-
tant role in toxicity biomarker discovery and validation [18,19].
Studies which employ this proteomic technique have been used in
experiments involving silica nanoparticles [20], multi-walled
carbon nanotubes [21], titanium dioxide nanoparticles [22],
airborne particulate matter [23] and silver nanoparticles [24] but
there are few on AuNPs [25].
In this present study, the protein NDUFS1 is the core and largest
subunit of the mitochondrial membrane respiratory chain NADH
dehydrogenase (also known as complex I) was found to be highly
upregulated in AuNP treated lung ﬁbroblasts. NDUFS1 is the most
basic unit required for catalysis reactions. Complex I functions in
the transfer of electrons from NADH to the respiratory chain with
ubiquinone as the immediate electron acceptor. It has an iron-
sulfur protein (IP) component that forms part of the active site
crevice where NADH is oxidized. Hence, complex 1 is known to be
the major source of superoxide O2 and ROS in human ﬁbroblasts
[26] which correlates with our previous ﬁndings of induction of
oxidative stress in AuNP treated cells [5].
AuNP treatment also affects other oxidative stress related
proteins, particularly the antioxidant proteins. PDIA3, better known
as ER60 or ERp57, is known to display protective ability against H2O2
toxicity (oxidative stress) and upon binding to protein Ref-1, arePlease cite this article in press as: Li JJ, et al., Genomic instability of gold n
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surprisingly, the upregulation of this protein is also accompanied by
a similar upregulation of various transcription and translation factors
in the 2D-GE results. This same complex has also been implicated in
DNA repair, as cellular sensors for DNA damage mismatch repairs
[28,29]. Increased expression of PDIA3, which has an antioxidant
function, is also an appropriate cellular response to oxidative stress
and DNA damage caused by AuNP treatment. TXNL1, which is
reported to be protective against glucose deprivation cytotoxicity
[17] was also down-regulated. Both PDIA3 and TXNL1 are part of the
thioredoxin superfamily of which is also known to regulate cellular
redox potential and prostaglandin synthase [30].
The downregulation of heterogeneous nuclear ribonucleus
protein C1/C2 (hnRNPC1/C2) expression is another point of interest.
The main function of this protein is binding to pre-mRNA and
nucleates the assembly of 40S hnRNP particles [31]. They also
modulate the stability and the level of translation of bound mRNA
molecules. Interestingly, downregulation of hnRNP C1/C2 sensitizes
cells to stress [32].Moreover, a numberof studieshave linkedhnRNP
C1/C2 with repair of DNA strand breaks [33,34], implicating its role
in coordinating DNA repair mechanisms in the cell. Our ﬁndings are
believed to point towards the non-homologous end-joining (NHEJ)
pathway of DNAdamage repair in the AuNP treated lung ﬁbroblasts.
The comet and the FISH assays in this current study also showed
evidence of DNA and chromosomal breaks. Therefore, it is plausible
that AuNPs can induce DNA damage and impair DNA repairanoparticle treated human lung ﬁbroblast cells, Biomaterials (2011),
J.J. Li et al. / Biomaterials xxx (2011) 1e98responses through the dysregulation of DNA repair genes involved
in the NHEJ pathway [11] leading to persistent DNA damage. In our
previous paper [5], we found upregulation of polynucleotide kinase
(PNK) gene, another gene known to be involved with the NHEJ
pathway [35,36] corroborating the results of this present study.
The rest of the differentially expressed proteins are mainly
involved as cell cycle regulators or have involvement in the cell
cytoskeleton or even possibly tumorigenesis. Vimentins are inter-
mediary ﬁlaments found abundantly in ﬁbroblast cells [37].
Secernin-1 (SCN1) is a cytosolic protein with roles in the regulation
of exocytosis in mast cells and recently found to be a prognostic
marker for gastric cancer [38,39]. Translationally-controlled tumor
protein (TCPT) stablizes microtubules and has calcium binding
properties [40]. Early translation factor proteins are the eukaryotic
translation initiation factor2 (eIF2-beta) [41] and lysyl-tRNAsythase
(lysRNA), the latter also has roles as a proinﬂammatory signaling
molecule and can cause cell toxicity when bound to mutant form of
superoxide dismutase [42,43]. The upregulation of these proteins in
our study signals the role of these proteins in AuNP-induced
oxidative stress in ﬁbroblasts. Another cell cycle protein includes
the C-terminal-binding protein II (CtBP2) is known as a corepressor
of transcription [44] with important regulatory roles in develop-
ment and oncogenesis [45]. V-type proton ATPase subunit B2
(VATB2) is part of a larger complex of V-ATPases proton pumps that
acidify endocytic and exocytic organelles [46]. Erlin 2 (SPFH2)
belongs to a family of prohibitin proteins on the endoplasmic
reticulum that degrade IP3 receptions on the ER membrane [47],
dysregulation of this protein could disrupt cellular signaling path-
ways. Glutathione S transferase P (GSTP1-1) is a detoxiﬁcation
enzyme that catalyzes the conjunction of various hydrophilic
compounds and electrophilic compounds with glutathione [48].
Ribonuclease inhibitor (RNH) in tissueshas strong afﬁnity binding to
ribonucleases and recent studies show that it may have anti-tumor
effects in hematopoietic cells [49]. Notmuch is known about protein
kinase C delta-binding protein (hSRBC) however it may possess
some tumor suppressor properties inprimary lung cancers [50]. The
ubiquitin carboxyl terminal hydrolase isozyme L1 (UCH-L1) is a thiol
protease that has been reported to possess tumor suppressor char-
acteristics in nasopharyngeal carcinomas [51].
5. Conclusion
We have employed the use of 2D-GE proteomic technique to
uncover more of the cellular changes occurring within the MRC-5
ﬁbroblasts during AuNP treatment. Proteins that were differen-
tially expressed were found to cover a range of functions including
oxidative stress response as well as regulation of cell cycle and
cytoskeleton. AuNP treatment also caused sustained DNA strand
breaks and chromosomal breaks induced by oxidative stress. We
propose that these changes reﬂect the state of oxidative stress inside
the cell and they are cellular responses of protection and repair.
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Abstract
In recent decades, advances in nanotechnology engineering have given rise to the rapid development of many novel
applications in the biomedical field. However, studies into the health and safety of these nanomaterials are still lacking.
The main concerns are the adverse effects to health caused by acute or chronic exposure to nanoparticles (NPs),
especially in the workplace environment. The lung is one of the main routes of entry for NPs into the body and, hence, a
likely site for accumulation of NPs. Once NPs enter the interstitial air spaces and are quickly taken up by alveolar cells,
they are likely to induce toxic effects. In this review, we highlight the different aspects of lung toxicity resulting from NP
exposure, such as generation of oxidative stress, DNA damage and inflammation leading to fibrosis and pneumoconiosis,
and the underlying mechanisms causing pulmonary toxicity.
Keywords: nanoparticles, particulate matter, nanotoxicity, oxidative stress, lung injury, pulmonary fibrosis
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Introduction
The study of nanotechnology has emerged in the last few
decades due to advances in the ﬁeld of engineering,
which have facilitated rapid and mass production of engin-
eered nanomaterials. These particles, deﬁned as having at
least one dimension in the nanoscale, are so small that
they can easily enter or diffuse through pores of mem-
branes. They also possess characteristics much different
from their bulk counterparts. Nanomaterials form the foun-
dation for the development of ground-breaking nanomedi-
cal devices applied in drug delivery and biomarker
discovery, as well as in molecular diagnostics.1 Even now,
various nanomaterials are increasingly incorporated into
many consumer items, such as clothing and plastic
wares,1,2 thus increasing the risk of human contact and
exposure to nanomaterials, not just in the industrial work
places, but also in the home environment.
The future prospects for nanotechnology are bright and
promising. While the attention of current researchers has
been toward enhancing the applications of this novel tech-
nology, comparatively less research has been performed
to assess the potential deleterious health effects of these
unique materials. The sheer diversity of size, shape, struc-
ture and elemental constituents, including surface modiﬁ-
cations of engineered nanoparticles (NPs), makes their
evaluation tedious and challenging. Adding to the con-
fusion, older literature would use the term ultraﬁne particles
(UFPs) to deﬁne both engineered NPs as well as ‘uninten-
tionally generated NP’, including combustion-derived pro-
ducts such as carbon black. With such a blanket term
used, it would give misleading reports if toxicity were to
be due to engineered NPs where properties are better estab-
lished than the accidental NPs generated (of which com-
ponents are an unknown mixture).
There are three main routes of entry of the NPs into the
human body. First, NPs are inhaled into the body from
atmospheric air via the upper respiratory tract. Exposure
to metal NPs like iron, nickel and titanium oxide NPs
(TiO2NPs), as well as the carbon-based NPs in the work
place environment has become a common event.3,4 Oral
ingestion and entry via the dermal route, either by injection
into the dermal layer or absorption through the pores of the
skin, are mainly mediated by exposure from therapeutic or
cosmetic applications.5 We have opted to focus on the res-
piratory route, which is the most important consideration
for study of atmospheric exposure to NPs. The lungs
would be the ﬁrst line of contact for particles that gained
entry into the body and hence the most likely organ for
accumulation and long-term exposure. In one inhalation
study, the lung showed the highest bioavailability of gold
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nanoparticles (AuNPs) within ﬁve days of NP exposure and
signiﬁcant accumulation over 15 days exposure.6 The data
from another report also highlighted that aggregates of
silver NPs (AgNPs) could be retained in the lung for
seven days, while the non-aggregated ones can easily trans-
locate to other organs.7 These studies remain even more
important as more NPs are increasingly being manufac-
tured, leading to increased occupational exposure and
release into the atmospheric environment.8
In this review, we will examine the issue of lung injury
and diseases induced by nanotoxicity, with a distinct
focus on metal-based engineered NPs. At times, we will
refer to early studies on UFP pollutants because they are
the foundation for much of the present research into the pul-
monary toxicity of NPs. As the ﬁeld continues to develop
and mature, it may not be long before safety evaluation of
engineered NPs becomes a prerequisite before use in biome-
dical applications.9–11
Intrinsic toxicity of NPs
It has been known for some time that NPs are not innocuous
but may harbor harmful effects. The ‘NP hypothesis’ ﬁrst
originated from information available on particulate
matter (PM), especially work on PM with less than 10 mm
diameter (PM10), which formed the basis for extensive
studies into nanotoxicology.12 The hypothesis suggests
that NPs are the main drivers of proinﬂammatory effects
in cases of PM toxicity because they are the main particulate
type found in PM mixtures, thus implying that NPs may
possess some intrinsic toxicity. What are the properties of
NPs that would give rise to toxic effects? One would be
the small size of NPs as it would give rise to a high
surface area per unit mass, and from what we know about
particle toxicology, this is often correlated with higher reac-
tivity.12 In addition, the larger surface area also leads to
an increased possibility for the formation of free radicals
(i.e. superoxide anions or hydroxyl radicals), which conse-
quently drive oxidative stress, especially for metal-based
NPs. Thus, this forms the underlying mechanism respon-
sible for inﬂammatory responses to NP exposure.13
Certain NPs such as heavy metal cadmium quantum dots
and AgNPs are also known to induce oxidative stress and
are highly toxic.14,15 However, not all cases of oxidative
stressed are caused by direct effects of NPs. Metal contami-
nants on the cell surface have also been shown to be the
main causative agents that generate free radicals.16 While
size does play a big part in particle toxicity, the shape of
the NP as well as the surface modiﬁcations may also affect
their uptake and toxic potential.17,18
Another effect of the large surface area per unit mass of
the NP is that it may be responsible for the adsorption of
various organic compounds from ambient air and this
phenomenon enhances biological interactions within the
organism.19 It has been shown by a number of epidemiolo-
gical studies that airborne PM from combustion sources like
motor vehicles or industrial exhausts contributes to respirat-
ory and cardiovascular morbidity and mortality.20–22 A
speciﬁc toxicological role has been observed for particles
with diameter ,0.1 mm (UFPs in particular), which are
generated in incomplete fuel combustion. UFPs have been
found to induce inﬂammatory and prothrombotic
responses, promote atherosclerosis, thrombogenesis and
may be the cause of other cardiovascular events.23 Besides
affecting lung physiology, these particulates have also
been shown to affect the autonomic nervous system or, in
other cases, act directly on cells in various organs and
may possess mutagenic potential.24,25
The lung as a route of entry
The human lung is a vulnerable organ for NP invasion as
there is approximately 2300 km of airways and 300 million
alveoli, giving rise to a large surface area, which is in
contact with the environmental atmosphere and the ultraﬁne
particulate pollutants present in it.2 Even though nasal cilia
and mechanical actions, such as coughing, could trap and
expel larger size particles from the airways, they may not
be so effective in getting rid of NPs. The small size of NPs
allows them to easily penetrate into the deep air spaces
of the alveoli (Figure 1) and be readily taken up by lung
epithelial cells and ﬁbroblasts (Figure 2).
There is only a single-cell layer that separates inhaled air
from the blood capillaries, which makes for a poor barrier
against the entry of NPs from the alveolar lumen into the
blood circulation (Figure 1). UFPs from combustion
engines are not taken up by macrophages in the lungs
and instead translocate to other organs beyond the lungs
as evidenced by controlled clinical and animal studies.4,26
NPs have been reported to cross the alveolar–capillary
barrier (with the aid of caveolae) into the circulatory
system.27 Some research groups have found that AuNPs
and carbon-based NPs could potentially overcome the
Figure 1 Entry of NPs into alveolar cells and the pulmonary circulation. NP,
nanoparticle
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blood–brain barrier and translocate to the brain by the
uptake of these NPs through the olfactory bulb.6,28
Because much of the concern regarding exposure to NP tox-
icity in the workplace comes from either accidental or indir-
ect release of NP as aerosols into the atmosphere during the
manufacturing process, the respiratory system invariably
becomes the ﬁrst line of contact and main route of entry
of atmospheric NPs into the body.
Translocation and deposition of NPs
in the body
Once the respiratory system is exposed to UFPs, trans-
location to other organs is rapid and the particles may
appear in the liver, heart and nervous system in a
matter of hours.28–30 The main mechanisms of NP depo-
sition in the lungs are impaction (PM .100 mm), sedimen-
tation (particles in the range of 0.1 and 50 mm) and
diffusion (UFPs).31 Whether UFPs accumulate in the nasal
cavity, conducting airways, and the alveoli by diffusional
displacement are dependent on the size of the particles.
Larger particles (with diameter greater than 1 mm) deposited
on the epithelial surface may, however, be cleared by bodily
responses, such as coughing, or by mucociliary transport,
and/or phagocytosis by alveolar macrophages.32–34
Conversely, UFPs seem to penetrate cellular membranes
rapidly.28,33,34 Besides, there have been in vitro studies
showing that UFPs induce oxidative stress and mitochon-
drial damage via penetration into the epithelial cells, and
that UFPs are more potent than PM2.5 and PM10.35
The lung is not just an entry point for NPs, but as a result
of the close connection with the circulatory system, NPs in
the lungs have the potential to translocate to other organs
quite readily. Exposure of rats to AuNPs showed that
inhaled NPs accumulate signiﬁcantly in the lungs and are
detected in other organs a few weeks later.6 In another in
vivo study, AuNPs injected intravenously into rats were
found to accumulate in the liver and kidneys up to one
month postinjection, implying that these organs may be
reservoirs for NP deposition and that there could be an inhi-
bition of natural excretion of NP from the body.36 Therefore,
it would seem that the smaller the size of the NPs, the wider
will be the biodistribution in the body, and the longer the
biopersistence (which reduces clearance from the body),
the greater will be the impact on toxicity in cells, tissues
Figure 2 TEM of MRC-5 human lung fibroblast and primary human SAECs treated with AuNPs. MRC lung fibroblasts and SAECs were routinely cultured in four-
chambered coverglass (Lab-tek Chambered Coverglass System, Nalge Nunc International, Rochester, NY, USA) at a density of 7000 cells/well and exposed to
1 nmol/L AuNPs (20 nm in diameter) for 72 h. Post-treatment, cells were fixed in 3% glutaldehyde, osmicated with 1% osmium tetroxide, dehydrated and embedded
in araldite. Ultrathin sections were cut and viewed in an Olympus EM208S TEM after double staining with uranyl acetate and lead citrate. (a) Low magnification image
of an MRC-5 fibroblast. Scale bar ¼ 5 mm. (b) Higher magnification with arrows pointing to AuNP clusters in cellular vacuoles present in the cytoplasm of the fibro-
blasts. Scale bar ¼ 0.2 mm. (c) Low magnification image of an SAEC. Scale bar ¼ 5 mm. (d) AuNP clusters are also similarly deposited in the vacuoles present in the
cytoplasm of the SAEC. Scale bar ¼ 0.5 mm. TEM, transmission electron microscopy; SAEC, small airways epithelial cell; AuNP, gold nanoparticle
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and organ systems. To understand the effect of NPs in the
lung, we will next consider the mechanisms associated
with NP toxicity at the cellular level.
Underlying cellular mechanisms
of NP-induced toxicity
Ineffective clearance of NPs
The epithelial cells in the respiratory tract are covered and
protected by a thin liquid layer called the epithelial lining
ﬂuid, which is composed of various neutralizing agents.37
The main component is surfactant whose main function is
to displace PM ,6 mm in order to facilitate mucociliary
clearance.34 Proteins in the surfactant play a role in opsoni-
zation as well as in the clearance of PM by macrophages.37
Furthermore, UFPs are physically aggregated into agglom-
erates, thus making them easy targets of phagocytosis by
the macrophages, in particular the alveolar macrophages,
on the epithelial surfaces of the alveoli.33,34 Their primary
role is to engulf and process particles that are not cleared
by mucociliary action and coughing.38,39 However, depend-
ing on the level of agglomeration of NPs, macrophages may
not be efﬁcient in clearing them, resulting in granulomatous
lesions.35 Also, when alveolar macrophages are activated
following PM phagocytosis, substantial amounts of
oxygen radicals, proteolytic enzymes, proinﬂammatory
mediators and growth-regulating proteins are released,
which may lead to both acute and chronic lung inﬂam-
mation.40,41 These mediators may also stimulate epithelial
and endothelial cells and promote leukocyte recruitment
into the lungs.42 Furthermore, studies have elicited that
lung epithelial cells, when exposed to PM, produce a spec-
trum of proinﬂammatory mediators that attract leukocytes
and upregulate adhesion molecules on their cell surface so
as to recruit leukocytes into the air spaces.43–46
Surface functionalization on NPs is also another factor
that affects uptake, penetration and clearance. While there
is no unique functionalization that is speciﬁc for lung epi-
thelium, it is possible to develop speciﬁc targets for one
cell type, for example, nanodrugs that target cancer
cells.47,48 Just as size of the NPs determines the depth of
penetration into lungs, surface modiﬁcations can also
affect cellular targeting of NPs. This brings us to the ques-
tion as to how ‘sticky’ are NPs to their target sites and
their rate of clearance from the body. However, few research
studies have attempted to address this issue. A study by
Kim et al.49 showed that AgNPs preferentially accumulate
in the liver and kidneys. NP accumulation in the kidneys
is gender speciﬁc, with a two-fold higher amount of
AuNPs accumulating in female than in male mice. Choi
et al.50 have observed that quantum dots less than 5 nm in
size could be completely excreted from the kidneys.
Oxidative stress
Exposure to NPs and PMs are known to cause an increase in
reactive oxygen species (ROS), which could lead to oxidative
stress. ROS generation byNPs could be due to three factors as
outlined by Knaapen et al.:51 (i) active redox cycling on the
surface of NPs, particularly the metal-based NPs;52,53 (ii) oxi-
dative groups functionalized on NPs; and (iii) particle–cell
interactions, especially in the lungs where there is a rich
pool of ROS producers like the inﬂammatory phagocytes,
neutrophils and macrophages. Overproduction of ROS acti-
vates a series of cytokine cascades, which include an upregu-
lation of interleukins (IL), kinases and tumor necrosis factor
(TNF-a) proinﬂammatory signaling processes as a counter
reaction to oxidative stress45 (Figure 3). Studies on TiO2NPs
and C60 fullerenes have shown that these NPs induce
elevation of proinﬂammatory enzymes, such as IL-1,
TNF-a, IL-6, macrophage inhibitory protein and monocyte
chemotactic protein in rodent lungs.54,55 When receptor tyro-
sine kinases, mitogen-activated protein kinases and transcrip-
tional factors, such as nuclear factor-kB and signal transducer
and activator of transcription 1, are activated, the genes
involved in inﬂammation and ﬁbrosis are transcribed and
expressed.56,57 Stimulation of IL-1b and TNF-a heightens
the expression of proﬁbrotic proteins. More speciﬁcally, the
latter is known to upregulate the production of transforming
growth factor (TGF)-b1, which potentiates collagen depo-
sition by ﬁbroblasts,58 while the former is associated with
the expression of platelet-derived growth factor (PDGF)-AA
and its receptor, PDGF receptor-a, which increases
proliferation of myoﬁbroblasts, promoting the formation of
immature collagenous tissue within the lung.57
Genotoxicity
NanoGenotoxicology is yet another new term that was
coined to represent the growing trend of research into
Figure 3 Possible mechanistic pathway for pulmonary toxicity induced by
exposure to NPs. Exposure to NPs may lead to oxidative stress due to
increased production of ROS and downstream signaling responses that
promote fibrosis and produce genotoxicity. NP, nanoparticle; ROS, reactive
oxygen species
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NP-induced genotoxicity and carcinogenesis (an excellent
review on the genotoxicity of nanomaterials is given by
Singh et al.59). Although there are still no conclusive links
with NP-induced genotoxicity and lung cancer from past
epidemiological studies and in vivo rodent experiments,
some researchers have pointed out that long-term inﬂam-
mation and oxidative stress present in tissue environment
eventually induces DNA damage in cells and tissues.59
This is of particular concern, especially if the NPs continue
to generate an oxidative environment in the cell that causes
gene mutations/deletions. This can lead to larger-scale
mutagenesis (Figure 3) and carcinogenicity, and sub-
sequently development of tumors and cancer.51 Already,
more evidence has emerged regarding the DNA damaging
properties of certain classes of NPs, particularly the metal-
based NPs like AgNPs, AuNPs and TiO2NPs.60–63 One pro-
posed mode of action for NP genotoxicity is the ability of
signaling peptides functionalized on NPs such as carbon
nanotubes (CNTs) that enable them to enter the nucleus
via nuclear pores.64 It is yet to be shown that such CNTs
are able to cause genotoxicity, but it is believed that
there is a greater potential of damage when NPs are able
to get in close proximity to DNA. There are also other
different mechanisms that may be speciﬁc to the elemental
composition and shape of NPs, which could lead to
DNA damage such as single-strand breaks, double-strand
breaks, DNA deletions and genomic instability in
the form of increase in 8-hydroxy-20-deoxyguanosine
levels.65,66 While some researchers have found that
exposure to TiO2NPs in rats could cause formation of
lung granulomas,54 others have cautioned that appearance
of granulomas does not necessarily mean that the tissue is
cancerous as most tissues probably remain benign.67 As
most reports regarding NP toxicity were observed from
experiments involving ultraviolet or irradiation exposure,
the clinical relevance of these mechanistic experiments
are questioned.68 Nevertheless, a recent study has shown
that TiO2NPs may be able to switch on regressive cancer
cells. In vivo preimplantation of TiO2NP, followed by
co-culturing of a regressive cancer cell line over the implan-
tation site, was observed to induce tumorigenic character-
istics such as an upregulation of TGF-b and prostaglandin
E2.69 According to Mroz et al.70 cells with long-term
exposure to NPs, like nanoparticulates in PM10, displayed
genome instability under comet assay analysis, altered
cell cycle kinetics in ﬂow cytometry and induced protein
expression of p53 and DNA repair-related proteins,
similar to that observed in irradiated cells. Hence, they pos-
tulate that these NPs could activate signaling pathways
similar to ionizing radiation, resulting in carcinogenesis as
a consequence of errors in DNA replication. DNA repair
in ionizing radiation requires activation of ataxia telangiec-
tasia mutated protein, which is a serine/threonine-speciﬁc
kinase, and subsequently, the ubiquitylation signaling
cascade and sumoylation pathway. A postulated mechan-
ism for the repair of damaged DNA from exposure to
NPs based on the ionizing radiation model is shown in
Figure 4. However, as cancer is a multifactorial disease,
there may not be only one deﬁning cause for an individual
to develop neoplasm. Instead, it may be more pertinent
to place the risk factor from NP exposure alongside other
risk factors for cancer as well.
Inflammation of lung tissues
induced by NPs
Among all the adverse effects caused by NPs, inﬂam-
mation (a biological reaction of tissues to harmful
stimuli) appears to be the most common factor. In fact,
different types of NPs can induce diverse inﬂammatory
responses in the lung. For instance, the toxicity of single-
wall CNTs in inducing epithelioid granulomas and inter-
stitial inﬂammation in mice lungs seven and 90 days
after intratracheal instillation has been reported to be
higher as compared with other NPs, like carbon black
and quartz particles.71 Oxidative stress is most likely the
major underlying mechanism driving inﬂammation
responses by NPs, which lead to the activation of different
transcription factors with subsequent enhanced synthesis of
proinﬂammatory proteins. TiO2NPs are able to induce pul-
monary neutrophilia mediated via increased production of
neutrophil-attracting chemokines CXCL1, TNF-a and
IL-8,72,73 together with a surge in counts of eosinophils and
lymphocytes in the bronchoalveolar lavage ﬂuid.74 CNTs
and NPs are also believed to cause adverse effects through
inﬂammation and induction of proinﬂammatorymolecules.75
However, it must be noted that some researchers have found
metal contaminants (such as iron and nickel) in the nanotube
production process to be the main causative agent of oxi-
dative stress.16,76 Pulmonary inﬂammation may also result
in changes in membrane permeability, which in turn can
result in particle distribution extending beyond the lung
and indirectly affecting cardiovascular performance.24,77
Moreover, NPs have the potential to enter the brain28 and
blood circulation,78 and subsequently other major organs,
Figure 4 Postulated mechanism for the repair of damaged DNA on exposure
to NP based on the ionizing radiation model. NP, nanoparticle; ATM, ataxia tel-
angiectasia mutated
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inciting inﬂammation in these places. Needless to say,
inﬂammation arising as a result of NP exposure could lead
to pulmonary diseases or exacerbation of existing lung
disorders.
Lung disorders that may arise from
NP exposure
Pulmonary fibrosis
Pulmonary ﬁbrosis occurs as a result of increased tissue
reactivity leading to the formation and accumulation of
ﬁbrous connective tissue. Fibrosis can take many forms,
varying from severe forms that cause distortion of lung
architecture, inducing bronchiectasis and chronic respirat-
ory infection, to milder forms, which comprise of restrictive
ventilatory defects causing hypoxemia, cor pulmonale and
pulmonary hypertension.79,80 The ﬁrst step in pulmonary
ﬁbrosis is inﬂammatory response when immune cells com-
prising macrophages and neutrophils are excessively acti-
vated. These immune cells release toxic mediators, which
result in the loss of epithelial integrity and promotion of
tissue injury. When this happens, the cell normally
employs a repair mechanism wherein mesenchymal cells
are activated. These mesenchymal cells have a three-fold
role, which includes extracellular matrix deposition,
re-epithelialization and restoration of normal lung architec-
ture. However, certain patients show an abnormality in
tissue remodeling and excessive matrix deposition, which
leads to progressive scarring and ﬁbrosis.80 Recently, some
researchers have also observed the presence of multiwalled
CNTs (MWCNTs) in the subpleural region in lungs of mice
giving rise to ﬁbrosis and scarring.81 This has become a
matter of grave concern as non-clearance and persistence
of MWCNTs could cause inﬂammation in the sensitive
mesothelium, leading to mesothelioma formation. Another
study also suggests that pulmonary ﬁbrosis induced by
MWCNTs may be exacerbated in people with existing
lung inﬂammation.82 As aptly put by Byrne and Baugh,13
the irregularity in tissue remodeling and ﬁbrosis, with refer-
ence to particle inhalation, may be due to an exaggerated
inﬂammatory response that is driven by inability to clear
toxic particles from the lungs via the usual protective mech-
anisms. This whole cascade may be initiated by interactions
of alveolar macrophages with lung epithelial cells, or even
directly by interstitial ﬁbroblasts.13
The extent of ﬁbrotic response may also determine the
severity of loss of tissue function. Generally ﬁbrosis occurs
in the following sequence:83 (a) organization of the imma-
ture ﬁbrinous tissue with the formation of new blood
vessels and increased blood supply; (b) proliferation of
myoﬁbroblasts; (c) increased deposition of extracellular
matrix; and ﬁnally (d) scar formation. Under conditions of
normal lung function, immature intralumenal collagenous
tissue may be eliminated by the ﬁbrinolytic system with
concomitant apoptosis of myoﬁbroblasts, thus favoring
re-epithelialization.84 Depending on the degree of injury to
the alveoli, removing the continual exposure to NPs may
allow re-epithelialization. In chronic cases of injury,
however, lung function may be lost.
Pneumoconiosis
Pneumoconiosis, an occupational lung disease, is clinico-
pathologically classiﬁed into two categories, ﬁbrotic and
non-ﬁbrotic. While the ﬁbrotic process involves focal
nodular or diffuse ﬁbrosis, non-ﬁbrotic lesions involve
particle-laden macrophages, with minimal or no ﬁbrosis.85
The former comprises silicosis, coal worker’s pneumoconio-
sis, asbestosis and berylliosis, which are caused by sus-
tained inhalation of silica particles, washed coal particles,
asbestos ﬁbers and beryllium particles, respectively.13
Non-ﬁbrotic lesions cover siderosis, stannosis and baritosis
that are caused by particles of iron oxide, tin oxide and
barium sulfate, respectively. Among these pulmonary
lesions, silicosis, coal worker’s pneumoconiosis and asbesto-
sis dominate the clinical cases.85 Over the last three decades,
death rates due to asbestosis have increased tremendously,
overwhelming the decrease in death rates due to the other
two types of pneumoconiosis.86 Here it is to be noted that
these clinical conditions are inﬂuenced by a multitude of
particle types, varying in size and concentration. These par-
ticulate clouds are mineral and combustion-derived, and are
found most commonly in developing nations. NPs are the
most toxic of the particles found in particulate clouds and
are the most signiﬁcant contributors to ﬁbrogenicity.87 It is
hypothesized that NPs could also behave like asbestos in
vivo since some NPs, particularly the carbon rods, have
similar shape, size and properties. A study showed evidence
of asbestos-like pathogenic behavior of MWCNTs in mice,
inducing inﬂammation and formation of graulomas.88
Although there have not been any conﬁrmed reported clini-
cal cases of engineered NP-induced pulmonary ﬁbrosis, it
should be remembered that the rapidly increasing exposure
levels may cause serious issues, considering the extent to
which NPs are integrated into technology.71
Exacerbation of asthma
Asthma is a disease whereby inﬂammation of the airways
induces lung hypersensitivity, and hence asthmatic individ-
uals are more likely to be vulnerable to NP-induced lung
toxicity. Many early studies have shown that deposition
of ﬁne particles are most enhanced in the lungs of
patients with chronic obstructive lung disease, including
asthma.89,90 Since inhaled UFPs have higher deposition efﬁ-
ciency in the pulmonary region, more UFPs are retained in
the lung with each breath in comparison with larger par-
ticles.89,91,92 In cases of asthmatic patients, airway obstruc-
tion causes air trapping and thus an increase in alveolar
volume, causing a net increase in UFP deposition through
diffusion, although impairment of alveolar ventilation may
prove inhibitory. Since alveolar volume increases during
exercise, the deposition in healthy individuals is also
higher during exercise than while at rest. However, this
increase is not signiﬁcant in asthmatic patients, perhaps
because the increased alveolar volume and airway turbu-
lence is innately present.93 Dead space ventilation increases
the minute respiration of patients with obstructive lung
disease.94 This phenomenon along with hyperinﬂation,
which is seen even in mild cases of asthma, is speculated
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to increase the diffusional deposition of UFPs in the distal
airways and alveoli. The increase in particle number in the
lung has been reported to be 74% in asthmatic patients com-
pared with healthy subjects.93 Therefore, it would appear
that greater NP deposition in the lung would exacerbate
airway inﬂammation in susceptible individuals.
Another concern would be how the use of steroids in
asthmatic individuals would affect NP lung toxicity.
Steroids, such as the various forms of corticosteroids, are
used in the treatment of asthma as it helps to control and
reduce inﬂammation in the airways by inhibiting cyclooxy-
genases and production of superoxides.95,96 How effective
steroids are in counteracting NP toxicity is still not known.
Our preliminary study has shown that dexamethasone did
not affect the viability of NP-treated lung epithelial cells in
vitro (Figure 5). Even so, there are proponents for the
novel use of platinum NPs as an antioxidant treatment for
pulmonary inﬂammation.97 Moreover, fullerenes (C60 NPs)
have also been reported to exert anti-inﬂammatory
properties.98
Conclusion
It is still early days in the study of NP-induced pulmonary
toxicity and there is a diversity of factors that need to be
taken into consideration before we can truly understand
the impact of NP exposure on human health. Even in
studies of nanotoxicology, many have called for greater
caution in making conclusions about the relevance of any
toxicological study on NPs. A recent clinical case study of
workers developing pulmonary disease from NP exposure
had received criticism from ﬁeld experts for presumptuous
conclusions drawn outside of the study’s limitations.99,100
In the meantime, the cautionary procedure would be to
handle the use of engineered NPs with discretion and
with appropriate workplace and safety protocols.
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Nanotechnology has created opportunities for engineers to manufacture superior and more eﬃcient devices and products.
Nanomaterials (NMs) are now widely used in consumer products as well as for research applications. However, while the lists
of known toxic eﬀects of nanomaterials and nanoparticles (NPs) continue to grow, there is still a vast gap in our knowledge about
the genotoxicity of NMs. In this paper, we highlight some NMs of interest and discuss the current in vivo and in vitro studies into
genotoxic eﬀects of NMs.
1. Introduction
Materials in the nanoscale are used in many commercial
products and industrial practices in the new millennium.
They are now increasingly found in plastic wares, clothing,
cosmetics, electrical appliances, and even food products.
Their applications also extend into the biomedical field and
healthcare, particularly in medical imaging and diagnosis,
pharmaceuticals, drug delivery, and therapy [1]. The demand
for nanomaterials (NMs) in the market in the areas defined
above is escalating and estimated to reach sales of up to
US$1 trillion by 2015 [2]. The recent burgeoning research
interest and development of NMs, nanotechnology, and
nanomedicine have led to a vast potential for novel ways
of rapid disease diagnosis, treatment, and enhancement of
the quality of life. NMs consist of one or more compo-
nents present in various forms that possess at least one-
dimensional structure of diameters in the range of 1 to
100 nm [3]. Engineered NMs, including nanoparticles (NPs)
and nanofibres, are generally categorized into four classes,
which include carbon-based materials, metal-based materi-
als (quantum dots, nanosilver, and nanogold), dendrimers
(nanosized polymers), and composites. Their characteristic
features are durability, high conductivity, and reactivity
[4].
Many researchers have commented that in actuality, there
is still much more to be understood about nanomaterials,
especially with regard to the health risks and hazards. The
Royal Society and Royal Academy of Engineering first raised
this concern in 2004 [5]. This has paved the way for a
rapid increase in investigational studies in the toxicity of
nanobased materials, in particular, genotoxicity studies of
NMs and nanoparticles (NP). A quick search through the
Pubmed literature database shows that the bulk of the
research articles on NM genotoxicity were published within
the past 3 years. As the development of nanotechnological
applications continue to grow, it is anticipated that there will
be an even greater demand for safety and health and risk
assessments studies in the coming years. There have been
excellent reviews regarding the methodologies for studying
NM-induced toxicity [6–8].
In this paper, we would like to briefly discuss the
methodologies currently available for genotoxic studies and
present a survey of the in vitro and in vivo genotoxicological
studies of NMs conducted in recent years.
2. Methodologies in Genotoxicity Studies
The study of NM toxicology has its roots in ultrafine particle
study, mostly starting out as particulate matter (PM10) and
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carbon black. The first wave of nanotoxicological studies
were assessments of NM cytotoxicity which had been com-
prehensively outlined by Lewinski et al. [9]. Currently, there
is an increasing focus on specific nanotoxic eﬀects, and thus
the advent of a subfield called “nanogenotoxicology” [10]
which generally refers to the study of toxic eﬀects of NMs
on genomic stability and integrity. Common in vitro tests for
measuring insults to DNA would centre on single-strand and
double-strand breaks, mutations, deletions, chromosomal
aberrations, impairment in DNA repair and cell-cycle while
tumorigenesis and carcinogenicity are the main focus in in
vivo studies. There are as many diﬀerent kinds of NMs as
there are elements and compounds. NMs, depending on the
size, shape, elemental materials, and the surface functional
groups were observed to have a range of detrimental
eﬀects on cells. Compounding the diﬃculties in toxicological
studies, Stone et al. [6] and Landsiedel et al. [7] reiterated
that based on existing knowledge, specific NMs probably
induce definitive genotoxic eﬀects. Nevertheless, some of the
more common tests used in current genotoxic studies are
described below.
2.1. In Vitro Techniques and Approaches
2.1.1. Ames Test (Bacterial ReversionMutation Test). This test
is used to assess the mutagenicity of a chemical compound
[11]. Various strains of the histidine dependent bacterium,
Salmonella typhimurium, contain mutations in the genes that
impair synthesis of histidine required for cell growth. Test
substances or compounds are added to diﬀerent areas on
the agar plate, and the bacterium is then plated onto the
minimal histidine media. The test compound is deemed to
have mutagenic potential if it is able to cause mutations that
allow the bacterium to revert back its histidine synthesis
ability. The downside of this test is that it is diﬃcult to
translate prokaryotic data for eukaryotic genotoxicity testing,
and the test is known to generate false positive results [12].
Specific to NM toxicity testing, there are doubts if the Ames
test is accurately representative of genotoxicity. Some NMs
are not able to cross the bacterial wall, and some kill the test
organism as they are bactericidal [7]. Therefore, data should
be followed up with other tests after the initial screening.
2.1.2. Comet Assay (Single-Cell Gel Electrophoresis Assay).
This is a simple, inexpensive, and sensitive technique to
test for DNA damage. It was first described in 1988 by
Singh et al. [13] and has since become the standard test
for DNA damage. Cell samples from in vitro or in vivo
experiments are first suspended in low melting point agarose
and cast onto microscope slides. The cells are lysed so that
only the DNA remains, which is then made to undergo-
electrophoresis in order to separate the DNA strands based
on molecular weight. The DNA strains are subsequently
stained with, for example, SYBR green dye and viewed under
a fluorescence microscope. Under specific conditions, this
test is able to distinguish single-and double-strand breaks
in DNA. It is a quick way to assess DNA lesions and extent
of genotoxicity in individual eukaryotic cells. However, due
to its sensitivity, samples should be handled appropriately to
ensure reproducibility of the results.
2.1.3. Micronucleus Test (MN)/Cytokinesis Block Micronucleus
Test (CBMN). This assay is based on scoring the number
of micronuclei (MNi) in treated cells [14]. MNi are formed
during anaphase from chromosomal fragments or whole
chromosomes that are left behind when the nucleus divides.
Over time, the assay has evolved to include a pretreatment
with cytochalasin-B (Cyt-B), a cytokinesis blocking agent
that inhibits cell-division, thereby giving the cells a binucle-
ated appearance. This enables more accurate scoring and the
ability to sieve out the dividing cells (where MNi would be
found) from the nondividing ones, thereby reducing the inci-
dence of false positives. The CBMN method is now routinely
used for measuring chromosome breakage, impairment in
DNA repair, chromosome loss, nondisjunction, necrosis,
apoptosis and cytostasis.
2.1.4. Hydroxy-Deoxyguanosine (8-OHdG) Analysis. Oxida-
tive stress is considered one of the foremost reasons for
DNA damage. Reactive oxygen species (ROS) generated in
metabolizing cells could attack DNA base guanine forming
the 8-OHdG lesions, which is known to have mutagenic
potential and hence used routinely as a biomarker for
carcinogenesis [15]. There are a few methods to measure
the extent of 8-OHdG lesions and the most established is
HPLC (high-performance lipid chromatography), which is
often coupled with mass spectrometry, also known as the
HPLC-MS/MS. Other methods include performing antibody
probes for DNA repair proteins or posttreatment with the
enzyme formamidopyrimidine DNA N-glycosylase before
quantitative analysis with the comet assay to determine DNA
strand breaks [16].
2.2. In Vivo Approaches. There is a need for validation of
animal models for studies in NM toxicity. The diﬃculties lie
in devising the correct approach in interpreting the studies
and deciding on the parameters that should be considered in
examining NM toxicity in in vivo systems.Many investigators
have administered NMs through inhalation exposure or
orally, ingestion by feed or water supply, and direct instil-
lation or injection into the body. Usually, the subsequent
bioavailablity and translocation of the NMs are evaluated,
including the organ of entry as well as in other organs
where accumulation is more significant. The tests used for
assessment of genotoxicity are similar to those used in the in
vitro studies.
3. Nanomaterials and their Genotoxic Status
A summary of some of the current genotoxic studies in
nanomaterials are shown in Tables 1 and 2, which display the
in vivo and in vitro studies, respectively.
3.1. Carbon Fullerenes. Carbon fullerenes, which are ultra-
fine particulate matter, are one of the most ubiquitous NMs
found [46]. They are generally present in polluted air as
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Table 1: Selected in vivo genotoxicity studies on NMs.
Type of NP Size and form
Experimental
design/genotoxic tests
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they are often released in soot resulting from the process
of fuel combustion. Engineered carbon fullerenes are stable,
soccer ball-like carbon atoms with hexagonal and pentagonal
shapes. The most notable fullerene would be C60, a highly
reactive biomolecules that has the ability to cross blood brain
barrier (BBB) [47]. C60 fullerene is highly used in industry
as catalysts, reactive oxygen species scavengers [48] and tools
in drug delivery systems [49].
Since the early 1990s, there have been concerns about
the potential dermal and inhalation eﬀects of fullerenes
due to their strong oxidizing and phototoxic properties
[50]. In vitro experiments have shown C60 to be generally
noncytotoxic with no mutagenic response [17, 24] in
Chinese hamster ovary (CHO-K1) cells and mouse lung
epithelial cells [28] using the Ames test and CBMN tests,
respectively. Another report has found that C60 treatment
also increases formamidopyrimidine [fapy]-DNA glycosylase
(FPG) sensitive sites, accounting for short-term DNA strand
damage. Xu et al. observed that C60 induced an increase
in mutation yield in primary mouse embryo fibroblast cells
and dose-dependent formation of free radical ONOO− [25]
using dihydrorohodamine radical probes. However, in the
in vivo setting, C60 treatment was found to be associated
with increased DNA damage 8-hydroxydeoxyguanosine (8-
OHdG) in mouse lung and liver [18]. Not surprisingly,
inflammatory cytokines such as the interleukins and MIP
and MCP genes were found to be upregulated although C60
extent of damage was lower as compared to other NMs.
3.2. Carbon Nanotubes. Carbon nanotubes are the byprod-
ucts of combustion, which are commonly present in air
pollution and soot. Engineered carbon nanotubes can also
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Table 2: Selected in vitro genotoxicity studies on NMs.
Type of NP Size and form
Experimental
design/genotoxic tests
Summary of findings References
Carbons
C60 0.92m2/g surface area Ames test
No mutagenic response,
and no incidence of
chromosomal aberration







No genotoxicity at all doses
(11−221μM)





















No genotoxicity eﬀects but
SWCNT induces mitotic
inhibition
Szendi and Varga; 2008
[19]
MWSCNT agglomerates
V79 cells treated for 18 h






Wirnitzer et al., 2009
[26]
MWSCNT nanotubes
Ames test on Salmonella
typhimurium TA 98 and TA
100 strains, and on
Escherichia coli WP2uvrA
strain, in presence and in
absence of the metabolic
activation system S9














No cell death. Slower
proliferation and cell-cycle
arrest at G1 with SWCNT.
Mutant frequency
unaﬀected by 576 h
exposure

































CBMN and comet assay
but no dose-dependency.
Increase of type III foci
Ponti et al.; 2009 [30]
Co 100−500 nm
Peripheral blood leulocytes
at 24, 48 h timepoints in









Colognato et al.; 2008
[31]
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Table 2: Continued.
Type of NP Size and form
Experimental
design/genotoxic tests








MN frequencies increase at
0.5 and 1μg/mL TiO2 and
0.5−10μg/mL AL2O3.
SCE higher at 1−5μg/mL
TiO2 treatment, and at
1−25μg/mL Al2O3






cells (BEAS 2B) with




Both induce DNA damage
at all treatment times. Only
nanosize rutile increase
frequency of MN cells at
10, 60μg/cm2, 72 h.

















Shi et al.; 2010 [34]
TiO2




Short-term treatment at 24,
48 and 72 h.
Long-term treatment, cell



























TiO2 treatment showed no
DNA breakage, DNA
adduct nor free radical
generation. Fe2O3 had
significant DNA damage
after 24 h in IMR-90 cells
















Xu et al.; 2009 [25]
TiO2 100 nm
Human lymphoblastoid
cells. Treatment with 26,









2-3 folds and 2.5 fold in
mutation frequency.
65μg/mL treatment induce
5 fold increase in comet tail
moments
Wang et al.; 2007 [37]
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Table 2: Continued.
Type of NP Size and form
Experimental
design/genotoxic tests
Summary of findings References
ZnO nanospheres




Significant DNA damage in
comet assay. Induces
oxidative stress
Sharma et al.; 2009 [38]
Ag 30 nm, nanospheres
Medaka fish cell lines




Wise et al.; 2010 [39]









prominent in cancer cells
with more chromosomal
aberrations.












Upregulation of p53, Rad
51 and phosphorylated
H2AX protein expression.
Coated AgNP show more
severe damage than
uncoated AgNP






treated with nAu at 0,
0.5 and 1 nm
concentrations.
8-OHdG analysis
Significant DNA damage in
1 nm treatment compared
to control.
Li et al.; 2008 [42]
Platinum (Pt NP)





of DNA damage, arrest at
cell-cycle S phase and
apoptosis
Asharani et al.; 2010 [43]
Other Nanomaterials
Nanoceria (CeO2) nanoparticles





No DNA damage nor SCE








No significant diﬀerence in
MN assay and no cell-cycle
delay. SCE found to be
higher in 5 kinds of
PELGE-NP than in
negative controls
He et al.; 2009 [45]
come in a variety of shapes and conformations, with the
most common being the single-walled carbon nanotubes
(SWCNTs) and the multiwalled carbon nanotubes (MWC-
NTs). They are also found in a wide range of applications
in the industry as composites, polymers, as well as in
the biomedical and pharmaceutical fields. Great physical
strength, flexibility, electrical conductivity, insolubility and
nonbiodegradability are among the valued properties of
carbon nanotubes [51]. On the other hand, it has been
postulated that these nanotubes could possess health hazards
upon inhalation as their durability, biopersistency, and
long and thin shape resembling asbestos fibers [52]. In
addition, trace contaminations with iron and nickel have
been reported to be the major cause of toxicity in carbon
nanotubes [53].
There is a scarcity of information regarding SWCNTs
and genotoxicity. SWCNTs have been reported to induce
slower proliferation rate and cell-cycle arrest at G1 phase
in mice lung epithelial cells [28] and mitotic inhibition in
human lymphocyte cultures [19]. In in vivo experiments,
oral administration of SWCNTs in mice is found to be
associated with increase in 8-OHdG levels in liver and lung
[18]. SWCNTs, compared to carbon black, only causes mod-
erate inflammation in ApoE knockout mice [20]. However,
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agglomerates of MWCNTs were found to possess neither
clastogenic nor mutagenic eﬀects [19, 26, 27] when put
under the Ames test and chromosome aberration test.
3.3. Titanium Dioxide and Zinc Oxide Nanoparticles (TiO2
and ZnO NPs). TiO2 and ZnO NPs, which have the proper-
ties of high refractive index and brightness, are regularly used
as whitening pigments or reflective optical coats [54]. These
specific properties lead to the application in commercial
products such as paint andwhitening agents in food products
[55]. Nanoparticulate suspensions of ZnO and TiO2 also
appear transparent in air and liquid under visible light. As
such, ultrafine TiO2 is also extensively used in cosmetics,
skin care, and sunscreen products, as their application does
not leave unsightly white residue on skin unlike bulk TiO2
[56]. ZnO is quite well known to be cytotoxic to cells in
culture [57], while the toxicity of TiO2NP is rapidly gaining
attention due to the increased use and applications in many
accessible medical and cosmetic products. TiO2NP comes
in two common shapes, namely, the rutile and anatase
forms. Although both are found to be genotoxic, one study
showed that the anatase form induced greater DNA damage
in human bronchial epithelium [33]. TiO2NP could also
increase cell sensitivity to phototoxicity [34], as well as
induce more DNA adducts, strand breaks, base-pair muta-
tions and chromosomal damage [21, 25, 37]. Interestingly,
Huang et al. reported that while long-term exposure to
TiO2NP slowed down cell-division and induced aberrant
multipolar spreads, chromatin alignment, and segregation,
short-term exposure increased cell survival and growth and
number of multinucleated cells [35]. Another group of
investigators did not observe DNA breakage under TiO2NP
treatment but found positive DNA adduct formation and
free radical generation [36].
Although ZnONPs are probably the less studied of the
two, there is also evidence to suggest that they may also
induce significant DNA damage through oxidative stress,
albeit with less obvious eﬀects than in TiO2NPs [38].
3.4. Aluminium Oxide Nanoparticles (Al2O3NPs). Al2O3NP,
or alumina NP as it is commonly known, belongs to a class
of materials known as nanoceramics. It is widely used in
industrial and medical product such as orthopaedic parts
and composite repellants. However, the toxic and genotoxic
eﬀects of Al2O3NP are not well known, and there are very
few research studies on the toxicity of this material. Thus far,
Al2O3NPs were found to significantly increase micronucleus
frequencies, chromosomal loss, and gain mutations as well as
polyploidy but no sister chromatid exchanges were found to
take place [29, 32].
3.5. Cobalt and Cobalt-Chromium Nanoparticles (CoNPs and
CoCrNPs). Cobalt and its alloy are commonly used in hip
joint replacements and other orthopedic joint replacements.
Unfortunately, the friction produced in movement of the
replacement joints generate NPs of the metal which could
reach out and aﬀect the surrounding tissue and even
lymphocytes, thereby lead to some concerns regarding the
genotoxicity observed from clinical studies [58]. Hence,
much interest was generated to study the eﬀects of these
wear particles and a significant amount of research into Co
and CoCr NPs are centered around these issues. The results,
although not surprising, are generally aligned to positive
indications of genotoxicity. Analysis of peripheral blood
leukocytes of patients with cobalt alloy joint replacements
showed positive DNA damage in comet assays [31]. However,
it was also suggested that these results could possibly be
modulated by donor characteristics and may be due to
Co2+ release instead of CoNPs per se. Recent studies show
that by 24 h, CoCrNPs induced a dose-dependant increase
in micronucleus containing cells as well as chromosomal
loss, gains, deletions, and polyploidy [29]. In a separate
study with CoNPs on Balb/3T3 cells, there were significant
results in micronuclei and comet assay for NP induced
DNA damage but the results were not dose-dependent
[30].
3.6. Quantum Dots. Quantum dots are crystalline semi-
conducting NPs. They are comprised of a metalloid crys-
talline core and a “cap” or “shell” that shields the core or
renders the dots biologically compatible [4]. The metalloid
crystalline core is normally made up of heavy metals like
cadmium and lead or sometimes from other semiconductor,
noble, and transition metals. These are also quantum dots
that are coated with materials such as polyethylene glycol,
zinc sulphide, or polyacrate [59] Quantum dots are used
in composites, paints, inks, solar cells, and optoelectronics
[4]. Due to their bright fluorescence, narrow emission, broad
UV excitation, and photostability, they have been used as
alternative fluorescent dyes for labeling cell structure in vitro
and for fluorescence imaging in vivo [60].
They are considered one of the most toxic of substances
and there are many studies showing the acute cytotoxicity
of quantum dots [61]. The cadmium and lead metals
themselves are considered potent human carcinogens. Cad-
mium induces DNA damage and mutation through ROS
production and inhibition of DNA repair and methylation
[62]. It also incites disruption of E-cadherin cell-to-cell
adhesion which could lead to tumor formation. Lead and
its compounds are listed under group 2B of possible human
carcinogens in IARC reports [63], as they are found to induce
lipid peroxidation and inhibit enzymes and antioxidants
thereby putting the cell under an environment of oxidative
stress [64]. However, few have ventured into exploring the
genotoxicity of such QDs. One experiment with Apo E
knockout mice showed that such mice were more sensitized
to QD-induced inflammation, upregulating gene expressions
of cytokines, IL-6, Mip 2 and Mcp signaling molecules
[20].
3.7. Silver and Gold Nanoparticles (AgNPs and AuNPs).
AgNPs and AuNPs are the most marketable NPs and widely
used in consumer products. AgNPs are particulary known
for their antimicrobial qualities, while AuNPs are used in
bioimaging and diagnosis applications. They are also easily
synthesized from their salt compounds and are convenient
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to handle, which also makes them another popular choice
of NMs to work with. What is of concern is that several
studies have found AgNPs to be toxic in aquatic animals
[65] and AuNPs to possess some degree of toxicity in vitro
[66]. Many researchers have focused on AgNPs because of
the acute toxicity shown in vitro experiments. AgNPs were
found to induce DNA damage in human glioblastoma cells
as well as chromosomal aberrations in human fibroblast
cells [40]. Other genotoxic reactions include upregulation
of p53 and DNA repair protein Rad51 observed in mouse
embryonic stem cells and fibroblasts [41]. In the same study,
AgNPwhen functionalized with polysaccharide on its surface
was more DNA damaging than uncoated AgNPs. In long-
term rodent studies, oral administration of high-dose AgNPs
for 28 days resulted in liver damage but no significant
genotoxicity in erythrocytes and bone marrow [22]. A
number of studies have also shown that AgNP treatment
induced DNA damaging eﬀects on aquatic and plant cells
with impairment of cell-division [39, 65]. Although less
dramatic than AgNPs, AuNPs are also able to induce DNA
damage in the form of single-strand lesions in human lung
fibroblasts [42].
3.8. Other Nanoparticles. There are a few research groups
working with new types of NPs. The rare earth metal
cerium oxide NPs (nanoceria) is one example. Researchers
have found nanaoceria to be a radical scavenger with
antiinflammatory eﬀects [67] which causes no DNA damage
[44]. They are currently being developed for application
in human lens epithelium. Although this is a promising
NM for future applications, it has also been reported that
nanoceria exerts diﬀerential growth in soybean seedlings
[68]. Silica NPs, or often known as mesoporous silica, are
also popular materials for development of drug delivery and
cell-imaging systems [69, 70]. There are few genotoxicity
studies on silica NPs but a notable one by Sayes et al. [23]
has shown that there are no significant inflammatory or
genotoxic eﬀects in mouse lungs on short-term exposure.
Metal NPs such as platinum NPs (PtNPs) and iron oxide
Fe2O3NPs are also popular alternatives. There is one report
on PtNP toxicity which showed an increase in DNA damage
concurrent with p53, p21 downregulation, and cell-cycle
arrest at the S-phase [43]. Fe and Fe2O3NPs are also
known to be toxic and can cause significant DNA damage
[36].
Other particles of note are the nanopolymers. Although
there is a wide variety of such nanopolymers, they are gener-
ally known as a family of compounds that consists of chain
units, which could be fashioned into nano-sized particles.
These are also largely being developed for use in drug delivery
[71]. Current genotoxicity studies suggest that some of these
nanopolymers show antiinflammatory properties and also
non or limited DNA damage [45, 72]. However, a recent
report has implicated long-term nanopolymer exposure to
pulmonary fibrosis and granuloma formation, resulting in
two fatal deaths [73]. This case cannot be taken in isolation
and others have raised the concern that the workplace
condition as well as health or other pre-dispositions of the
workers involved should be considered [74].
4. NMs and Carcinogenesis
While it has been shown in many in vitro experiments
that NMs are able to induce DNA damage and some
form of mutagenesis, there is still a lack of evidence for
tumorigenicity of NPs. Of note, in vivo studies involving
MWCNT has demonstrated formation of mesotheliomas
in rodents in works by Takagi and colleagues [75] and
Sakamoto et al. [76]. Wide spread deposition of MWCNTs
were observed in the peritoneal cavity where the nanotubes
were injected. In the study by Sakamoto et al., they have
even foundmesotheliomas in the peritoneal cavity away from
the original site of injection, suggesting that MWCNTs may
easily translocate and also exert eﬀects away from organ of
exposure. Both studies emphasized on the persistency, size
and shape on the carcinogenic potential of MWCNTs. While
such studies may provide some insight into the outcome of
NM toxicity, one must take into account the diﬀerences in
how the nanotubes were prepared as well as the experimental
design. Muller et al. conducted similar tests on MWCNTs
but reported no carcinogenicity after a 2 year period of
exposure [77]. They speculate that tumor formation could be
dependent on size and length of the nanotubes administered
and the p53 knockout mice used in the Takagi study
produced a more sensitive carcinogenic reaction. However,
NMs can induce oxidative stress and trigger inflammatory
responses, which could form the starting point for carcino-
genesis to occur. NMs that are highly reactive are also more
likely to absorb endogenous substances, react with proteins
and enzymes, trigger cytokine release. This would mediate
inflammatory responses and potentially initiate a series of
toxic responses far from the initial site of deposition [78, 79].
C60 fullerene, for example, was reported to cause photo-
induced DNA damage by interacting with biological reduc-
ing agents such as NADH to cleave supercoiled DNA [80].
Similarly, exposure to carbon nanotubes in atmospheric air
pollution has been associated with adverse cardiovascular
eﬀects by causing aortic DNA damage, platelet aggregation
and enhances vascular thrombosis through inflammatory
events [81].
Biopersistence of NMs pose a certain degree of adverse
health eﬀect. For instance, when the clearance rate is slower
than the accumulative rate, the NMs will remain in the lungs;
and those containing mutagenic substances will increase
the risk of developing cancer. To address this concern,
Sera et al. conducted a mutagenicity test using 3 diﬀerent
strains of Salmonella and found C60 Fullerene to exert
mutagenic activity due to the oxidized phospholipids in rat
liver microsoms [82].
There are also certain shortcomings in the current
research field. The short-term nature of toxicology tests in
the treatment period for NMs generally lasts only up to
three days, which implies that testing is limited to acute
toxicity. In vitro and in vivo genotoxicity testing will have
to be conducted for longer periods to observe if there are
long-term eﬀects of NMs such as tumour formation and
carcinogenesis. Treatment intervals will have to go beyond
days to weeks or even months in animal studies. It will also
be useful to look at the clearance of NMs from the body and
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to study if there is a preference for accumulation in certain
organs and any eﬀect from biopersistence of such NMs.
On the public front, safety measures have been imple-
mented to safeguard the public health. The International
Agency for Research on Cancer (IARC) recently classified
TiO2 as a potential Group 2B human carcinogen. This deci-
sion was made on the experimental animal carcinogenicity
data [83]. There had been four previous epidemiological
studies conducted among the male production workers at
TiO2 industry from Western Europe and North America.
After comparing the risk for lung and kidney cancer with
the general population, they concluded that these data
were not supportive enough to conclude the association
between occupational exposure of TiO2 and cancer risk.
Hence, data collected were inadequate in classifying TiO2 as
potential carcinogen. However, there was suﬃcient animal
carcinogenicity data that provided evidence of TiO2-induced
carcinogenicity. Several TiO2 exposure routes were chosen
for experimental animal studies. These include oral, inhala-
tion, intratracheal, subcutaneous injection, and intraperi-
toneal administration. Researchers observed an increase in
tumor incidence in these experimental animals upon TiO2
exposure. After considering other relevant data such as
clearance kinetics of TiO2 and micronucleus formation, a
conclusion that TiO2 possess possible carcinogenicity to
human was made.
5. Conclusion
The field of nanotoxicology, besides investigations on the
adverse eﬀects of NMs, also include continuous monitoring
and risk assessment of NMs. Despite the many nanotoxi-
cological studies that are ongoing, there are questions that
need to be answered and addressed. There is diﬃculty in
interpreting data in view of variable parameters utilized
in the study, for example, the sizes of the NMs and its
composing materials. The most critical research gap is the
lack of studies on real-time NM exposure. Moreover, there
is a need for long-term nanomaterials exposure assessment
for studies on tumourigenesis. At the industry level, close
monitoring and followup on the levels of emissions from
NM production industries are essential in protecting public
health and our environment. However, there still exists a
lack of appropriate epidemiological studies and equipment
for accurate collection of data in assessing the real risk
of NM exposure in the workplace. Despite the promising
applications of NMs, there are still doubts regarding their
safety. There is some certainty that NMs do pose a certain
degree of health risk that would require further investigation.
A proper guideline on NM usage is imperative to ensure the
safety of NMs for consumer usage and environment.
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According to the World Health Organization (WHO), cancer 
accounted for 7.9 million deaths in 2007 making it the lead-
ing cause of death in the world.  Deaths from cancer around 
the globe are expected to climb upwards with an estimated 
12 million deaths by cancer in 2030[1].  The frontiers of can-
cer research are therefore consistently challenged in order to 
advance the most effective means of cancer diagnosis, moni-
toring and treatment.  Findings gleaned from cancer research 
would inevitably benefit mankind and save countless lives.  
Current therapies employed for the treatment of cancer 
include surgery, chemotherapy and radiation therapy among 
others.  While these methods have been accepted and prac-
ticed for decades, they have their drawbacks and side effects. 
Surgical removal of tumors is restricted mainly to large, resec-
table and accessible tumors.  Chemotherapeutic drugs target 
rapidly dividing cells, and thus not only kill cancer cells, but 
also destroy normal cells like bone marrow cells and immune 
cells[2].  This gives rise to widespread “collateral damage” in 
the patient’s body.  Radiation therapy involves the use of high-
energy radiation like X-rays and gamma rays to destroy tumor 
cells, and inevitably causes deleterious effects to healthy tis-
sues along the radiation path[3].  
In light of the shortcomings of current treatment modalities 
for cancer, a critical thrust towards improving cancer therapy 
is to specifically target therapeutic agents to tumor cells while 
sparing healthy tissues from harm.  This is one of the emerging 
interests in nanotechnology research.  Nanotechnology refers 
to the manufacture of materials having nanoscale dimensions 
between 1 nm and 100 nm[4].  The small size of these nano-
materials confers their uniqueness with chemical and physical 
properties that are distinct from their bulk materials[5].  The 
rapid expansion in nanomaterial research increases the future 
prospect of novel diagnostic methods and treatment of dis-
eases that plague mankind.  This branch of nanotechnology in 
disease diagnosis, monitoring and treatment has been termed 
“nanomedicine” by the National Institutes of Health in the 
USA[4].  
Among the many nanomaterials being developed for nano-
medicine applications, this review will focus on gold nano-
particles (AuNPs) and their potential as tumor sensors, drug 
delivery agents and enhancers in plasmonic photothermal 
therapy for the eradication of cancers.  The use of AuNPs is 
gaining popularity in these areas of research for several rea-
sons.  Firstly, AuNPs are considered to be relatively biologi-
cally non-reactive and therefore suitable for in vivo applica-
tions compared to the very toxic cadmium and silver NPs[6] 
although various groups (as explained in the later sections) are 
challenging this view.  Other advantageous qualities include 
the strong optical properties of AuNPs due to localized sur-
face plasmon resonance (LSPR)[7], easily controllable surface 
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chemistry which enables versatility in adding surface func-
tional groups[8], and lastly, the ease in control over particle size 
and shape during synthesis[9].  AuNPs may be considered to 
be fully multifunctional, with the possibility of combining dif-
ferent desired functionalities in one molecular-sized package. 
All these factors contribute to the strong interest and prefer-
ence for the use of AuNPs over other NPs[10].  Examples of 
other nanomaterials for biomedical applications can be found 
in other published papers which expound on the utilization of 
quantum dots[11, 12], functionalized fullerene-based nanomateri-
als[13] and magnetic NPs[14, 15] for the diagnosis and treatment of 
human diseases.
AuNPs and cytotoxicity
As the utility of AuNPs largely depends on the degree of 
inherent toxicity, studies on the toxicological profile of these 
NPs are discussed proceeding to their usage in cancer man-
agement.  Since NPs exhibit properties which are markedly 
different from that of their much larger counterparts, their 
behaviour and effects cannot be extrapolated from informa-
tion derived from their bulk materials.  Bulk gold has gen-
erally been considered an inert metal valued for medicinal 
purposes[16] and AuNPs have been thought to be likewise.  In 
the literature, AuNPs have been reported to lack the ability to 
induce adverse and acute toxicity[17] and are thus deemed to be 
biocompatible entities for use in biomedical applications[17, 18]. 
However, recent studies have shown that there could be more 
to AuNP toxicity than already surmised and that the extent 
of toxicity response is closely associated with the size of the 
AuNPs[19, 20].  Investigations have revealed that decreasing the 
size of NPs correlated with more widespread tissue distribu-
tion, heightened potential to deeper penetration within certain 
tissues, more effective internalization by cells, and increased 
toxic effects[21].  In terms of surface functionality, studies have 
shown that modification of the AuNP surface affect its uptake, 
interactions with cellular constituents and cytotoxicity[22, 23].
In vitro studies on cytotoxicity of AuNPs
Multiple studies have shown that AuNPs exert their cytotox-
icity through the induction of oxidative stress.  For example, 
when exposed to 1.4 nm AuNPs, HeLa cervical carcinoma cells 
exhibited increased reactive oxygen species (ROS) production 
and oxidative stress, leading to protein and lipid oxidation, 
severely impaired mitochondrial function, and eventually cell 
death[23].  The same investigators showed that Z-VAD-fmk, a 
caspase inhibitor was unable to rescue the cells from dying, 
leading to the conclusion that cells were killed by necrosis. 
Furthermore, genome-wide mRNA expression analysis veri-
fied that treatment with AuNPs caused up-regulation of 
stress-related and inflammation-related genes and a concomi-
tant decrease in the expression of cell cycle genes.  It appears 
that continual production of endogenous ROS within the cell 
exhausted the intracellular antioxidant pool and therefore 
induced irreversible damage that eventually lead to necrosis.
Oxidative stress was observed in MRC-5 fetal human lung 
fibroblast cells following exposure to 20 nm AuNPs[24] with 
concomitant down-regulation of cell cycle genes such as 
Cyclin B2 and B1 and DNA damage response genes.  In a 
follow-up study, the same investigators observed the presence 
of autophagy (validated by biochemical and morphological 
parameters) concurrent with oxidative stress in the lung fibro-
blasts following uptake of AuNPs[25].  It was also demonstrated 
in the same study that AuNP treatment led to the up-regula-
tion of antioxidants and expression of stress-response genes 
and proteins, lending support to the hypothesis that oxidative 
stress could be a manifestation of AuNP cytotoxicity.  
In vivo studies on cytotoxicity of AuNPs
In a recent study, blue mussel Mytilus edulis was observed 
to experience oxidative stress within 24 h of exposure to 
AuNPs[26], indicating the possible impact of AuNPs to the eco-
system and aquatic animals.  The same investigators also pro-
posed the use of M edulis as an ideal animal model for envi-
ronmental toxicology studies of NPs.  Another in vivo study 
utilized zebrafish embryos to assess the feasibility of AuNPs as 
probes for embryonic imaging[27].  In this study, the real-time 
effects of AuNPs on zebrafish embryos were investigated, and 
results showed that owing to the random diffusion of AuNPs 
to various parts of the embryo, toxic effects influencing the 
developmental outcome of the embryo were largely stochastic 
in nature.  Among the 76% of zebrafish embryos that survived, 
only a minority (2%) of zebrafish embryos exhibited defor-
mities while the remaining 74% developed normally.  The 
authors therefore proposed that given its relatively non-toxic 
nature, AuNPs could be exploited for in vivo imaging applica-
tions for embryonic studies.
For mammals, however, there is at present limited informa-
tion regarding the in vivo toxicity of AuNPs.  Studies have 
largely focused on the biodistribution of AuNPs in the body. 
A rat model study revealed the size-dependent organ distribu-
tion of AuNPs following intravenous (iv) administration.  For 
10 nm AuNPs, the distribution was found to be widespread, 
permeating the blood and organs of the cardio-respiratory 
system, immune system (such as spleen and thymus) and 
reproductive system, liver, kidney, and brain, whereas larger 
AuNPs (50, 100, and 250 nm) were localized only to the blood, 
liver and spleen[28].  A similar study conducted using 15, 50, 
100, and 200 nm AuNPs showed that while the AuNPs with 
the largest dimension could only accumulate minimally in 
organs following iv administration into mice, AuNPs with 
the smallest dimension were detected in all tissues including 
blood and other organs such as the liver, lung, spleen, kidney, 
brain, stomach, and heart[29].  The results imply that smaller 
size AuNPs are more accessible to various tissues in the body 
and therefore the propensity to cause widespread harm, if any. 
Another group of researchers assessed the in vivo toxicity 
of 13 nm AuNPs coated with poly (ethylene) glycol (PEG) in 
mice and showed that following iv injection of AuNPs, the 
NPs accumulated in mouse liver and spleen for up to a week, 
and induced acute inflammation and apoptosis in the liver[30]. 
The same group of investigators also demonstrated that iv 
administration of 4 nm or 100 nm PEG-coated AuNPs in mice 
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induced up-regulation of common genes associated with 
apoptosis, cell cycle, inflammation, and metabolic process in 
liver tissues[31].
A major challenge in the field of investigating in vivo cyto-
toxicity of NPs is the plausibility of translating observed cel-
lular and immunological toxicity in animal models to humans, 
since there are distinct intra- and interspecies variations which 
need to be considered.  
Applications of AuNPs in cancer management 
AuNPs as sensors for probing and imaging tumor cells
AuNPs are good candidates for labelling applications because 
of their ability to interact strongly with visible light.  Upon 
exposure to light, free electrons in gold atoms are excited to a 
state of collective oscillation known as surface plasmon reso-
nance (SPR), conferring gold the ability to absorb and scatter 
visible light[32].  In labelling applications, AuNPs are targeted 
and accumulated at the site of interest and based on their 
optical scattering properties, they enable visualization of the 
region under study.  AuNPs may then be detected by any of 
the following ways: phase contrast optical microscopy, dark 
field microscopy, photothermal imaging, and photoacous-
tic imaging[33].  In addition, owing to its high atomic weight, 
AuNPs remain the preferred label for visualization and 
immuno-staining at the ultrastructural level using transmis-
sion electron microscopy[34].  
A crucial step in successful cancer therapy involves early 
diagnosis.  The strong optical scattering properties of AuNPs, 
coupled with their relative biocompatibility, make them 
suitable as probes for cancer imaging.  Through the conju-
gation of antibodies specific for antigens overexpressed on 
tumor cells, AuNPs can be directed to tumor cells, thus pin 
pointing their precise location in the body (Figure 1).  It has 
been demonstrated that antibody-conjugated hollow gold 
nanospheres can be used for the surface-enhanced Raman 
spectroscopy (SERS) imaging of tumor biomarkers which are 
overexpressed in MCF7 breast cancer cells[35].  Raman scatter-
ing is a phenomenon that results from the inelastic collision 
of photons with molecules where energy, which is either lost 
or gained, translates to a change in the frequency of the scat-
tered photons.  This unique shift of frequency depends on the 
characteristic energy of molecular vibrations constituting the 
signal, hence a Raman spectrum consisting of different signals 
from molecular vibrations forms a “vibrational fingerprint” 
of a molecule[36].  In SERS, these Raman signals are amplified 
several folds by nanostructures present in the vicinity of the 
molecules.  Gold and silver have been shown to cause signifi-
cant enhancement[37] and are thus the favoured nanostructures 
used as sensors[24].  By attaching a reporter to SERS sensors, 
targeted sensitive probing of molecules or structures within 
cells may be achieved[36].
Recent studies have demonstrated the potential use of 
AuNPs for in vivo targeted imaging of cancer using Raman 
spectroscopy.  Large optical enhancements can possibly be 
achieved in the detection of tumors in live animals owing 
to the 14–15 orders of magnitude signal amplification by 
AuNPs[38].  Following the conjugation of AuNPs with appro-
priate ligands, cancer markers such as epidermal growth factor 
receptors present on the surface of human cancer cells and in 
xenograft tumor models could be targeted for detection.  This 
shows the potential of using AuNPs for biomedical imaging 
in live subjects.  However, it is important to note that the suc-
cessful optical imaging performed in mice cannot be directly 
scaled up for in vivo imaging of human subjects because the 
optical signals possess limited tissue penetration ability[39].  At 
present, optical imaging only appears useful for tissues close 
to the skin surface or accessible by endoscopy.  Hence, addi-
tional technological improvements are needed before Raman 
scattering by AuNPs can be used in a clinical setting.  
The utility of AuNPs as novel biosensors for the detection of 
tumor cells can be demonstrated through the use of a screen-
printed carbon electrode (SPCE) coupled with a NP-based 
electrocatalytic method[40].  Using this technique, in situ tumor 
cell proliferation was detected and quantified via the reaction 
of cell surface proteins with specific antibodies conjugated to 
AuNPs.  Human tumor HMy2 cells (human leukocyte antigen 
(HLA-DR) class II positive B cells) and human tumor PC-3 
cells (HLA-DR class II negative prostrate carcinoma) were first 
grown on the surface of SPCEs, following which they were 
incubated with a commercial monoclonal antibody (mAb) spe-
cific to DR molecules conjugated to AuNPs (direct method) or 
unconjugated mAb followed by secondary antibodies conju-
gated to AuNPs (indirect method).  When hydrogen ions were 
catalytically reduced to hydrogen in the presence of AuNPs, 
the amount of AuNPs (and thus a corresponding indication of 
the quantity of attached tumor cells) could be quantified.  In 
both methods, the AuNP immunosensor was able to distin-
guish DR-positive tumor cells from DR-negative tumor cells, 
showing the efficiency of this novel biosensor in detecting spe-
cific tumor cells.  
Figure 1.  Schematic diagram showing the localization of antibody 
conjugated gold to receptors present on the plasma membrane of cells.
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AuNPs as drug delivery agents targeted to cancer cells
A prominent application of AuNPs is their use as vehicles for 
delivery of molecules into cells.  AuNPs have been described 
as “promising nanocarriers for therapeutics” owing to their 
ease of synthesis and functionalization, relative biocompatibil-
ity[41] as well as low toxicity in preliminary assays[9].  However, 
various factors need to be considered in designing an effective 
drug delivery system.  The properties of AuNPs such as their 
size, charge and surface chemistry have been shown to affect 
the uptake of AuNPs into cells as well as their subsequent 
intracellular fate.  In addition, effective drug delivery strate-
gies must take into account the nature of drug-AuNP interac-
tion (covalent/non-covalent binding) as well as the means 
of drug release following introduction of the drug-AuNP 
complexes to cells[42].  If AuNPs are used solely as carriers into 
cells, it is also critical to monitor any toxic effects of residual 
materials in the cell after delivery; a biodegradable NP vec-
tor whose lifespan is limited to the therapeutic window of the 
drug would be ideal[43].  If the NP vector is cleared from the 
system once its purpose is reached, it will reduce exposure 
and limit its toxic effects in the body.  
Another issue of concern is the penetration rate of AuNPs 
into tumors and the specificity of the target sites.  Particularly, 
the epithelial and endothelial barriers are considered to be the 
main hindrance for the NPs to overcome.  Penetration enhanc-
ers like metalloproteases against basement membranes and 
toxins against intracellular tight junctions, may be useful in 
aiding the uptake of drug-loaded AuNPs into the tumor[44]. 
Another factor to be considered is the AuNP retention in 
blood circulation.  Some researchers have found that particle 
retention is also size-dependent and longer circulation time is 
correlated to higher rate of reaching tumor target[45].  In addi-
tion, most studies have only investigated on drug delivery to 
solid tumors, where it is site specific and easier for quantifica-
tion of results.  It remains to be seen if AuNPs will be effective 
against non-solid cancers like leukemia where strategies for 
targeting and treating such cancers can be different from that 
for solid tumors.
Drug attachment and release from NPs is another challeng-
ing area.  While the ease of surface modification is what makes 
AuNP attractive for drug delivery, the strength of drug attach-
ment and timing of the release needs to be suitably controlled 
to produce the highest therapeutic efficacy.  Foremost, the 
method of release at the tumor site is dependent on how the 
drug is attached to the AuNP, whether covalently or through 
non-covalent binding.  Generally, drugs in the active form 
are loaded non-covalently while the covalent-conjugation of 
the drug to AuNP is in the pro-drug form, thereby requiring 
a second reaction to release the drug from the attachment as 
well as to activate it.  Although there have been quite a num-
ber of strategies proposed for the triggering of drug release at 
the tumor site, they can generally be narrowed down to three 
methods: light or photothermal release[46, 47], glutatione-medi-
ated[48], and non-covalent encapsulation of the active drug 
with subsequent off-loading by diffusion through the mem-
brane[9].  The others are principally a modification of one or 
a combination of these methods.  Thus far, the in vitro works 
done by Kim et al[9] have yielded promising results.  However, 
more work is required as there is still the need to assess if 
these methods are practical for application in vivo.  
Similarly in the field of cancer therapy, AuNPs are cur-
rently being explored as potential drug delivery agents for the 
introduction of drugs into tumor cells[49].  Cells are known to 
take up colloidal AuNPs of various shapes and sizes[22] either 
by specific (via ligand-receptor interaction) or non-specific 
means.  An example of AuNPs being taken up by breast 
cancer cells in vitro is shown in Figure 2.  In order to ensure 
the specific killing of cancer cells while sparing healthy cells, 
AuNPs were conjugated with appropriate surface ligands 
which directed them only to tumor cells (Figure 3).  Huang et 
al (2008) have described two methods for tumor targeting: the 
first involved conjugation of AuNPs to PEG, and the second 
involved conjugation of AuNPs with specific antibodies which 
Figure 2.  Transmission electron microscopy (TEM) of AuNP treated MCF-7 
breast cancer cells.  The cells were treated with 1 nmol/L AuNP for 72 h. 
(A) A cluster of AuNPs (indicated by an arrow) is found in the cytoplasm 
of a cell.  Bar=0.2 µm.  (B) TEM specimens were subjected for elemental 
analysis with a CM120 BioTWIN electron microscope coupled with a 
Philips EDAX Microanalysis system.  The electron dense particles in AuNP 
treated cells showed the presence of two peaks corresponding to the gold 
M shell (2.2 KeV) and L shell (9.7 KeV).  The treatment sample, registered 
a P/B ratio (ratio of the intensity of the detected element against the 
background) of 230.27 (Au L shell).  For the element to be significantly 
present in the sample, the P/B ratio value needs to be 3.0 and above.  
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bind unique biomarkers expressed on tumor cells[50].  PEG 
prevented AuNP aggregation and lengthened their retention 
time in blood.  This facilitated the preferential accumulation 
of AuNPs in tumor cells over healthy cells because of the 
elevated permeability of poorly differentiated blood vessels 
around tumors following angiogenesis (Figure 4), as well as 
the decreased clearance rate caused by the deficit of functional 
lymphatic vessels in tumors[4].  Using PEG is considered a pas-
sive targeting approach, as opposed to the active targeting of 
tumor cells through the help of specific antibodies.  Following 
cellular uptake, AuNPs are stored in endosomal/lysosomal 
vesicles.  In order to liberate these AuNPs and introduce the 
drug which has been delivered into the cell cytoplasm, the 
NPs need to be modified by the conjugation of membrane-
translocating sequence-based peptides which enable them to 
traverse monolayers[51].  
Tumor necrosis factor-alpha (TNF-α) is a potent, multi-
functional cytokine which not only plays a critical role in 
inflammation and immunity, but also exhibits anticancer 
properties[52].  However, its systemic toxicity due to their indis-
criminate actions on both normal and malignant tissues is well 
established[16].  Indeed, it was shown in one study using the 
mouse model that increasing doses of native TNF correlated 
with the severity of toxicities observed[49].  In the same study, 
it was revealed that in contrast to native TNF, TNF conjugated 
to a colloidal gold platform interspersed with thiol-derivatized 
PEG was more efficacious in reducing tumor burden in a colon 
cancer xenograft model, without causing death of the animals. 
A Phase 1 clinical trial on the PEGylated colloidal gold–TNF 
construct (CYT-6091) conducted in patients with advanced 
stage solid cancers has shown potential[53].  The CYT-6091 
complex appears to be well-tolerated in this first clinical trial 
on human subjects although fever developed in two patients, 
which was not unexpected (as evidenced by preclinical data) 
and were easily controlled.  It is unclear if the fever was due 
to a reaction to the AuNPs or the recombinant TNF (rhTNF) 
construct.  It appears that the AuNP and rhTNF construct 
produces less adverse reaction than the rhTNF alone even at 
the highest drug-AuNP concentrations in the pre-clinical find-
ings.  Dose-limiting toxic reaction of hypotension was also not 
seen in any patient under the trial although there were some 
retrafficking of leukocytes.  AuNPs were found in the tumor 
as well as in the liver biopsies but no toxic adverse effects 
were observed.  In sum, the authors concluded that the clinical 
results correlated well with the preclinical data, which bodes 
well for future translational studies for AuNPs.  However, it 
must be borne in mind that data generated with one type of 
AuNP may not be extrapolated to other kinds of AuNPs with 
a different shape, size or surface modification.
In a separate study, the effect of incorporating PEG-coated 
AuNPs with TNF-α for the targeting killing of SCK mammary 
carcinomas grown in mice combined with heat treatment has 
also been investigated[54].  While AuNPs loaded with TNF-α 
alone and heat treatment alone showed tumor growth delay, 
the most drastic effect was observed when TNF-α loaded 
AuNPs were intravenously introduced, followed by local 
heating.  This combination treatment proved effective in 
decreasing the in vivo and in vitro tumor cell survival rates, 
demonstrating the prospect of using AuNPs as drug delivery 
carriers coupled with subsequent thermal treatment for effec-
tive eradication of tumor cells.  
The effects of AuNPs conjugated with methotrexate (MTX) 
in inducing cytoxicity in vitro and anti-tumorigenic effects in 
vivo have been reported[55].  It was observed that accumulation 
of Au-MTX in tumor cells occurred more rapidly and at higher 
concentrations than those treated with free MTX.  As a result, 
enhanced cytotoxic effects were also present in several tumor 
cell lines compared with an identical dosage of free MTX. 
These results warrant further investigation as they suggest 
that the conjugation of AuNPs with a chemotherapeutic drug 
such as MTX was more efficacious than the administration of 
free MTX alone, displaying the potential of AuNPs as drug 
carriers targeting only tumor cells.  
Figure 3.  Schematic diagram showing AuNP carriers conjugated with 
anticancer drugs and ligands which are recognized by receptors on the 
surface of tumor cells. 
Figure 4.  Schematic diagram showing accumulation of ligand-targeted 
gold nanoparticles conjugated with anticancer drugs in cancer cells 
mediated via extravasation of the gold nanocarriers through gaps in the 
endothelial cells (“leaky tumor vasculature”).
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However, given the vast array of AuNPs of different shapes 
and sizes, it is still unclear which type(s) of AuNPs would be 
the most suitable for drug delivery applications[39].  It is likely 
that this variety of AuNPs will be custom made to suit the 
needs for patient treatment.  The use of AuNPs in such a man-
ner is not without its disadvantages.  There are inherent prob-
lems and potential problems to the use of NPs in the delivery 
of drugs to the target site such as size of the NP and drug 
conjugate, intratumoral pressure and differential expression of 
receptors at the tumor site.  Optimism towards the utilization 
of AuNPs as drug delivery vectors into cells should be kept in 
check as many of the complications regarding targeted drug 
delivery as well as the toxicity of NPs to cells is a concern yet 
to be fully addressed.  Therefore, the use of AuNPs prior to 
appropriate assessment of their toxic effects may reap more 
harm than benefit.  
AuNPs in plasmonic photothermal therapy
Traditionally, heat has been used in the treatment of cancer 
via the induction of hyperthermia, a condition in which cells 
are subjected to high temperatures which kill them.  While the 
sources of heat varies from microwaves, radiowaves, ultra-
sound waves to laser light in the past, such approaches to 
cancer therapy have not been widely used because of the con-
sequential damage to normal tissues surrounding the targeted 
tumor.  With the advent of nanotechnology, diverse nano-
structures have been manufactured for the purpose of photo-
thermal therapeutics.  Noble metal NPs such as AuNPs (and 
including Au nanospheres, nanorods, and nanocages) attract 
particular interest because they possess enhanced absorption 
cross-sections[50, 56].  Their strong absorbance enables effective 
laser therapy with minimal “collateral damage” to the sur-
rounding healthy tissue.  The mechanism by which AuNPs 
exert their photothermal effect is through SPR.  This leads to 
the formation of a heated electron gas which then cools rap-
idly within about 1 ps through exchanging energy with the 
NP lattice.  The NP lattice in turn heats up the surrounding 
environment through the rapid transfer of energy spanning 
only about 100 ps[57].  The speed at which energy is converted 
and dissipated to the surrounding environment presents an 
efficient means of rapidly inducing hyperthermia in the vicin-
ity of AuNPs following irradiation with light.  Irreversible cell 
damage resulting from denaturation of proteins and disrup-
tion of cell membrane will occur in the areas subjected to high 
temperatures.  
The underlying concept of using antibody-conjugated 
AuNPs hinges on the necessity of tumor cells in express-
ing characteristic biomarkers, which are otherwise absent or 
expressed in significantly lower levels in normal cells.  The 
successful detection and eradication of breast carcinoma cells 
overexpressing human epidermal growth factor receptor 2 
(HER2) through the usage of anti-HER2 immunotargeted gold 
nanoshells with subsequent irradiation by near infra-red light 
to potentiate the gold nanoshells-induced photothermal effect 
has been reported[58].  The antibody-mediated targeting of 
AuNPs to tumor cells was considered to be the more specific 
and efficient of the two approaches to tumor targeting.  It is 
apparent from here that plasmonic AuNPs exhibit vast poten-
tial in the field of photothermal cancer therapy by providing a 
means to specifically target tumor cells.  
AuNPs in radiation therapy
Numerous studies have revealed that AuNPs may have 
important applications as radiosensitizers (which are drugs 
that potentiate the effect of radiation for cancer therapy).  A 
study on mice bearing subcutaneous EMT-6 mammary carci-
nomas showed that not only were AuNPs (1.9 nm in diameter) 
non-toxic in nature and cleared from the body via the kidneys, 
they possessed the ability to enhance the effect of X-ray ther-
apy leading to a remarkable survival rate of 86% as opposed 
to 20% with X-rays alone and 0% with AuNPs alone[59].  How-
ever, it is crucial to note that while 1.9 nm AuNPs seem to 
show potential as radiation enhancing agents, a recent study 
discovered evidence for acute cytotoxicity, DNA damage and 
apoptosis mediated by oxidative stress induced by cellular 
uptake of 1.9 nm AuNPs[60].  There is a need for further under-
standing of cellular responses to AuNPs when exploring their 
potential to be used in radiation therapy to cure cancer.
The effectiveness of AuNPs as radiosensitizers seems to be 
closely related to their surface functionality.  While the above 
studies utilized uncoated AuNPs, another study showed that 
5 nm AuNPs coated with the gadolinium chelating agent 
dithiolated diethylenetriaminepentaacetic gadolinium (Au@
DTDTPA:Gd) did not exhibit radiosensitizing effect in both 
tumor cells in vitro and in vivo models (MC7-L1 tumor-bearing 
mice)[61].  Instead, a chemotherapeutic effect was observed, 
which warrants further investigation.  The authors suggest 
that the radiosensitizing properties of AuNPs could possibly 
be strongly reliant on the nature of their coating.  However, 
the discrepancy over the radiosensitizing effects of AuNPs 
may also be attributed to the different dimensions of AuNPs 
used as well as the type of tumor cells under study.  
AuNPs as antiangiogenic agents
Interestingly, AuNPs have been reported to possess antiangio-
genic property[62].  The exact mechanism of action is still not 
clearly understood but it was observed that AuNPs bind pref-
erentially to vascular permeability factor/vascular endothelial 
growth factor (VPF/VEGF)-165 and basic fibroblast growth 
factor (bFGF) primarily through the heparin-binding domain. 
This has led researchers to suggest that AuNPs are able to 
inhibit angiogenesis by preventing the downstream signaling 
effects of these mitogens on angiogenesis in cancer cells[63].
Conclusion
The field of NP research presents exciting potential for bio-
medical applications.  Together with an expanding knowledge 
base on the properties and effects of AuNPs, they are currently 
explored as potential tools for cancer therapy.  Presently, 
exploiting AuNPs as sensitive probes in the detection and 
imaging of tumors for diagnostic purposes, delivery agents 
for the specific targeting of chemotherapeutic drugs to tumor 
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cells, and enhancers in plasmonic photothermal therapy and 
radiation therapy for the eradication of tumor cells appear to 
show promise.  In nanomedicine, the ultimate aim is to utilize 
NPs efficiently for the in vivo targeted killing of tumor cells 
with no or minimal side effects.  However, even the concept of 
attaching ligands to the NPs so as to allow them to hone to the 
tumor appears logical and simple but is in fact fraught with 
difficulties.  In this light, NP research is still at its infancy since 
many factors remain to be optimized before the application of 
NPs in cancer therapy becomes a clinical reality.
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